Compounds > methadone
Page last updated: 2024-10-30

methadone and HIV Coinfection

methadone has been researched along with HIV Coinfection in 751 studies

Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.

Research Excerpts

ExcerptRelevanceReference
" This study investigates HIV, drug use, and mental health stigmas in three dimensions (social, internalized, and professional) around PWH on methadone maintenance treatment (MMT) who have common mental disorders (CMDs) including depression, anxiety, and stress-related disorders in Hanoi, Vietnam."9.51Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study. ( Chibanda, D; Filipowicz, TR; Gaynes, BN; Go, VF; Ho, HT; Landrum, KR; Le, GM; Nguyen, MX; Nong, HTT; Pence, BW; Tran, HV; Tran, TTT; Verhey, R, 2022)
"Despite the efforts to curb viral hepatitis and HIV infections through Methadone clinics, infection rates among people who use drugs are still high and the general knowledge on preventive measures is inadequate."8.02Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study. ( Bakshi, FA; Gunda, DW; Jaka, H; Kalokola, F; Kilonzo, SB; Majinge, DC; Manyiri, PM; Mtui, G; Shao, ER; Stephano, A, 2021)
"Whether HIV-positive injecting drug users (IDUs) are at higher risk of developing drug resistance mutations (DRMs) after methadone maintenance therapy (MMT) than any other HIV-positive population is unclear."7.96No Increase in HIV Drug Resistance Mutations among Injecting Drug Users on Methadone Maintenance Therapy: A Prospective Cohort Study. ( Abdullah, AS; Hu, X; Huang, C; Huang, J; Jiang, J; Lao, F; Liang, B; Liang, H; Liu, H; Luo, C; Ning, C; Yang, Q; Yang, Y; Ye, L; Zang, N; Zhang, Y, 2020)
"People on methadone treatment have increased their life expectancy, aging prematurely with comorbidities."7.91[Aging in a methadone maintenance program. A perspective from the framework of social determinants of health]. ( Gutiérrez-Cáceres, S; Pedraz-Marcos, A; Serrano-Gallardo, P, 2019)
"To assess trends and related factors in HIV and/or hepatitis C virus (HCV) antibody testing and infection among injection drug users (IDUs) newly entering methadone maintenance treatment (MMT) in Guangdong Province, China."7.85Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. ( Chen, W; Ling, L; Liu, Y; Zou, X, 2017)
"The aim of this study was to characterize the epidemiology and disease related to hepatitis C in a population attending a low-threshold methadone program."7.85Hepatitis C in a Mobile Low-Threshold Methadone Program. ( Água-Doce, I; Balsa, C; Belo, E; Coutinho, R; Lopes, P; Loureiro, R; Martins, HC; Pádua, E; Pereira, C; Silva, MJ, 2017)
"We tested an interaction between substance use and depression on HAART adherence among methadone maintenance patients."7.81The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance. ( Berg, KM; Gonzalez, JS; Newville, H, 2015)
"This study explores the trends and associated factors of HIV, hepatitis C virus (HCV) and syphilis seroconversion among Chinese methadone maintenance treatment (MMT) clients over a follow-up period of up to 7 years."7.81Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study. ( Ling, L; Zhang, L; Zou, X, 2015)
"This study investigates the prevalence and correlates of hepatitis C virus (HCV) infections among heroin dependent individuals who received methadone maintenance therapy in Taiwan."7.79High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. ( Chang, TJ; Chen, VC; Chou, JY; Gossop, M; Lee, PC; Lin, TY; Ng, MH; Shao, WC, 2013)
"This pilot study explores somatic, psychological, and urogenital menopause symptoms associated with HIV drug and sexual risk among midlife women with substance abuse histories in methadone maintenance treatment."7.79Relationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot study. ( Daneshyar, S; Kull, RM; Pennington, LE; Tuchman, E, 2013)
"To provide evidence for policy makers for human immunodeficiency virus (HIV) prevention and control, we investigated HIV, syphilis, and hepatitis C virus (HCV) infection and the availability of methadone maintenance treatment (MMT) among migrant drug users in Beijing."7.78High prevalence of HIV, syphilis and HCV, and low methadone maintenance treatment in a migrant population in Beijing. ( Cao, X; Chu, P; Jia, Z; Li, D; Li, S; Liu, Z; Lu, L; Ruan, Y; Yang, Y, 2012)
"This article describes menopause symptom attributions among 135 midlife methadone-maintained women between the ages of 40 and 55 years."7.76Menopause symptom attribution among midlife women in methadone treatment. ( Tuchman, E, 2010)
" These data show that on-site HCV treatment with pegylated interferon and ribavirin is effective in methadone-maintained patients, many of whom are active drug users, psychiatrically ill, or HIV coinfected, and that methadone maintenance treatment programs represent an opportunity to safely treat chronic hepatitis C."7.75Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. ( Arnsten, JH; Gourevitch, MN; Harris, KA; Kaswan, D; Litwin, AH; Nahvi, S; Soloway, IJ; Tenore, PL; Zamor, PJ, 2009)
"We examined the impact of methadone maintenance treatment (MMT) on risk behaviors for transmission of blood-borne diseases in polydrug users who had tested positive or negative for hepatitis C virus (HCV)."7.74Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. ( Belendiuk, KA; Epstein, DH; Preston, KL; Schmittner, J; Willner-Reid, J, 2008)
"The safety, efficacy, and tolerability of nelfinavir (NFV)-containing antiretroviral therapy were evaluated in patients coinfected with HIV and hepatitis C undergoing methadone maintenance at an urban outpatient opioid treatment program serving a minority adult population."7.73Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance. ( Brown, LS; Chu, M; Kritz, S; Madray, C, 2006)
"The prevalence of human immunodeficiency virus (HIV) infection and hepatitis B, C, and G virus infections was determined in a selected group of 40 intravenous drug addicts on methadone maintenance treatment."7.72Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor. ( Baklan, Z; Gorisek, JR; Pisec, A; Poljak, M, 2004)
"To investigate hepatitis C (HCV) and human immunodeficiency virus (HIV-1) prevalence in former opiate or heroin addicts currently in methadone maintenance treatment (MMT)."7.71Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. ( Borg, L; Ho, A; Kreek, MJ; Lin, A; Melia, D; Piccolo, P, 2002)
" We studied the associations between retention in methadone treatment and drug use behaviors and incidence of hepatitis B and C in a cohort of IDUs in the Seattle, Washington, area."7.70Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. ( Hagan, H; Murrill, CS; Thiede, H, 2000)
" This study investigates HIV, drug use, and mental health stigmas in three dimensions (social, internalized, and professional) around PWH on methadone maintenance treatment (MMT) who have common mental disorders (CMDs) including depression, anxiety, and stress-related disorders in Hanoi, Vietnam."5.51Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study. ( Chibanda, D; Filipowicz, TR; Gaynes, BN; Go, VF; Ho, HT; Landrum, KR; Le, GM; Nguyen, MX; Nong, HTT; Pence, BW; Tran, HV; Tran, TTT; Verhey, R, 2022)
"Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module."5.48Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. ( Cooper, C; Cox, J; Hamelin, AM; Harper, S; Klein, MB; McLinden, T; Moodie, EEM; Rossi, C; Rourke, SB; Walmsley, SL, 2018)
"A methadone maintenance treatment (MMT) program to curb the dual epidemics of HIV/AIDS and drug use has been administered by China since 2004."5.46Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. ( He, C; Huang, W; Lan, G; Li, C; Li, M; Li, R; Liang, N; Peng, Z; Shen, Z; Tang, X; Zhong, F, 2017)
"The diagnosis of pulmonary tuberculosis associated with Kaposi's sarcoma and immunosuppression caused by HIV was retained."5.46[TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case]. ( Cisse Diallo, VMP; Deguenonvo, LF; Dièye, A; Diop Nyafouna, SA; Diop, M; Ka, D; Lakhe, NA; Massaly, A; Mbaye, KD; Ndiaye, I; Ndour, CT; Seydi, M; Thioub, D, 2017)
"Patients with opioid use disorders on opioid agonist therapy (OAT) have lower pain tolerance compared to controls."5.42Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. ( Alford, DP; Cheng, DM; Edwards, RR; Liebschutz, JM; Lira, MC; Mao, J; Samet, JH; Tsui, JI; Winter, MR, 2015)
"Per oral methadone maintenance therapy [MMT] was introduced as part of harm reduction strategy to manage rising numbers of HIV infections caused by intravenous use of illicit drugs."5.41Side Effects of Chronic Methadone Use in Opioid Addiction: A Scoping Review on Hematological Derangements. ( Ang, WC; Anuar, A; Jamaluddin, R; Khalid, K, 2023)
"Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006."5.39High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. ( Chen, W; Ling, L; Zhang, D; Zhang, L; Zou, X, 2013)
"Hypogonadism was found in 68 % of the participants, and about 68."5.38Depression, Testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV Infection. ( Amini Lari, M; Faramarzi, H; Marzban, M; Parsa, N; Shams, M, 2012)
"Depression was assessed via clinician ratings (Clinical Global Impression Scale and Montgomery Asberg Depression Rating Scale) and self-report (Beck Depression Inventory-Short Form)."5.37Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment. ( Applebaum, A; Batchelder, A; Gonzalez, JS; Newville, H; Psaros, C; Safren, SA, 2011)
"Menopause is a natural process that occurs in women's lives as part of normal aging."5.34Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment. ( Tuchman, E, 2007)
"Methadone maintenance treatment reduces drug-related-harm."5.32[Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment]. ( Aragonés, A; Barril, J; Esteban, J; Gimeno, C; Pellín, Mde L, 2003)
"Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs."5.32Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs. ( Amofa, J; Driver, CR; Fujiwara, PI; Gourevitch, MN; Highley, E; Kaye, K; Munsiff, SS; Rubino, MA; Scholten, JN; Seewald, R; Trim, C, 2003)
" However, there are no special HCV or HIV (human immunodeficiency virus)-related intervention programs that are tailored for drug users in China; to fill this gap, the purpose of this study was to explore HCV and HIV-related knowledge among drug users in MMT (methadone maintenance treatment) sites of China and to investigate the effectiveness of HCV and HIV-related education for improving the knowledge of IDUs (injection drug users) and their awareness of infection."5.30DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China. ( Du, J; Huang, LP; Li, Z; Li, ZB; Wang, J; Zhan, GL; Zhang, JY; Zhang, L; Zhao, M, 2019)
"Methadone clinic-based directly observed antiretroviral therapy (DOT) has been shown to be more efficacious for improving adherence and suppressing human immunodeficiency virus (HIV) load than antiretroviral self-administration."5.15Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention. ( Arnsten, JH; Berg, KM; Heo, M; Li, X; Litwin, AH, 2011)
"In two trials of a small-group AIDS prevention approach, 50 methadone maintenance patients and 98 heroin abusers in outpatient detoxification were randomly assigned to experimental or comparison conditions."5.07Psychoeducational group approach: HIV risk reduction in drug users. ( Acree, M; Dumontet, R; Gibson, DR; Heitzmann, C; London, J; Morales, ES; Sorensen, JL, 1994)
" Examples of situations that characterise these special populations are: co-infection with hepatitis virus B and/or C, pregnancy, lipodystrophy, cardiovascular risk, renal failure, treatment of children and adolescents, immigrant health care, and the management of patients receiving methadone replacement therapy, among others."4.84[Utility of atazanavir in special populations]. ( Antela López, A, 2008)
" Modeling data suggest that methadone maintenance treatment (MMT) scale-up in prison with continuation after release could substantially reduce new HIV infections."4.12Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study. ( Altice, FL; Azbel, L; Cugut, S; Doltu, S; Liberman, AR; Marcus, R; O'Hara, GL; Polonsky, M, 2022)
"Despite the efforts to curb viral hepatitis and HIV infections through Methadone clinics, infection rates among people who use drugs are still high and the general knowledge on preventive measures is inadequate."4.02Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study. ( Bakshi, FA; Gunda, DW; Jaka, H; Kalokola, F; Kilonzo, SB; Majinge, DC; Manyiri, PM; Mtui, G; Shao, ER; Stephano, A, 2021)
"Whether HIV-positive injecting drug users (IDUs) are at higher risk of developing drug resistance mutations (DRMs) after methadone maintenance therapy (MMT) than any other HIV-positive population is unclear."3.96No Increase in HIV Drug Resistance Mutations among Injecting Drug Users on Methadone Maintenance Therapy: A Prospective Cohort Study. ( Abdullah, AS; Hu, X; Huang, C; Huang, J; Jiang, J; Lao, F; Liang, B; Liang, H; Liu, H; Luo, C; Ning, C; Yang, Q; Yang, Y; Ye, L; Zang, N; Zhang, Y, 2020)
"People on methadone treatment have increased their life expectancy, aging prematurely with comorbidities."3.91[Aging in a methadone maintenance program. A perspective from the framework of social determinants of health]. ( Gutiérrez-Cáceres, S; Pedraz-Marcos, A; Serrano-Gallardo, P, 2019)
"Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections among methadone maintenance treatment (MMT) participants remain high."3.88Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study. ( Chen, W; Gong, C; Ling, L; Liu, Y; Xia, Y; Xu, Y; Zou, X, 2018)
"To assess trends and related factors in HIV and/or hepatitis C virus (HCV) antibody testing and infection among injection drug users (IDUs) newly entering methadone maintenance treatment (MMT) in Guangdong Province, China."3.85Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. ( Chen, W; Ling, L; Liu, Y; Zou, X, 2017)
"The aim of this study was to characterize the epidemiology and disease related to hepatitis C in a population attending a low-threshold methadone program."3.85Hepatitis C in a Mobile Low-Threshold Methadone Program. ( Água-Doce, I; Balsa, C; Belo, E; Coutinho, R; Lopes, P; Loureiro, R; Martins, HC; Pádua, E; Pereira, C; Silva, MJ, 2017)
"We tested an interaction between substance use and depression on HAART adherence among methadone maintenance patients."3.81The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance. ( Berg, KM; Gonzalez, JS; Newville, H, 2015)
"Routinely collected data included: demographic information; drug use, sexual and criminal behaviours; status of infection with human immunodeficiency virus (HIV), hepatitis C virus (HCV) and syphilis; random urine-opiate test results; and the daily methadone dose received."3.81Who uses methadone services in China? Monitoring the world's largest methadone programme. ( Cao, X; Liu, E; Luo, W; Mi, G; Pang, L; Rou, K; Sullivan, SG; Wang, C; Wu, Z; Yin, W, 2015)
"This study explores the trends and associated factors of HIV, hepatitis C virus (HCV) and syphilis seroconversion among Chinese methadone maintenance treatment (MMT) clients over a follow-up period of up to 7 years."3.81Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study. ( Ling, L; Zhang, L; Zou, X, 2015)
"Methadone is largely used as the primary opioid substitution therapy for the treatment of heroin addiction; the objective of the study was to describe the clinical characteristics of heroin abusers admitted into a methadone maintenance program (MMP) in metropolitan Barcelona."3.80[Characteristics of heroin dependent patients admitted to a methadone treatment program]. ( Faure, E; Fuster, D; Muga, R; Muñoz, T; Rivas, I; Rubio, M; Sanvisens, A; Tor, J, 2014)
"This study investigates the prevalence and correlates of hepatitis C virus (HCV) infections among heroin dependent individuals who received methadone maintenance therapy in Taiwan."3.79High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. ( Chang, TJ; Chen, VC; Chou, JY; Gossop, M; Lee, PC; Lin, TY; Ng, MH; Shao, WC, 2013)
"This pilot study explores somatic, psychological, and urogenital menopause symptoms associated with HIV drug and sexual risk among midlife women with substance abuse histories in methadone maintenance treatment."3.79Relationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot study. ( Daneshyar, S; Kull, RM; Pennington, LE; Tuchman, E, 2013)
"1646 cases of ventricular arrhythmia or cardiac arrest and 379 cases of QTc prolongation or torsade de pointes were associated with methadone."3.79Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data. ( Bucher Bartelson, B; Dart, R; Kao, D; Katz, D; Khatri, V; Krantz, MJ; Mehler, PS, 2013)
"To provide evidence for policy makers for human immunodeficiency virus (HIV) prevention and control, we investigated HIV, syphilis, and hepatitis C virus (HCV) infection and the availability of methadone maintenance treatment (MMT) among migrant drug users in Beijing."3.78High prevalence of HIV, syphilis and HCV, and low methadone maintenance treatment in a migrant population in Beijing. ( Cao, X; Chu, P; Jia, Z; Li, D; Li, S; Liu, Z; Lu, L; Ruan, Y; Yang, Y, 2012)
" Additional factors associated with BMD decline were: postmenopausal status, lower BMI, and methadone use at the lumbar spine; postmenopausal status and hepatitis C seropositivity at the femoral neck; and postmenopausal status, age, smoking, and lower BMI at the total hip (all p<."3.77Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. ( Cohen, HW; Freeman, R; Santoro, N; Schoenbaum, EE; Sharma, A, 2011)
"This article describes menopause symptom attributions among 135 midlife methadone-maintained women between the ages of 40 and 55 years."3.76Menopause symptom attribution among midlife women in methadone treatment. ( Tuchman, E, 2010)
" These data show that on-site HCV treatment with pegylated interferon and ribavirin is effective in methadone-maintained patients, many of whom are active drug users, psychiatrically ill, or HIV coinfected, and that methadone maintenance treatment programs represent an opportunity to safely treat chronic hepatitis C."3.75Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. ( Arnsten, JH; Gourevitch, MN; Harris, KA; Kaswan, D; Litwin, AH; Nahvi, S; Soloway, IJ; Tenore, PL; Zamor, PJ, 2009)
"We examined the impact of methadone maintenance treatment (MMT) on risk behaviors for transmission of blood-borne diseases in polydrug users who had tested positive or negative for hepatitis C virus (HCV)."3.74Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. ( Belendiuk, KA; Epstein, DH; Preston, KL; Schmittner, J; Willner-Reid, J, 2008)
"The safety, efficacy, and tolerability of nelfinavir (NFV)-containing antiretroviral therapy were evaluated in patients coinfected with HIV and hepatitis C undergoing methadone maintenance at an urban outpatient opioid treatment program serving a minority adult population."3.73Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance. ( Brown, LS; Chu, M; Kritz, S; Madray, C, 2006)
" Severity of psychological distress was related to current substance-related diagnoses, benzodiazepine abuse, higher methadone dosage, risk-taking behavior and the presence of hepatitis C."3.73Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. ( Adelson, M; Bleich, A; Gelkopf, M; Melamed, Y; Weizman, T, 2006)
"The prevalence of human immunodeficiency virus (HIV) infection and hepatitis B, C, and G virus infections was determined in a selected group of 40 intravenous drug addicts on methadone maintenance treatment."3.72Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor. ( Baklan, Z; Gorisek, JR; Pisec, A; Poljak, M, 2004)
"To investigate hepatitis C (HCV) and human immunodeficiency virus (HIV-1) prevalence in former opiate or heroin addicts currently in methadone maintenance treatment (MMT)."3.71Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. ( Borg, L; Ho, A; Kreek, MJ; Lin, A; Melia, D; Piccolo, P, 2002)
"To analyse prevalence of hidden hepatitis B infection (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and tuberculosis infection in drug users (DU) in a maintenance programme with methadone (MPM)."3.71[Prevalence of chronic hidden infections in a cohort of patients in substitutive treatment with methadone]. ( Belda, J; de Estudio Protocolo-INH, G; Esteban, J; Isabel Manso, M; Llinares, R; Portilla, J; Sánchez-Payá, J, 2001)
" The descriptive analysis in heroin-assisted treatment showed a reduction in infection risk for viral hepatitis corresponding to the lower risk behaviour of patients."3.71HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. ( Blättler, R; Gutzwiller, F; Steffen, T; Zwahlen, M, 2001)
" The delay in N75 latency was strongly correlated with self-reported years of heroin abuse, but not with years of cocaine, alcohol, or other drug abuse."3.70Effects of chronic opioid dependence and HIV-1 infection on pattern shift visual evoked potentials. ( Bauer, LO, 1998)
" We studied the associations between retention in methadone treatment and drug use behaviors and incidence of hepatitis B and C in a cohort of IDUs in the Seattle, Washington, area."3.70Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. ( Hagan, H; Murrill, CS; Thiede, H, 2000)
"We examined the effect of methadone treatment, duration of Medicaid enrollment during pregnancy, and other maternal characteristics on receipt of prenatal care by 2,254 women infected with human immunodeficiency virus (HIV) delivering a singleton in New York state from 1985 through 1990."3.69Prenatal care of HIV-infected women: analysis of a large New York State cohort. ( Cocroft, J; Fanning, T; Hauck, W; Markson, L; Turner, BJ, 1995)
"This study examines the predictors of alcoholism among 201 patients from three methadone maintenance treatment programs (MMTPs) in New York City."3.68Correlates of alcohol use among methadone patients. ( el-Bassel, N; Schilling, RF; Su, KH; Turnbull, JE, 1993)
" All MOUD doses were directly observed and abstracted from dosing logs."3.11Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam. ( Bart, G; Blazes, CK; Button, D; Cook, R; Giang, LM; Khuyen, TT; King, C; Korthuis, PT; Kunkel, L; Nguyen, DB; Thuy, DT, 2022)
"To evaluate the effect of methadone maintenance treatment (MMT) combined with rilpivirine (RPV)-based regimens on drug use of HIV individuals."3.01Outcomes of Methadone Maintenance Therapy Combined with Rilpivirine/Efavirenz in Treatment-Naive HIV-Infected Patients. ( Dong, X; Hong, L; Huang, S; Lei, S; Li, H; Li, X; Xie, R; Xin, J; Yang, C; Yang, X; Zhang, B; Zhang, R, 2021)
"Doravirine is a novel nonnucleoside reverse transcriptase inhibitor indicated for the treatment of HIV type 1 infection."2.94Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone. ( Bouhajib, M; Fan, L; Iwamoto, M; Khalilieh, S; Sanchez, RI; Searle, S; Vaynshteyn, K; Yee, KL, 2020)
"Study 206216 (NCT02666001) was a Phase I, open-label study, assessing the effect of FTR 600 mg (extended-release formulation) twice daily on pharmacokinetics of MET or BUP and norBUP, in non-HIV-infected participants on stable maintenance therapy with MET (40-120 mg; n = 16) or BUP plus naloxone (8-24 mg plus 2-6 mg; n = 16); pharmacodynamic response was assessed using standard opioid rating scales."2.90Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid-dependent, human immunodeficiency virus seronegative participants. ( Ackerman, P; Chang, M; Llamoso, C; Lubin, S; Magee, M; Moore, K; Myers, E; Sevinsky, H, 2019)
"However, alcohol use disorder was significantly associated with HRBS sex subscale scores (t=2."2.84Alcohol use disorders are associated with increased HIV risk behaviors in cocaine-dependent methadone patients. ( Meredith, SE; Petry, NM; Rash, CJ, 2017)
"DOT should be considered for substance users attending methadone maintenance clinics who are at high risk of nonadherence."2.76Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance. ( Arnsten, JH; Berg, KM; Brust, JC; Heo, M; Li, X; Litwin, AH, 2011)
"Methadone maintenance treatment has been made available in China in response to the rapid spread of human immunodeficiency virus (HIV), but high rates of dropout and relapse are problematic."2.76Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. ( Chang, YJ; Du, J; Evans, E; Hser, YI; Huang, D; Jiang, H; Li, J; Peng, C; Roll, J; Stitzer, ML; Wu, F; Zhang, B; Zhang, C; Zhang, R; Zhao, M, 2011)
"Twelve-week HIV and substance abuse treatment outcomes are reported as a sub-study for those selecting BPN/NLX."2.75Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. ( Altice, FL; Chen, S; Springer, SA, 2010)
"Buprenorphine patients were also less likely than methadone patients to withdraw voluntarily from medication while in jail (3% vs."2.74Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. ( Hershberger, J; Joseph, H; Lee, JD; Magura, S; Marsch, L; Rosenblum, A; Shropshire, C, 2009)
"The aim of this study was to determine, using methadone pharmacokinetic properties, whether methadone dosage adjustments are needed on initiation of treatment with pegIFN alfa-2b for HCV in methadone-maintained HIV-positive patients."2.73Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment. ( Arnsten, JH; Berk, SI; Du, E; Gourevitch, MN; Litwin, AH; Soloway, I, 2007)
"Methadone maintenance treatment or buprenorphine therapy can be effective in reducing sex- and drug-related HIV risk behaviors among African, Caribbean, and Black people."2.72Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean, and Black people: a systematic review. ( Buzuayew, A; Kahan, M; Mohamud, H; Nelson, LE; Nguemo Djiometio, JB; Njoroge, I, 2021)
"Methadone maintenance was augmented with cognitive-behavioral therapy (CBT), contingency management (CM), both (CBT+CM), or neither."2.72Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. ( Epstein, DH; Preston, KL; Schroeder, JR; Umbricht, A, 2006)
" Individually optimized flexible dosing was used for each group, with weekly possible doses of 255-391 mg of LAAM, 56-112 mg of BUP, and 420-700 mg of METH."2.72HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. ( Bigelow, GE; Brooner, RK; Johnson, RE; Lott, DC; Strain, EC, 2006)
"Methadone-maintenance treatment clinics are strategically appealing sites for provision of directly administered antiretroviral therapy (DAART) to human immunodeficiency virus type 1 (HIV-1)-infected injection drug users (IDUs)."2.71Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. ( Hader, S; Lucas, GM; Moore, RD; Weidle, PJ, 2004)
"No methadone dosage was changed in any subject."2.71Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects. ( Bigelow, GE; Christopher, J; Fuchs, EJ; Hendrix, CW; Lou, Y; Martinez, E; Snidow, JW; Wakeford, J; Wire, MB, 2004)
" The mean area under the methadone concentration curve 0-24 h (AUC(0,24 h)) was also significantly reduced from 12341 (range 3682-34147) to 5309 (range 2430-10349) ng ml(-1) h in the presence of efavirenz, P = 0."2.70The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. ( Back, DJ; Barry, MG; Clarke, SM; Gibbons, SE; Mulcahy, FM; Reynolds, HE; Tjia, J, 2001)
"Methadone concentration was measured by a chiral plasma assay because the drug is administered as a racemic mixture of R- and S-methadone, but only the R-isomer is active."2.70Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401. ( Aberg, J; Aweeka, F; D'Amico, R; Flexner, C; Gal, J; Gerber, JG; Gulick, R; Hsu, A; Hughes, V; Mildvan, D; Rosenkranz, S; Segal, Y, 2001)
"This study examines the prevalence of psychiatric disorders in an opioid dependent population maintained on methadone."2.67Psychiatric disorders of opioid addicts entering treatment: preliminary data. ( Abbott, PJ; Walker, SR; Weller, SB, 1994)
"Most methadone treatment programs have insufficient resources to provide medical care."2.67Providing medical care to methadone clinic patients: referral vs on-site care. ( Bigelow, GE; Ginn, DH; Pabst, KM; Umbricht-Schneiter, A, 1994)
"Medication-assisted treatment for opioid use disorder with methadone or buprenorphine may ameliorate some of this risk; however, there is presently limited research in humans, including in non-HIV populations, describing changes in immune activation on these treatments which is of paramount importance for those with HIV infection."2.61The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV. ( Hileman, CO; McComsey, GA, 2019)
"Providing medications for opioid use disorder (MOUD) with methadone, buprenorphine, and extended-release naltrexone is essential to achieving optimal HIV treatment outcomes including viral suppression and retention in treatment."2.61Medications for Treatment of Opioid Use Disorder among Persons Living with HIV. ( Fanucchi, L; Korthuis, PT; Springer, SA, 2019)
"Methadone exposure was either decreased or unchanged when it was coadministered with weak to strong CYP3A inhibitors or a moderate CYP3A4 inducer."2.61Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned. ( Lakota, EA; Patel, V; Sahajwalla, CG; Volpe, DA; Xu, Y; Younis, IR, 2019)
"Intravenous drug abuse is a major risk factor for HIV-1 infection, and opioids have been shown to alter the progression and severity of HAND."2.53Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis. ( Berman, JW; Carvallo, L; Jaureguiberry-Bravo, M; Wilson, R, 2016)
"To describe potential drug-drug interactions in the area of HIV/hepatitis C virus (HCV) coinfection and injection drug use, including those between antiretrovirals (ARVs), direct-acting antivirals (DAAs), and opioid-agonist therapy, and to supply a practical approach to their management."2.52Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy. ( Christensen, S; Gillessen, A; Hanhoff, N; Meemken, L; Tseng, A, 2015)
"Methadone maintenance treatment (MMT) was implemented in China since 2004."2.48HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. ( Chow, EP; Liang, Y; Wang, Y; Wilson, DP; Zhang, L; Zhuang, X, 2012)
"Methadone maintenance treatment (MMT) has rapidly expanded in China, from 8 pilot sites to 696 clinics covering 27 provinces, during 2004-2010."2.48Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis. ( Chow, EP; Liang, Y; Wang, Y; Wilson, DP; Zhang, L; Zhuang, X, 2012)
"Etravirine (ETR) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with a potent and broad in vitro spectrum of activity against HIV-1 and viruses with NNRTI resistances, allowing sequential use of drugs of this family."2.45[Etravirine in first-line therapy]. ( Garcés, PA; Tena, EV, 2009)
"While drug abuse abated following the establishment of People's Republic of China, modernization and Westernization in the 1980s led to the reemergence of this problem."2.44Drug addiction in China. ( Lu, L; Wang, X, 2008)
"The methadone maintenance treatment (MMT) program has run for more than 20 years and the public has become more tolerant of addicts."2.44Comparison of drug abuse in Germany and China. ( Fang, YX; Lu, L; Michels, II; Zhao, D; Zhao, LY, 2007)
"Today, drug abuse is highly linked to the spread of HIV/AIDS and to drug-related crimes in China."2.44Drug abuse in China: past, present and future. ( Fang, Y; Lu, L; Wang, X, 2008)
"Methadone has significant, adverse drug-drug interactions with many antiretroviral therapeutic agents that can contribute to nonadherence and poor clinical outcomes in this high-risk population."2.43Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents. ( McCance-Katz, EF, 2005)
"Methadone maintenance treatment is associated with statistically significant reductions in injecting use and sharing of injecting equipment."2.43Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection. ( Ali, RL; Bornemann, R; Farrell, M; Gowing, LR; Sullivan, LE, 2006)
" Global access to opioid agonist therapy and HIV treatment is expanding but when concurrently used, problematic pharmacokinetic drug interactions can occur."2.43Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. ( Altice, FL; Bruce, RD; Friedland, GH; Gourevitch, MN, 2006)
"Methadone maintenance treatment (MMT) has not been officially approved by the Chinese government for widespread implementation, but some pilot studies are currently underway."2.43Opiate addiction in China: current situation and treatments. ( Cubells, JF; Tang, YL; Zhao, C; Zhao, D, 2006)
"Methadone maintenance treatment for heroin (diamorphine) addiction has been extensively researched."2.41A risk-benefit analysis of methadone maintenance treatment. ( Bell, J; Zador, D, 2000)
"Methadone has been used for substitution in the US."2.38[Drug abuse, pregnancy and HIV infection]. ( Beck, L; Bender, HG; Halberstadt, E; Hartmann, L; Jahn, K, 1991)
"Medications for opioid use disorder (MOUD) are associated with positive health outcomes."1.91Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study. ( Kidorf, M; Knight, D; Latkin, C; Nkya, IH; Saleem, HT; West, NS; Yang, C, 2023)
"For those on medication to treat opioid use disorder (MOUD), incarceration in either setting may disrupt treatment."1.72Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam. ( Bart, G; Cook, R; Giang, LM; Hoffman, K; King, C; Korthuis, PT; Waddell, EN, 2022)
"Persons with HIV (PWH) and opioid use disorder (OUD) can have poor health outcomes."1.72Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. ( Bryant, K; Edelman, EJ; Fiellin, DA; Gordon, AJ; Justice, A; Kennedy, AJ; Korthuis, PT; Kraemer, KL; McGinnis, KA; Merlin, JS; Oldfield, B; Skanderson, M; Williams, EC; Wyse, J, 2022)
"Methadone treatment of opioid use disorder in HIV-infected individuals is complicated by drug-drug interactions."1.62Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study. ( Bart, G; Brundage, RC; Giang, LM; Hodges, JS; Yen, H, 2021)
"Methadone maintenance treatment (MMT) has been scaled up significantly in recent years."1.51Polysubstance Use among Patients Enrolling in Methadone Maintenance Treatment Program in a Vietnam Province with Drug-Driven HIV Epidemic. ( Ho, CSH; Ho, RCM; Hoang, CL; Latkin, CA; Le, TA; Nguyen, CT; Pham, DTT; Quek, TTC; Tran, BX; Tran, NHT; Tran, TH; Tran, TT; Vu, GT; Vuong, QH, 2019)
" Data collected included demographic data, laboratory tests, antiretroviral treatment history, methadone dosing and drug abstinence."1.51Risk factors for kidney disease among HIV-1 positive persons in the methadone program. ( Firląg-Burkacka, E; Grycner, E; Horban, A; Kowalska, JD; Matłosz, B; Pietraszkiewicz, E, 2019)
"Methadone maintenance treatment (MMT) programs have been used worldwide to reduce the number of drug users and for HIV prevention; however, evidence of their effectiveness in mountainous areas is limited."1.51Changes in Substance Abuse and HIV Risk Behaviors over 12-Month Methadone Maintenance Treatment among Vietnamese Patients in Mountainous Provinces. ( Dam, NV; Do, HN; Doan, LP; Fleming, M; Ho, CS; Ho, MT; Ho, RC; Latkin, C; Nguyen, TMT; Tran, BX; Vu, GT; Vuong, QH; Vuong, TT, 2019)
"Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module."1.48Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. ( Cooper, C; Cox, J; Hamelin, AM; Harper, S; Klein, MB; McLinden, T; Moodie, EEM; Rossi, C; Rourke, SB; Walmsley, SL, 2018)
"Methadone Maintenance Treatment (MMT) program has been considered a medium through which human immunodeficiency virus (HIV) risks assessment and prevention on drug use/HIV-infected population can be effectively conducted."1.48Methadone Maintenance Treatment Reduces the Vulnerability of Drug Users on HIV/AIDS in Vietnamese Remote Settings: Assessing the Changes in HIV Knowledge, Perceived Risk, and Testing Uptake after a 12-Month Follow-Up. ( Dam, VN; Do, HN; Do, HP; Doan, PL; Fleming, M; Ho, CS; Ho, MT; Ho, RC; Hoang, VH; Latkin, CA; Le, HT; Le, XTT; Nguyen, ALT; Nguyen, HH; Nguyen, HLT; Nguyen, LT; Nguyen, TH; Nguyen, TMT; Nguyen, V; Pham, MD; Tran, BX; Vuong, QH; Vuong, TT, 2018)
" The results confirm the importance of adequate OAT dosing (≥60mg of methadone, ≥8mg of buprenorphine)."1.46Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic. ( Altice, FL; Chernova, O; Dumchev, K; Dvoryak, S; Morozova, O, 2017)
"The methadone maintenance treatment (MMT) has been initiated in Wuhan, China since early 2006."1.46Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China. ( Dong, QL; Liu, C; Liu, PL; Luo, L; Wang, X; Xu, J; Zhou, W, 2017)
"A methadone maintenance treatment (MMT) program to curb the dual epidemics of HIV/AIDS and drug use has been administered by China since 2004."1.46Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. ( He, C; Huang, W; Lan, G; Li, C; Li, M; Li, R; Liang, N; Peng, Z; Shen, Z; Tang, X; Zhong, F, 2017)
"The diagnosis of pulmonary tuberculosis associated with Kaposi's sarcoma and immunosuppression caused by HIV was retained."1.46[TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case]. ( Cisse Diallo, VMP; Deguenonvo, LF; Dièye, A; Diop Nyafouna, SA; Diop, M; Ka, D; Lakhe, NA; Massaly, A; Mbaye, KD; Ndiaye, I; Ndour, CT; Seydi, M; Thioub, D, 2017)
" Consistent safe injection, however, was inversely associated with age (aOR=0."1.46Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. ( Altice, FL; Copenhaver, M; Huedo-Medina, TB; Karki, P; Madden, L; Meyer, JP; Shrestha, R, 2017)
"No significant change in substance use or methadone adherence was demonstrated in the 19 recruited participants."1.43Effect of integrating HIV and addiction care for non-engaging HIV-infected opiate-dependent patients. ( Bergin, C; Keating, S; Keenan, E; Kinahan, JC; Lyons, F; Mulcahy, F; Surah, S, 2016)
"Other salient factors include polysubstance use, depression, social support, recent incarceration, relationship characteristics, and HIV status."1.43Types and Characteristics of Childhood Sexual Abuse: How Do They Matter in HIV Sexual Risk Behaviors Among Women in Methadone Treatment in New York City? ( Engstrom, M; Gilbert, L; Winham, K, 2016)
"Facilities offering inpatient substance abuse care were more than six times as likely to offer HIV testing but not more likely to offer any other type of HIV service."1.43Characteristics of U.S. Substance Abuse Treatment Facilities Offering HIV Services: Results From a National Survey. ( Cohn, A; Ehlke, S; Elmasry, H; Niaura, R; Stanton, C, 2016)
"Methadone maintenance treatment (MMT) reduces HIV risk behaviors and improves access to HIV-related services among drug users."1.43Methadone Maintenance Treatment Promotes Referral and Uptake of HIV Testing and Counselling Services amongst Drug Users and Their Partners. ( Latkin, CA; Nguyen, CT; Nguyen, LH; Nguyen, LP; Phan, HT; Tran, BX, 2016)
" This case highlights that patients whose goal is not abstinence can be successfully treated for acute medical illnesses and comorbid substance use disorders using harm reduction approaches, including appropriate dosing of pharmacotherapy."1.43Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV. ( Ahamad, K; Fairgrieve, C; Joe, R; Voon, P, 2016)
"5, 1, 2, and 24 hours after dosing in subjects with confirmed cocaine use and abstinence."1.42The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection. ( DInh, AT; Fiellin, DA; Fiellin, LE; Lruie, BS; McCance-Katz, EF; Moody, DE; Tetrault, JM, 2015)
"While opioid dependence is a complex health condition, the treatment of HIV-infected individuals with opioid dependence presents additional challenges."1.42HIV-gp120 and physical dependence to buprenorphine. ( Abood, ME; Benamar, K; Palma, J, 2015)
" The interaction of ART and dosage of methadone were connected to the episodes of relapsing and the ART optimism would result in inconsistent condom use."1.42[Impact of antiretroviral therapy on drug-using and high risk sexual behaviors among HIV-positive methadone maintenance treatment clients: a qualitative study]. ( Cao, X; Duan, S; Jin, Y; Luo, W; Qian, X; Rou, K; Tang, R; Wang, C; Willa, D; Wu, Z; Zhang, B; Zhao, Y, 2015)
" Adequate methadone dosing is important in retaining clients to maximize HIV treatment benefits and allow for successful linkage to services."1.42Implementation and Operational Research: Linkage to Care Among Methadone Clients Living With HIV in Dar es Salaam, Tanzania. ( Bruce, RD; Lambdin, BH; Masao, F; Mbwambo, J; Sabuni, N; Tran, OC; Ubuguyu, O, 2015)
"Patients with opioid use disorders on opioid agonist therapy (OAT) have lower pain tolerance compared to controls."1.42Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. ( Alford, DP; Cheng, DM; Edwards, RR; Liebschutz, JM; Lira, MC; Mao, J; Samet, JH; Tsui, JI; Winter, MR, 2015)
"Methadone maintenance was well accepted by HIV+ and HIV- opioid dependent individuals and has the potential for significant public health impact if made more widely available with sustained access and support."1.40Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response. ( Booth, R; Chhatre, S; Chychula, N; Dvoriak, S; Karachevsky, A; Metzger, D; Pecoraro, A; Schumacher, J; Woody, G, 2014)
"Methadone dose was not associated with continued drug use while in treatment."1.40Continued drug use during methadone treatment in China: a retrospective analysis of 19,026 service users. ( Cao, X; Detels, R; Liu, E; Sullivan, SG; Wu, Z, 2014)
"Methadone maintenance treatment (MMT) is a key risk reduction measure for controlling HIV transmission among drug users."1.40Situation-specific factors predicting nonadherence to methadone maintenance treatment: a cross-sectional study using the case-crossover design in Guangzhou, China. ( Chen, L; Gu, J; Hao, C; Hao, Y; Lau, JT; Wang, Z; Xu, H, 2014)
" Future implementation strategies should focus on higher doses and flexible dosing strategies to optimize program retention and strengthened efforts for clients at higher risk of attrition."1.40Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. ( Bruce, RD; Chang, O; Kaduri, P; Lambdin, BH; Magimba, A; Masao, F; Mbwambo, J; Sabuni, N, 2014)
"Amid the global transition to treat opioid addiction as an illness, many people who inject drugs (PWID) face heterogeneous legal environments that include both punitive and harm reduction measures."1.40"In their perception we are addicts": social vulnerabilities and sources of support for men released from drug treatment centers in Vietnam. ( Binh, NT; Celentano, DD; Dat, do T; Go, VF; Huong, NM; Quan, VM; Tomori, C; Tuan, le N; Zelaya, CE, 2014)
"Methadone treatment was introduced in Taiwan in 2006 as a harm-reduction program for injection drug users (IDUs), among whom HIV was endemic."1.40Prevalence and factors associated with HIV infection among injection drug users at methadone clinics in Taipei, Taiwan. ( Chou, P; Deng, CY; Jiang, XR; Li, LH; Lin, T; Yen, MY; Yen, YF, 2014)
" Questionnaire was developed to collect information on demographic characters, behaviours on drug use, sexual behaviour, daily dosage of methadone intake, adherence to MMT, and psychological problems."1.40[A case-control study on the causes of new HIV infection among heroin addicts attendees at the methadone maintenance treatment clinics]. ( Cao, X; He, L; Luo, W; Pang, L; Rou, K; Wang, C; Wu, Z; Zhang, H, 2014)
"Thirty HIV-negative substance users were individually matched to 30 HIV-positive substance users on relevant medical and demographic factors, including reading level and methadone therapy status."1.39Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study. ( Byrd, DA; Elliott, K; Lighty, Q; Mindt, MR; Mintz, L; Morgello, S; Robinson-Papp, J, 2013)
"Prison-based MMT programmes can be effectively implemented but require adequate dosing and measures are needed to improve communication between prison and police authorities, prevent police harassment of MMT clients after their release, and improve systems for tracking release dates."1.39Implementing methadone maintenance treatment in prisons in Malaysia. ( Altice, FL; Kamarulzaman, A; Marcus, R; Wickersham, JA; Zahari, MM, 2013)
"Methadone maintenance treatment (MMT) was first introduced in Nepal in 1994."1.39The trajectory of methadone maintenance treatment in Nepal. ( Ambekar, A; Kishore, K; Kumar, S; Pun, A; Rao, R, 2013)
"Optimal methadone dosage and service profile is challenging in treatment of opioid dependence."1.39Higher methadone doses are associated with lower mortality in patients of opioid dependence in Taiwan. ( Chen, CH; Chen, PC; Cheng, JJ; Hsieh, CJ; Huang, YF; Liao, DL; Shih, WY, 2013)
"Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006."1.39High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. ( Chen, W; Ling, L; Zhang, D; Zhang, L; Zou, X, 2013)
"The correlation was -0."1.39The dual pathway of professional attitude among health care workers serving HIV/AIDS patients and drug users. ( Chen, CL; Deng, FL; Huang, TM; Huang, YH; Lin, SR; See, LC; Shen, YM, 2013)
"Methadone maintenance treatment (MMT) is efficacious in reducing drug use that may improve HIV/AIDS care and treatment outcomes."1.38Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. ( Do, NT; Duong, AT; Houston, S; Jacobs, P; Mills, S; Nguyen, LT; Ohinmaa, A; Tran, BX, 2012)
"The Methadone Maintenance Treatment Outcome Study was an 18-month prospective study from March 2007 to July 2008."1.38Self-efficacy and HIV risk behaviors among heroin users in Taiwan. ( Chung, KS; Hsu, ST; Ko, NY; Wang, PW; Wu, HC; Yeh, YC; Yen, CF; Yen, CN, 2012)
"Hypogonadism was found in 68 % of the participants, and about 68."1.38Depression, Testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV Infection. ( Amini Lari, M; Faramarzi, H; Marzban, M; Parsa, N; Shams, M, 2012)
"Methadone treatment is seen by some as in competition with their main task of coordinating conventional drug treatment in the rehabilitation center."1.38Harm reduction and "clean" community: can Viet Nam have both? ( Bui, TH; Crofts, N; Jardine, M; Khuat, TH; Moore, T; Nguyen, VA, 2012)
"In addition to treatment for opioid dependence, addressing other substance use, social issues, particularly housing, and mental health may have important implications for reducing HIV transmission in HIV-infected opioid-dependent patients."1.37Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care. ( Botsko, M; Chaudhry, AA; Egan, JE; Estrada, B; Fiellin, DA; Flanigan, TP; Lucas, GM; Mitty, J; Weiss, L; Woodson, T, 2011)
" Harm reduction intensity (HR) was measured by combining injecting drug use, methadone dosage and needle exchange, in different levels of participation, ranging from no/incomplete HR, complete HR to low or no dependence on HR."1.37Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam. ( Coutinho, RA; Lambers, FA; Prins, M; Stolte, IG; van den Berg, CH, 2011)
"Depression was assessed via clinician ratings (Clinical Global Impression Scale and Montgomery Asberg Depression Rating Scale) and self-report (Beck Depression Inventory-Short Form)."1.37Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment. ( Applebaum, A; Batchelder, A; Gonzalez, JS; Newville, H; Psaros, C; Safren, SA, 2011)
"To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the effect on antiretroviral therapy (ART) tolerability and efficacy in HIV-infected individuals according to age, ≥ 50 years or <50 years."1.37Ageing with HIV: medication use and risk for potential drug-drug interactions. ( Back, D; Battegay, M; Bernasconi, E; Calmy, A; Cavassini, M; Elzi, L; Furrer, H; Khoo, S; Marzolini, C; Vernazza, P; Weber, R, 2011)
"outpatient substance abuse treatment (OSAT) facilities provide HIV counseling and testing (C&T) to clients between 1995 and 2005."1.36HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005. ( D'Aunno, T; Pollack, HA, 2010)
"Potential drug-drug interactions (PDDIs) might expand with new combination antiretroviral therapies (ART) and polypharmacy related to increasing age and comorbidities."1.36Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. ( Back, D; Battegay, M; Bernasconi, E; Calmy, A; Cavassini, M; Chave, JP; Elzi, L; Furrer, H; Fux, C; Gibbons, S; Khoo, S; Ledergerber, B; Marzolini, C; Vernazza, P; Weber, R, 2010)
"China has been scaling up its national AIDS programs since 2004."1.36Quantitatively monitoring AIDS policy implementation in China. ( Liu, Y; Mao, Y; Rou, K; Wang, L; Wu, Z; Zhang, F, 2010)
"Integration of separate HIV/AIDS data systems was carried out in three phases."1.36Development of a unified web-based national HIV/AIDS information system in China. ( Ma, W; Ma, Y; Mao, Y; Poundstone, K; Qin, Q; Wang, C; Wu, Z, 2010)
" Use of these illicit substances have other consequences like compromising the dosing schedule or adherence / poor compliance to ARTs/ARVs among those enrolled."1.36Methadone maintenance therapy as evidence based drug abuse planning in developed countries: can developing countries afford and learn from this experience? ( Nsimba, SE, 2010)
"Methadone maintenance treatment (MMT) has been shown to dramatically reduce illicit opioid use and criminal activity among injection drug users (IDU)."1.35Effect of methadone treatment on incarceration rates among injection drug users. ( Kerr, T; Li, K; Marsh, D; Montaner, J; Werb, D; Wood, E, 2008)
"We describe 2 cases of symptomatic ventricular tachycardia associated with prolonged QT interval."1.35Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports. ( Gallagher, DP; Kieran, J; Lambert, J; Mahon, N; Mallon, PW; Sheehan, G, 2008)
"Methadone clinics were used as the channel for accessing drug users in Hong Kong."1.35Multilevel analysis of HIV related risk behaviors among heroin users in a low prevalence community. ( Goggins, W; Lee, SS; Li, H, 2009)
"Methadone maintenance treatment (MMT) was first piloted in April 2004 in Yunnan, China, to reduce HIV transmission."1.35Societal perception and support for methadone maintenance treatment in a Chinese province with high HIV prevalence. ( Cheng, W; Dai, F; Li, H; Li, J; Qi, G; Ren, Z; Yang, L; Zhang, W; Zhang, Y, 2008)
"Expanded treatment for heroin dependence appears to have the greatest potential for improved care."1.35Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. ( Guillemi, S; Hogg, RS; Kerr, T; Montaner, JS; Palepu, A; Wood, E; Zhang, R, 2008)
"Methadone adherence was calculated as the fraction of days methadone was administered."1.34The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. ( Conway, B; DeVlaming, S; Duncan, F; Grebely, J; Khara, M; McLean, M; Mead, A; Petkau, AJ; Raffa, JD; Tossonian, H; Viljoen, M; Wong, T, 2007)
"Methadone maintenance treatment programs (MMTP) often provide onsite primary care."1.34Primary care affiliations of adults in a methadone program with onsite care. ( Arnsten, JH; Federman, AD, 2007)
" Noncompartmental pharmacokinetic analysis was performed."1.34Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily. ( Arroyo, E; Climent-Grana, E; Merino, E; Pérez-Ruixo, JJ; Portilla, J; Valenzuela, B, 2007)
"Self-medication for withdrawal symptoms is one plausible hypothesis."1.34Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users. ( Galai, N; Gern, R; Kirk, GD; Mehta, SH; O'Driscoll, P; Ompad, DC; Vlahov, D, 2007)
"Drug addiction is a complex problem which leads to many somatic, psychic and social diseases."1.34Serum magnesium concentration in drug-addicted patients. ( Brodowska, A; Brodowski, J; Chlubek, D; Karakiewicz, B; Kozielec, T; Laszczyńska, M; Noceń, I; Starczewski, A, 2007)
"Supervised dosing is a cornerstone of tuberculosis treatment."1.34Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. ( Hader, S; Lucas, GM; McCaul, ME; Moore, RD; Mullen, BA; Weidle, PJ, 2007)
"Menopause is a natural process that occurs in women's lives as part of normal aging."1.34Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment. ( Tuchman, E, 2007)
"Eight HIV seroconversions were found among 1153 clients during 12 months."1.34Effectiveness of first eight methadone maintenance treatment clinics in China. ( Hao, Y; Li, J; Luo, W; Mi, G; Pang, L; Rou, K; Wang, C; Wu, Z, 2007)
"We examined the association of substance abuse treatment services on hospitalization among participants in the HIV-Alcohol Longitudinal Cohort (HIV-ALC) study of HIV-infected individuals with a history of alcohol problems."1.33Substance abuse treatment and hospitalization among a cohort of HIV-infected individuals with alcohol problems. ( Horton, NJ; Meli, S; Palepu, A; Samet, JH; Tibbetts, N, 2005)
"To determine if atazanavir, a once-daily protease inhibitor and moderate inhibitor of P450 CYP3A4, exhibited pharmacokinetic interactions with (R)-methadone."1.33Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction. ( Agarwala, S; Andrews, L; Child, M; Daley, L; Friedland, G; O'Mara, E; Schreibman, T; Shi, J; Wang, Y, 2005)
"Methadone maintenance treatment of opiate addiction is highly effective at reducing drug use, drug-related criminal activity, and risk of HIV transmission."1.33Linkage with methadone treatment upon release from incarceration: a promising opportunity. ( Clarke, J; Key, RG; McKenzie, M; Poshkus, M; Rich, JD; Shield, DC; Wolf, FA, 2005)
"Methadone is a synthetic opiate used in the treatment of opiate addiction."1.33Dental management of patients taking methadone. ( Graham, CH; Meechan, JG, 2005)
"In a specialized heroin addiction treatment setting, patient compliance isjust as good as in other risk groups."1.33[HIV and drug users: current trends]. ( Golz, JH, 2005)
"Methadone treatment was also independently associated with reduced lumbar spine BMD."1.33HIV infection and bone mineral density in middle-aged women. ( Arnsten, JH; Floris-Moore, M; Freeman, R; Howard, AA; Santoro, N; Schoenbaum, EE, 2006)
"We examined the association of substance abuse treatment with access to liver specialty care among 231 persons coinfected with HIV and hepatitis C virus (HCV) with a history of alcohol problems who were recruited and followed up in the HIV-Longitudinal Interrelationships of Viruses and Ethanol cohort study from 2001 to 2004."1.33Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problems. ( Alperen, J; Cheng, DM; Kim, T; Nunes, D; Palepu, A; Saitz, R; Samet, JH; Vidaver, J, 2006)
"Methadone maintenance treatment reduces drug-related-harm."1.32[Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment]. ( Aragonés, A; Barril, J; Esteban, J; Gimeno, C; Pellín, Mde L, 2003)
"Lopinavir is a potent inducer of methadone metabolism, and treatment with L/R requires clinical monitoring and increased methadone doses in some patients, whereas ritonavir has no significant effect on methadone metabolism."1.32The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. ( Friedland, G; Jatlow, P; McCance-Katz, EF; Rainey, PM, 2003)
" To have any understanding of drug-drug interactions in HIV treatment we need to appreciate the importance of key pharmacological areas including: 1) how each drug in a regimen is eliminated; 2) the potential for a drug to either induce or inhibit metabolic enzymes and/or transporters; 3) the therapeutic index of each drug."1.32Pharmacokinetic drug interactions with nevirapine. ( Back, D; Gibbons, S; Khoo, S, 2003)
"Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs."1.32Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs. ( Amofa, J; Driver, CR; Fujiwara, PI; Gourevitch, MN; Highley, E; Kaye, K; Munsiff, SS; Rubino, MA; Scholten, JN; Seewald, R; Trim, C, 2003)
" Methadone dosage and frequency of methadone programme attendance in themselves were not significantly related to cessation of injecting."1.31Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. ( Coutinho, RA; Langendam, MW; van Ameijden, EJ; van Brussel, GH, 2000)
"Methadone treatment reduced the measured areas under the time-concentration curve (AUC0-6) by 63% for ddI (p =."1.31Interaction of methadone with didanosine and stavudine. ( Andrews, L; Charles, C; Friedland, G; Jatlow, P; McCance-Katz, EF; Mitchell, SM; Rainey, PM, 2000)
"Methadone treatment had a beneficial effect on HIV risk behaviors, and though some risk behaviors improved signiticantly for both groups, comorbid subjects continued to have higher rates of HIV risk factors than noncomorbid subjects."1.31Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment. ( Brooner, RK; Kidorf, MS; King, VL; Stoller, KB, 2000)
"Each methadone user was matched with a control methadone non-user that had a similar CD4+ at the beginning of the study."1.31Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection. ( Ashar, N; Mathews, C; Quang-Cantagrel, ND; Wallace, MS, 2001)
"Among 385 IDUs seen twice, the HIV seroconversion rate was 0."1.30Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. ( Hahn, JA; Moss, AR; Vranizan, KM, 1997)
"A significant percentage of IDUs have antisocial personality disorder (APD)."1.30Validity of three measures of antisociality in predicting HIV risk behaviors in methadone-maintenance patients. ( Alterman, A; Cacciola, JS; McKay, JR; Metzger, D; Rutherford, M; Tourian, K, 1997)
"Providing health services to drug abuse treatment clients improves their outcomes."1.30On-site primary care and mental health services in outpatient drug abuse treatment units. ( Alexander, JA; D'Aunno, TA; Friedmann, PD; Jin, L, 1999)
"Methadone has two roles in human immunodeficiency viral infection: pain management and treatment of opioid abuse."1.30Methadone withdrawal when starting an antiretroviral regimen including nevirapine. ( Heelon, MW; Meade, LB, 1999)
"In the national Drug Abuse Treatment Outcome Studies (DATOS), many clients in outpatient methadone treatment (OMT) and outpatient drug-free (ODF) modalities were admitted with multiple sex and needle-risk behaviors, but they reduced these risks significantly during treatment."1.30HIV risk reduction in outpatient drug abuse treatment: individual and geographic differences. ( Broome, KM; Joe, GW; Simpson, DD, 1999)
"6, compared with no change] and increase in methadone dosage (RR, 0."1.30Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. ( Coutinho, RA; Langendam, MW; van Ameijden, EJ; van Brussel, GH, 1999)
"A study of patients taking ritonavir and methadone indicates that ritonavir lowers bioavailability of methadone by 30 to 40 percent."1.30Ritonavir (Norvir) and methadone. ( , 1998)
"Methadone is an effective treatment for heroin addiction; however, insufficient information is available on its interactions with HAART."1.30Methadone and antiretroviral medications, part I. ( Friedland, GH; Gourevitch, MN, 1999)
"Several sessions at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) described interactions, toxicities, and dosing options of new anti-HIV drugs."1.30New anti-HIV drug interactions, toxicities, and dosing options. ( Bartnof, HS, 1999)
" Until the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), there was little information available on how common drugs interact with anti-HIV treatments."1.30Drug interactions studied at ICAAC. ( Gaylord, G, 1999)
"However, intravenous drug abusers (IVDAs) remain at higher risk for exposure to HIV-1 because they are likelier to have sexual contact with other IVDAs and former IVDAs."1.29Condom use rates for specific sexual behaviors among opioid abusers entering treatment. ( Bigelow, GE; Brooner, RK; Felch, LJ; Gazaway, PM; King, VL; Schmidt, CW, 1994)
" It is concluded that the reduction of HIV transmission could be enhanced by improvements in methadone programs, particularly ensuring adequate dosing and high retention rates."1.29Injecting behaviour and risky needle use amongst methadone maintenance clients. ( Ali, RL; Cormack, S; Dyer, KR; Gaughwin, MD; White, JM, 1994)
"Methadone maintenance treatment was introduced in Austria in 1987."1.29[Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province]. ( Rittmannsberger, H; Ruschak, M; Silberbauer, C, 1994)
"47 had experienced the AIDS-related deaths of 1 or more family members and 16 of those married were HIV-seropositive."1.29HIV infection and the meaning of condoms. ( Pivnick, A, 1993)
" As a basis for designing a questionnaire aimed at the IDU population, we conducted 5 focus groups to collect information on knowledge of and attitudes toward safe sex as held by male and female IDUs in methadone treatment."1.29Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach. ( Quirinale, J; Weiss, SH; Weston, CB, 1993)
"Methadone treatment and medical cover within the GMS Scheme emerged as important influences on the behaviour of clients with respect to general practitioners."1.29The use of primary care services by drug users attending a HIV prevention unit. ( Bury, G; O'Kelly, F; Pomeroy, L, 1993)
"Subjects were 281 intravenous drug abusers, 146 enrolled in outpatient methadone treatment (Treatment group) and 135 not in treatment (Community group)."1.29Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. ( Bigelow, GE; Brooner, RK; Greenfield, L, 1995)
"The implications of study findings for AIDS prevention programming are discussed."1.29Psychological dysfunction and HIV/AIDS risk behavior. ( Brown, BS; Camacho, LM; Simpson, DD, 1996)
"To study the incidence of AIDS-defining and non-AIDS-defining malignancies in injecting drug users with and without HIV infection in a methadone maintenance treatment program (MMTP)."1.28Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985-1991. ( Budner, NS; Gachupin-Garcia, A; Selwyn, PA, 1992)
" Serum and urine ZDV and ZDV-glucuronide concentrations were measured by both high pressure liquid chromatography (HPLC) and radioimmunoassay (RIA), and pharmacokinetic parameters determined at least twice in each of nine methadone-maintained former IVDU patients initiating ZDV therapy."1.28Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection. ( Brechbühl, AB; Friedland, GH; Kahl, P; Miller, MA; Schwartz, EL; Selwyn, PA, 1992)
"To assess trends in HIV infection and AIDS risk behaviors among intravenous drug users (IVDUs), a series of nonblinded point-prevalence surveys was conducted with admissions to methadone treatment in seven areas, including New York City; Trenton and Asbury Park, New Jersey; Baltimore; Chicago; San Antonio, Texas; and Los Angeles County between February and December 1987 (n = 713), January and June 1988 (n = 1,089), July and December 1988 (n = 932), and January and June 1989 (n = 1,110)."1.28HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities. ( Amsel, Z; Battjes, RJ; Pickens, RW, 1991)
"Methadone treatment offers a first step toward social rehabilitation for drug addicts who have been living as criminals on the fringe of society."1.28[Stabilizing the social and health status of drug dependent patients with methadone. Long-term maintainance therapy--Vienna results]. ( Hollerer, E; Loimer, N; Pfersmann, V; Presslich, O; Schmid-Siegel, B; Werner, E, 1991)
"Methadone treatment and the use of needle exchanges were related in subsequent analysis to the sharing of injecting equipment."1.28The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges. ( Faugier, J; Hayes, C; Klee, H; Morris, J, 1991)
"Relapses were even more frequent than among active abusers, especially if the drug-free period before admission had been shorter than 1 year."1.28A prospective assessment of opiate addiction treatment protocols for inpatients with HIV-related syndromes. ( Di Giannantonio, M; Persico, AM; Tempesta, E, 1991)
"HIV-positive former drug abusers show a tendency to relapse to drug abuse."1.28[Experiences from two HIV prevention projects among drug abusers in Oslo. Is methadone maintenance treatment useful?]. ( Skogstad, M, 1990)
" In very few patients the permanent success of the treatment was at high risk due to unsatisfactory social care, lack of social security measures, progression of the underlying disease, a too low methadone dosage level, and partnership conflicts."1.28[Medical and psychosocial effects of methadone substitution in HIV infected substance-dependent patients]. ( Baumgart, P; Dorst, KG; Kupfer, U; von Eiff, M; Walger, P; Wilke, G, 1989)

Research

Studies (751)

TimeframeStudies, this research(%)All Research%
pre-19908 (1.07)18.7374
1990's175 (23.30)18.2507
2000's226 (30.09)29.6817
2010's292 (38.88)24.3611
2020's50 (6.66)2.80

Authors

AuthorsStudies
Bart, G6
Giang, LM7
Yen, H1
Hodges, JS1
Brundage, RC1
Wyse, JJ1
McGinnis, KA2
Edelman, EJ3
Gordon, AJ2
Manhapra, A1
Fiellin, DA7
Moore, BA2
Korthuis, PT11
Kennedy, AJ2
Oldfield, BJ1
Gaither, JR1
Gordon, KS1
Skanderson, M2
Barry, DT1
Bryant, K2
Crystal, S1
Justice, AC1
Kraemer, KL2
Edsall, A2
Hoffman, KA1
Thuy, DT4
Mai, PP2
Hang, NT1
Khuyen, TT3
Trang, NT2
Kunkel, LE2
Button, D1
Cook, R2
King, C4
Kunkel, L2
Nguyen, DB3
Blazes, CK1
O'Hara, GL1
Liberman, AR1
Polonsky, M3
Azbel, L4
Marcus, R4
Doltu, S1
Cugut, S1
Altice, FL28
Bachireddy, C4
Shrestha, R11
Bromberg, DJ1
Kurmanalieva, A3
Wegman, M1
Shumskaya, N2
Rozanova, J2
Meyer, JP2
Mitra, S1
Grant, C1
Nolan, S2
Mohd Salleh, NA3
Milloy, MJ10
Richardson, L4
Roberts, L1
Brown, PCM1
Dinh, TTT1
Nguyen, TH3
Hoffman, K2
Le, MG1
Diep, NB1
Thuy, DTD1
Hoe, HD1
Van, HTH1
Truc, TT1
Nguyen, HH2
Lai, NL1
Linh, PTD1
Vi, VTT1
Reback, CJ1
Leibowitz, A1
Li, L7
Lin, C3
Li, M2
Shoptaw, S1
Khalid, K1
Anuar, A1
Ang, WC1
Jamaluddin, R1
Smith, LR1
Shumskaia, N1
Patterson, TL1
Werb, D2
Blyum, A1
Algarin, AB1
Yeager, S1
Cepeda, J1
Azzoni, L1
Giron, LB1
Vadrevu, S1
Zhao, L4
Lalley-Chareczko, L1
Hiserodt, E1
Fair, M1
Lynn, K1
Trooskin, S1
Mounzer, K1
Abdel-Mohsen, M1
Montaner, LJ1
Tseng, AS3
Sambai, B3
Monroe-Wise, A3
Mbogo, LW3
Ludwig-Barron, NT2
Masyuko, SJ1
Chohan, BH2
Scott, JD1
Sinkele, W3
Herbeck, JT2
Farquhar, C3
Guthrie, BL3
Lier, AJ1
Seval, N1
Vander Wyk, B1
Di Paola, A1
Springer, SA3
Pes, F1
Onali, S1
Balestrieri, C1
Angioni, G1
Ortu, F1
Piano, P1
Lucia, B1
Scioscia, R1
Princic, E1
Bolliri, AC1
Casale, M1
Cola, A1
Conti, M1
Peddis, L1
Serra, G1
Vacca, S1
Loi, M1
Urru, E1
Murru, C1
Matta, L1
Del Giacco, S1
Babudieri, S1
Maida, I1
Chessa, L1
Yee, WL1
Draper, B1
Myint, KT1
Min, W1
Htay, H1
O'Keefe, D1
Hellard, M1
Bazazi, AR4
Culbert, GJ5
Wegman, MP3
Heimer, R1
Kamarulzaman, A6
Tran, HV2
Filipowicz, TR2
Landrum, KR2
Nong, HTT2
Tran, TTT2
Pence, BW3
Go, VF6
Le, GM2
Nguyen, MX2
Verhey, R2
Chibanda, D2
Ho, HT2
Gaynes, BN3
Tang, X2
Fan, C1
Wang, C15
Wang, W3
Chen, Z3
Xu, C2
Ling, L9
Doshi, S1
Kingston, H1
Masyuko, S2
Tram, KH1
Macharia, P2
Bukusi, D2
Knight, D1
Nkya, IH1
West, NS1
Yang, C6
Kidorf, M3
Latkin, C5
Saleem, HT2
Su, WW1
Yang, CC2
Chang, RW1
Yeh, YH1
Yen, HH1
Lee, YL1
Liu, CE1
Liang, SY1
Sung, ML1
Ko, SY1
Kuo, CY1
Chen, SL1
Yeh, YP1
Hu, TH1
Tavakoli, F1
Mcfarland, W1
Ghalekhani, N1
Khezri, M1
Haghdoost, AA3
Gouya, MM3
Mahboobi, M1
Hosseionpour, AM1
Komasi, A1
Ghorbanian, M1
Nasiri Moghadam, N1
Taghipour, M1
Sharifi, H1
Jaiswal, J2
Griffin, M2
LoSchiavo, C2
Cox, A2
Hascher, K2
Dunlap, K2
Walters, S1
Burton, WM1
Grin, B1
Mumba, M2
Eaton, E1
Roshanfekr, P1
Karimi, SE1
Narouee, S1
Moftakhar, L1
Vameghi, M1
Ali, D1
Higgs, P1
Soleimanvandiazar, N1
Gutiérrez-Cáceres, S1
Pedraz-Marcos, A1
Serrano-Gallardo, P1
Hileman, CO1
McComsey, GA1
Zhang, JY1
Li, ZB1
Zhang, L10
Wang, J8
Huang, LP1
Zhan, GL1
Li, Z3
Du, J4
Zhao, M6
Le, TA2
Pham, DTT1
Quek, TTC1
Vu, GT2
Hoang, CL1
Tran, TT1
Nguyen, CT3
Tran, NHT1
Vuong, QH4
Tran, TH1
Tran, BX14
Latkin, CA10
Ho, CSH2
Ho, RCM2
Alam, F1
Wright, N1
Roberts, P1
Dhadley, S1
Townley, J1
Webster, R1
Stöver, H1
Jamin, D1
Michels, II2
Knorr, B1
Keppler, K1
Deimel, D1
Choi, S1
Yerneni, R1
Healy, S1
Goyal, M1
Neighbors, CJ1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y8
Huang, L2
Hu, K1
Liu, H5
Wang, H5
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B5
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X12
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H4
He, C3
Xiao, Z1
Xu, J3
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X10
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z4
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH2
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X3
Yang, M2
Yang, Q2
Duan, S5
Yu, Y2
Han, J3
Zhang, C4
Chen, L3
Yang, X2
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H9
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y2
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y12
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y10
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H5
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J4
Li, J15
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y12
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H2
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J5
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J3
Chu, S1
Pan, Q1
Li, D3
Zheng, S2
Ma, L1
Wang, L5
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X2
Dai, T1
Yang, Y7
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N2
Li, Y6
Du, Q1
Hao, P1
Cao, X13
Li, CX2
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Luo, W11
Xiong, D1
Zhao, D4
Fang, J1
Zhou, Z2
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J4
Guo, W1
Liu, M2
Liu, T3
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S2
Duan, W1
Zhang, S3
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J2
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q2
Lyu, HD1
Deng, L1
Zhou, D2
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C4
Liu, W2
Chen, W8
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q4
Xu, Y3
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X4
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X3
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M3
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N2
Li, C4
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X4
Huang, Y2
Josephine Fauci, A1
Ma, Y2
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Hu, J1
Yao, C1
Zhang, B9
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F2
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Liang, H3
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J5
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W2
Ruan, Z1
Li, S3
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z3
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M2
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y3
Chen, S2
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J3
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P2
Xu, L1
Yuan, Y1
Luo, J2
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY3
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L2
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M2
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X3
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F4
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S2
Feng, YL2
Zhang, YW1
Wang, SP2
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N3
Gao, P1
Sun, YH1
Zhang, HB1
Juan, SC1
Chan, CH1
Chou, SY1
Chan, HY1
Chao, E2
Hung, CC2
Lin, CP1
Ku, YJ1
Ain, QU1
Metzger, DS6
Lee, TS2
Huang, C1
Ye, L2
Abdullah, AS1
Liang, B2
Ning, C1
Zang, N2
Hu, X1
Luo, C1
Lao, F1
Wang, MR1
Wu, DD1
Luo, F1
Zhong, CJ1
Wu, YJ1
Hu, HT1
Feng, Y1
Xiong, HR1
Hou, W1
Kiriazova, T3
Hershow, RB1
Hamilton, EL2
Sarasvita, R1
Bui, Q2
Lancaster, KE2
Dumchev, K3
Hoffman, IF2
Miller, WC3
Voon, P2
Karamouzian, M1
Mitchell, MM1
Kelly, SM5
O'Grady, KE5
Jaffe, JH4
Mitchell, SG4
Schwartz, RP6
Ni, Z1
Wickersham, JA4
Copenhaver, MM6
DiDomizio, EE1
Nelson, LE2
Sabin, KM1
Burke-Shyne, N1
Chang, J1
Daniels, C1
Nguyen, VTT1
Verster, A1
Cook, RR1
Nguyen, T1
Bielavitz, S1
Tam, NTM1
Brooner, RK6
Leoutsakos, JM1
Peirce, J2
Yan, H1
Nguemo Djiometio, JB1
Buzuayew, A1
Mohamud, H1
Njoroge, I1
Kahan, M1
Mughal, AY1
Stockton, MA1
Go, V1
Ha, TV3
Huang, S2
Xin, J1
Xie, R2
Zhang, R6
Lei, S2
Hong, L2
Waddell, EN1
Singer, SN1
Walters, SM1
Merlin, JS1
Williams, EC1
Wyse, J1
Oldfield, B1
Justice, A1
Kilonzo, SB1
Gunda, DW1
Majinge, DC1
Jaka, H1
Manyiri, PM1
Kalokola, F1
Mtui, G1
Shao, ER1
Bakshi, FA1
Stephano, A1
Chohan, B1
Dunbar, M1
Juma, E1
Gitau, E1
Bosire, R1
Musyoki, H1
Temu, TM1
Herbeck, J1
Gornalusse, GG1
Vojtech, LN1
Levy, CN1
Hughes, SM1
Valdez, R1
Pandey, U1
Ochsenbauer, C1
Astronomo, R1
McElrath, J1
Hladik, F1
Kuo, HW2
Shih, CL1
Tsung, JH1
Liu, SW2
Chu, SK1
Yang, HC1
Tsou, HH2
Wang, ZH1
Chen, AC2
Liu, YL2
Jin, Z1
Ye, R1
Tang, R3
Ding, Y2
He, N3
Roncero, C1
Fuster, D2
Palma-Álvarez, RF1
Rodriguez-Cintas, L1
Martinez-Luna, N1
Álvarez, FJ1
Gong, X2
Zhao, P1
Zou, X5
Socías, ME2
Wood, E14
McNeil, R1
Kerr, T14
Dong, H2
Shoveller, J3
Montaner, J6
Karki, P5
Copenhaver, M6
Pillai, V1
Al-Darraji, H1
Kenworthy, J1
Yi, Y1
Wright, A1
Brown, J1
Maria Madrigal, A1
Dunlop, WCN1
Birger, RB1
Le, T1
Kouyos, RD1
Grenfell, BT1
Hallett, TB1
Dubov, O1
Fraenkel, L1
Huedo-Medina, T1
Nguyen, QL1
Nguyen, LH5
Phan, HTT1
Le, HT3
Tran, TD1
Vu, TTM1
Dvoryak, S5
Chernova, O1
Morozova, O2
Michel, L1
Des Jarlais, DC8
Duong Thi, H1
Khuat Thi Hai, O1
Pham Minh, K2
Peries, M2
Vallo, R1
Nham Thi Tuyet, T1
Hoang Thi, G1
Le Sao, M1
Feelemyer, J2
Vu Hai, V1
Moles, JP2
Laureillard, D2
Nagot, N2
Simeone, C1
Shapiro, B2
Lum, PJ2
Liu, PL1
Dong, QL1
Zhou, W2
Mastroianni, A1
Ravaglia, G1
Madden, L2
Bojko, MJ2
Farnum, S1
Mazhnaya, A3
Fomenko, T1
Barry, D2
Ivanchuk, I1
Kolomiets, V1
Filippovych, S2
Li, R2
Shen, Z1
Liang, N1
Peng, Z1
Huang, W1
Zhong, F1
Lan, G1
Liao, Y1
Pan, P1
Su, J1
Zhou, B1
Cooke, A4
Saleem, H4
Mushi, D4
Mbwambo, J10
Hassan, S5
Lambdin, BH7
Meredith, SE1
Rash, CJ1
Petry, NM3
Cisse Diallo, VMP1
Deguenonvo, LF1
Mbaye, KD1
Ka, D1
Lakhe, NA1
Ndiaye, I1
Thioub, D1
Diop Nyafouna, SA1
Massaly, A1
Dièye, A1
Diop, M1
Ndour, CT1
Seydi, M1
Gong, C1
Rhodes, T7
McLinden, T1
Moodie, EEM1
Hamelin, AM1
Harper, S1
Rossi, C1
Walmsley, SL1
Rourke, SB1
Cooper, C1
Klein, MB1
Cox, J2
Lozano, R2
Domeque, N2
Frutos, AJ1
Perálvarez, C1
Torrellas, MD1
Gonzalo, C1
Hanscom, BS1
Djoerban, Z1
Rose, SM1
Dvoriak, S4
Mollan, KR1
Reifeis, SA1
Piwowar-Manning, EM1
Richardson, P1
Hudgens, MG1
Sugarman, J1
Eshleman, SH1
Susami, H1
Chu, VA1
Djauzi, S1
Bui, DD1
Strathdee, SA10
Burns, DN1
Mai, HT1
Fleming, M3
Do, HN3
Nguyen, TMT3
Ho, MT3
Van Dam, N1
Vuong, TT3
Ha, GH1
Truong, NT1
Matłosz, B1
Pietraszkiewicz, E1
Firląg-Burkacka, E1
Grycner, E1
Horban, A1
Kowalska, JD1
Meyer, J1
Zelenev, A1
Makarenko, I1
Pykalo, I2
Pham, MD1
Nguyen, LT5
Nguyen, ALT1
Hoang, VH1
Le, XTT1
Dam, VN1
Nguyen, V1
Nguyen, HLT1
Do, HP1
Doan, PL1
Ho, CS2
Ho, RC2
Waluyo, A2
Wang, M2
Putri, TA1
Fanucchi, L1
Lambdin, B3
Guise, A5
Ndimbii, J2
Igonya, EK1
Owiti, F1
Mammel, M1
Hayashi, K3
Younis, IR1
Lakota, EA1
Volpe, DA1
Patel, V1
Sahajwalla, CG1
Moore, K1
Magee, M1
Sevinsky, H1
Chang, M4
Lubin, S1
Myers, E1
Ackerman, P1
Llamoso, C1
Yi, S1
Mun, P1
Chhoun, P1
Chann, N1
Tuot, S1
Mburu, G2
Kwan, TH1
Wong, NS1
Lee, SS5
Khalilieh, S1
Yee, KL1
Sanchez, RI1
Vaynshteyn, K1
Fan, L2
Searle, S1
Bouhajib, M1
Iwamoto, M1
Bao, J1
Harrington, A1
Fan, X1
Ning, Z1
Shi, D1
Cai, Z1
Feng, N1
Hsieh, J1
Nguyen, TA1
Dam, NV1
Doan, LP1
Chandra, DK1
Nahaboo Solim, MA1
Tamraz, B1
Reisner, L1
French, AL1
King, ST1
Fischl, MA1
Ofotokun, I1
Kashuba, A1
Milam, J1
Murphy, K1
Augenbraun, M1
Finley, PR1
Aouizerat, B1
Cocohoba, J1
Gange, S1
Bacchetti, P1
Greenblatt, RM1
Fairbairn, N2
Barrios, R1
Ng, MH1
Chou, JY1
Chang, TJ1
Lee, PC1
Shao, WC1
Lin, TY2
Chen, VC1
Gossop, M1
Batchelder, AW1
Brisbane, M1
Litwin, AH6
Nahvi, S2
Berg, KM8
Arnsten, JH11
Gu, J2
Lau, JT2
Zhong, Y1
Hao, Y4
Ling, W3
Zahari, MM2
Azar, MM1
Byrd, DA1
Robinson-Papp, J1
Mindt, MR1
Mintz, L1
Elliott, K1
Lighty, Q1
Morgello, S1
Sullivan, S1
Wu, Z20
Clark, N1
Shi, CX3
McGoogan, JM3
Rou, K13
Zhang, F4
Bulterys, M2
Torrens, M5
Fonseca, F2
Castillo, C1
Domingo-Salvany, A2
Gowing, LR3
Hickman, M5
Degenhardt, L3
Harrison, T1
Miyahara, S1
Lee, A1
Evans, S1
Bastow, B1
Simpson, D1
Gilron, I1
Dworkin, R1
Daar, ES1
Wieclaw, L1
Clifford, DB1
Liu, E3
Pang, L6
Sullivan, SG5
Montaner, JS7
Detels, R4
Larney, S4
Zaller, ND1
Rich, JD3
Tuchman, E3
Pennington, LE1
Kull, RM1
Daneshyar, S1
Bruce, RD10
Moody, DE2
Gourevitch, MN9
Friedland, GH8
Kao, D1
Bucher Bartelson, B1
Khatri, V1
Dart, R1
Mehler, PS1
Katz, D1
Krantz, MJ1
Manan, MM1
Ali, SM1
Khan, MA1
Jafarian, S1
Hameed, MA1
Xia, YH2
McLaughlin, MM1
Tucker, JD3
Lee, IC1
Baldwin, P1
Seewald, R2
Elam, R1
Tio, R1
Lorenz, S1
Friedmann, P1
Rabin, D1
Garger, YB1
Bonilla, V1
Perlman, DC1
Ambekar, A2
Rao, R1
Pun, A1
Kumar, S1
Kishore, K1
Liao, DL1
Chen, PC1
Chen, CH1
Hsieh, CJ1
Huang, YF2
Shih, WY1
Cheng, JJ1
Chen, YC1
Chen, CK1
Lin, SK1
Chiang, SC1
Su, LW4
Wang, LJ1
Vallecillo, G2
Mojal, S2
Roquer, A2
Martinez, D2
Rossi, P1
Muga, R2
Mason, JW1
Otiashvili, D1
Piralishvili, G2
Sikharulidze, Z1
Kamkamidze, G1
Poole, S3
Woody, GE4
Reddon, H1
Simo, A1
Navadeh, S2
Mirzazadeh, A2
Farnia, M3
Alasvand, R1
Hong, Y1
Hall, BJ1
Zhang, D3
Dai, J1
Liang, Y4
Sajadi, L1
Osooli, M1
Khajehkazemi, R1
Fahimfar, N1
Zamani, O1
Chang, O2
Masao, F4
Mteza, I1
Nyandindi, C3
Zamudio-Haas, S2
Buma, D1
Dunbar, MS1
Kilonzo, G1
Cheng, XQ1
Cao, XB1
Wang, CH1
Li, RJ1
Rou, KM2
Wu, ZY4
Li, JH2
Sheu, YL1
Tang, HP2
Chang, WC1
Tang, TC1
Yeh, YC3
Wang, SY1
Liu, RH1
Jia, W1
Karachevsky, A1
Chhatre, S3
Booth, R1
Metzger, D4
Schumacher, J1
Chychula, N1
Pecoraro, A1
Woody, G3
Marco, A1
Gallego, C1
Caylà, JA1
Zhou, YB1
Liang, S2
Wang, QX1
Gong, YH1
Nie, SJ1
Nan, L1
Yang, AH1
Liao, Q1
Song, XX1
Jiang, QW1
Hao, C2
Bruce, D2
Hillhouse, M2
Jacobs, P5
Sorensen, J2
Saxon, AJ4
Fang, Y2
Chavchanidze, M1
Gamkrelidze, I1
Nikolaishvili, N1
Kaduri, P1
Magimba, A1
Sabuni, N3
Kazatchkine, M1
Tomori, C1
Tuan, le N1
Huong, NM1
Binh, NT1
Zelaya, CE1
Celentano, DD4
Dat, do T1
Quan, VM1
Yen, YF3
Yen, MY3
Lin, T1
Li, LH3
Jiang, XR3
Chou, P1
Deng, CY2
He, L1
Newville, H3
Gonzalez, JS2
Liebrenz, M1
Stohler, R2
Nordt, C1
Newman, RG1
Mao, W1
Jiang, B1
Xiao, Y1
Jia, Y1
Cassell, H1
Vermund, S1
Ti, L1
Kaplan, K1
Suwannawong, P1
Islam, Z1
Shost, A1
Prokhorova, T1
Rybak, N1
Flanigan, T1
Chu, CE1
He, X1
Cheng, Y1
Cai, W1
Volberding, P1
Tetrault, JM1
McCance-Katz, EF9
Lruie, BS1
DInh, AT1
Fiellin, LE2
Feit, J1
Kunc, M1
Walecki, P1
Gorzelańczyk, EJ1
Yin, W2
Mi, G2
Iriyanti, M1
Muchransyah, AP1
Chen, IM1
Huang, CL1
Yeh, BJ1
Chien, YL1
Strathdee, S2
Ngugi, E1
Platt, L2
Kurth, A1
Cleland, C1
Vickerman, P3
Palma, J1
Abood, ME1
Benamar, K1
Lin, CK1
Peng, CY2
Qian, X2
Jin, Y1
Willa, D1
Bai, H1
Wu, Q2
Shen, W1
Lin, H1
Meemken, L1
Hanhoff, N1
Tseng, A1
Christensen, S1
Gillessen, A1
Wang, PW2
Lin, HC1
Yen, CN2
Hsu, CY1
Chung, KS2
Chang, HC1
Wu, HC2
Yen, CF2
Tran, OC3
Ubuguyu, O2
Hwang, LL1
Wang, SC1
Wu, SL1
Dai, YW1
Liu, SC1
Ho, IK1
Hsiao, CF1
Kinahan, JC1
Surah, S1
Keating, S1
Bergin, C3
Mulcahy, F4
Lyons, F1
Keenan, E2
Tsui, JI1
Lira, MC1
Cheng, DM2
Winter, MR1
Alford, DP1
Liebschutz, JM1
Mao, J1
Edwards, RR1
Samet, JH3
Gryczynski, J1
Gervasoni, C1
Peri, AM1
Cattaneo, D1
Baldelli, S1
Rizzardini, G1
Milazzo, L1
Luan, R1
Min, X1
Bao, Y1
Chen, M1
Tan, H1
Phan, HT4
Nguyen, LK1
Lin, CY2
Chang, KC1
Wang, JD1
Lee, LJ1
Ahamad, K2
Nguyen, P1
Dobrer, S1
Schütz, CG2
Samos, P1
Luque, S1
Martires, PK1
Weisberg, DF1
Hoang, TV1
Ha, TT1
Hoang, TM1
Nhu, NT1
Quoc, NC1
Tam, Nt1
Mills, S4
Pu, L1
Su, Y1
Wang, G1
Wu, L1
Yan, G1
Gooden, L1
Metsch, LR2
Pereyra, MR1
Malotte, CK1
Haynes, LF1
Douaihy, A1
Chally, J1
Mandler, RN1
Feaster, DJ1
Mahenge, B1
Engstrom, M2
Winham, K1
Gilbert, L13
Closson, EF1
Paparini, S1
Vu, PB1
Latkin, SK1
Cohn, A1
Stanton, C1
Elmasry, H1
Ehlke, S1
Niaura, R1
Jaureguiberry-Bravo, M1
Wilson, R1
Carvallo, L1
Berman, JW1
Izenberg, J1
McCurdy, S1
Nguyen, LP1
Morales, GJ1
Mai, NT1
Brownson, RC1
Des Jarlais, D1
Duong, HT1
Khuat, OH1
Nham, TT1
Arasteh, K4
Heckathorn, DD1
Marotta, PL1
McCullagh, CA1
Gardner, LI1
Marks, G1
Loughlin, AM1
Del Rio, C1
Kerndt, P1
Mahoney, P1
Pitasi, MA1
Low, AJ1
Welton, NJ1
May, MT1
Davies, CF1
French, C1
Turner, KM1
Looker, KJ1
Christensen, H1
McLean, S1
Pan, MH1
Cheng, YP1
Su, T1
Wang, XW1
Nie, YG1
Ma, YM1
Yang, WJ1
Fan, PY1
Sun, DY1
Zhu, Q1
Joe, R1
Fairgrieve, C1
Chen, H1
Zhang, N1
Marienfeld, C1
Teoh Bing Fei, J1
Yee, A1
Habil, MH1
Danaee, M1
Small, W1
Balaji, D1
Mlunde, LB1
Matiko, E1
Douglas Bruce, R1
Alexandrescu, L1
Huedo-Medina, TB3
Krishnan, A1
Silva, MJ1
Pereira, C1
Loureiro, R1
Balsa, C1
Lopes, P1
Água-Doce, I1
Belo, E1
Martins, HC1
Coutinho, R2
Pádua, E1
Kamphuis, C1
Duo, L1
Chen, Y1
Richardus, JH1
Maremmani, I1
Pacini, M1
Lubrano, S1
Perugi, G1
Tagliamonte, A1
Pani, PP1
Gerra, G1
Shinderman, M1
Marsh, D2
Li, K4
Gallagher, DP1
Kieran, J1
Sheehan, G1
Lambert, J1
Mahon, N1
Mallon, PW1
Lawrinson, P1
Ali, R3
Buavirat, A1
Chiamwongpaet, S1
Habrat, B1
Jie, S1
Mardiati, R1
Mokri, A3
Moskalewicz, J1
Newcombe, D1
Poznyak, V1
Subata, E2
Uchtenhagen, A3
Utami, DS1
Vial, R1
Zhao, C2
Weinstock, J1
Roux, P3
Carrieri, MP10
Villes, V2
Dellamonica, P4
Poizot-Martin, I3
Ravaux, I3
Spire, B5
Magura, S3
Lee, JD1
Hershberger, J1
Joseph, H1
Marsch, L1
Shropshire, C1
Rosenblum, A3
Todadze, K1
Lezhava, G1
Lu, L5
Anglin, MD7
Conner, BT1
Annon, JJ2
Longshore, D3
Harris, KA1
Zamor, PJ1
Soloway, IJ1
Tenore, PL1
Kaswan, D1
Barnett, PG2
Sorensen, JL10
Wong, W1
Haug, NA5
Hall, SM2
DeBeck, K1
Suntharasamai, P1
Martin, M1
Vanichseni, S4
van Griensven, F1
Mock, PA2
Pitisuttithum, P1
Tappero, JW1
Sangkum, U1
Kitayaporn, D3
Gurwith, M1
Choopanya, K4
Corsi, KF1
Lehman, WK1
Booth, RE2
Calsyn, DA4
Hatch-Maillette, M1
Tross, S2
Doyle, SR2
Crits-Christoph, P2
Song, YS2
Harrer, JM1
Lalos, G1
Berns, SB1
Newman, R1
Reisinger, HS1
Peterson, JA1
Agar, MH1
Brown, BS3
Dolan, K4
Davstad, I1
Stenbacka, M3
Leifman, A3
Romelsjö, A4
Cooperman, NA1
Thirthalli, J1
Chand, PK1
Goggins, W1
Mouriz, J1
Duggan, E1
Goldberg, U1
Cohen, J6
McKnight, C1
Ringer, M1
Friedman, SR2
Achmad, YM1
Istiqomah, AN1
Iskandar, S1
Wisaksana, R1
van Crevel, R2
Hidayat, T2
Schaub, M1
Chtenguelov, V1
Weiler, G1
Shibusawa, T1
El-Bassel, N15
Klavs, I1
Bergant, N1
Kastelic, Z1
Lamut, A1
Kustec, T1
Perez, IR1
Olry de Labry Lima, A1
del Castillo, LS1
Bano, JR1
Ruz, MA1
del Arco Jimenez, A1
Müller, MC1
Pichler, M1
Martin, G1
Plörer, D1
Winter, C1
Pogarell, O1
Bogner, JR1
Epperson, MW3
Khan, MR2
Wu, E3
Hatch-Maillette, MA1
Coyer, S1
Pelta, S1
Antela López, A1
Garcés, PA1
Tena, EV1
Pollack, HA1
D'Aunno, T1
Mathers, BM1
Ali, H1
Wiessing, L1
Mattick, RP1
Myers, B1
Philbin, MM1
Uhlmann, S1
Guillemi, S3
Hogg, RS4
Miller, DP1
Perron, BE1
Curth, NK1
Hansson, LN1
Storm, F1
Lazarus, JV1
Wilson, ME1
Zamani, S2
Torknejad, A1
Alaei, BA1
Gholizadeh, M1
Kasraee, F1
Ono-Kihara, M1
Oba, K1
Kihara, M1
Wodak, A9
Ebrahimi, B1
Shams, A1
Benyamina, A1
Blecha, L1
Lebeau, B1
Reynaud, M1
Marzolini, C3
Elzi, L2
Gibbons, S2
Weber, R3
Fux, C1
Furrer, H2
Chave, JP1
Cavassini, M2
Bernasconi, E2
Calmy, A2
Vernazza, P2
Khoo, S3
Ledergerber, B2
Back, D3
Battegay, M2
Gruber, VA4
Kimber, J1
Copeland, L1
Macleod, J1
McKenzie, J1
De Angelis, D1
Robertson, JR1
Wolfe, D1
Shepard, D1
Deering, KN1
Tyndall, MW3
Gibson, K1
Irons, L1
Shannon, K1
Litwin, A1
Heo, M3
Protopopescu, C2
Brust, JC1
Li, F1
Lu, F1
Poundstone, K2
Zeng, G1
Xu, P1
Liu, K1
Liau, A1
Mao, Y2
Qin, Q1
Ma, W1
Chawarski, MC1
Schottenfeld, RS1
Taylor, LE1
Bowman, SE1
Chapman, S1
Stein, MD3
Cioe, PA1
Maynard, MA1
McGovern, BH1
Liu, EW2
Liang, T1
Shen, LM1
Zhong, H1
Chaudhry, AA1
Botsko, M2
Weiss, L2
Egan, JE2
Mitty, J1
Estrada, B1
Lucas, GM7
Woodson, T1
Flanigan, TP1
Netherland, J1
Finkelstein, R2
Durán, E1
Salvo, S1
Gil, J1
Sanjoaquín, I1
Claeson, M1
Salimi, S2
Nassirimanesh, B2
Mohsenifar, S2
Alistar, SS1
Owens, DK1
Brandeau, ML2
Lambers, FA1
Stolte, IG1
van den Berg, CH1
Coutinho, RA5
Prins, M2
Nsimba, SE1
Kuo, HS1
Lew-Ting, CY1
Tian, F1
Yang, CH1
Tsai, TI1
Gange, SJ1
Nelson, KE2
Deren, S5
Kang, SY3
Mino, M2
Guarino, H2
Psaros, C1
Batchelder, A1
Applebaum, A1
Safren, SA2
Ohinmaa, A3
Duong, AT3
Do, NT2
Nguyen, QC1
Houston, S3
Holzemer, WL1
Johnson, M1
Tulsky, JP3
Rose, CD1
Hser, YI2
Evans, E1
Chang, YJ1
Peng, C1
Huang, D1
Stitzer, ML1
Roll, J1
Gowing, L1
Farrell, MF1
Bornemann, R2
Sullivan, LE4
Jimenez-Treviño, L1
Saiz, PA1
García-Portilla, MP1
Díaz-Mesa, EM1
Sánchez-Lasheras, F1
Burón, P1
Casares, MJ1
Marina, P1
Gutiérrez, E1
Bobes, J1
Allsop, D1
Sharma, A1
Cohen, HW1
Freeman, R2
Santoro, N2
Schoenbaum, EE4
Chen, JS1
Esser, S1
Haberl, A2
Gölz, J1
Lazzarin, A1
Teofilo, E1
Vera, J1
Körber, A1
Staszewski, S2
Buxton, J1
Krusi, A1
Hogg, R1
Oʼgrady, KE1
Gandhi, D1
Arkin, E1
Lutnick, A1
Case, P1
Kral, AH1
Yang, YH2
Yu, WJ1
Chiu, HJ1
Pan, RN1
Bennett, C1
Wang, SJ1
Chen, ZS1
Li, XY1
A, LY1
Yang, YC1
Yang, SS1
Yang, YB1
Long, YC1
Li, GQ1
Yin, JS1
Xiang, LF1
Ye, RH1
Gao, J1
Tang, RH1
Smith, K1
Bartlett, N1
Wang, N1
Noori, R1
Narenjiha, H1
Aghabakhshi, H1
Habibi, G1
Khoshkrood Mansoori, B1
Golovanevskaya, M1
Vlasenko, L1
Saucier, R1
Ko, NY1
Hsu, ST1
Campbell, AN1
Hu, MC1
Pavlicova, M1
Nunes, EV1
Zhuang, X2
Chow, EP2
Wilson, DP2
Amini Lari, M1
Parsa, N1
Marzban, M1
Shams, M1
Faramarzi, H1
Khuat, TH1
Nguyen, VA1
Jardine, M1
Moore, T1
Bui, TH1
Crofts, N1
Rodwell, TC1
Hsu, YH1
Chuang, P2
Fang, YC1
Garfein, RS1
Shen, YM1
Lin, SR1
Chen, CL1
Huang, TM1
Huang, YH1
See, LC1
Deng, FL1
Wammes, JJ1
Siregar, AY1
Raya, RP1
van der Ven, AJ1
Baltussen, R1
Walley, AY1
Doe-Simkins, M1
Quinn, E1
Pierce, C1
Xuan, Z1
Ozonoff, A1
Larios, S1
Tulsky, J1
Powelson, E1
Logan, DP1
Gonzalez, A1
Mimiaga, MJ1
Israel, J1
Andres Bedoya, C1
Tan, L1
Hao, W1
MacArthur, GJ1
Minozzi, S1
Martin, N1
Bruneau, J1
Chu, P1
Ruan, Y2
Jia, Z1
Christie, B1
Vu, PX1
Sanvisens, A1
Rivas, I1
Faure, E1
Muñoz, T1
Rubio, M1
Tor, J1
Edington, C1
Bayer, R1
Margolin, A4
Avants, SK4
Warburton, LA1
Hawkins, KA1
Piccolo, P1
Borg, L1
Lin, A1
Melia, D1
Ho, A1
Kreek, MJ5
Baker, WC1
Sibbald, B1
Goldstein, MF2
Stancliff, S2
Myers, JE1
Steiner, S1
Drucker, E2
Witteveen, E1
van Ameijden, EJ4
Clarke, S2
Delamere, S1
McCullough, L1
Hopkins, S2
Arnsten, J1
Sarlo, J1
Rainey, P1
Jatlow, P4
Akerele, EO1
Levin, F1
Nunes, E1
Brady, R2
Kleber, H1
Umbricht, A2
Hoover, DR1
Tucker, MJ1
Leslie, JM1
Chaisson, RE1
Preston, KL4
Clarke, SM5
Mulcahy, FM5
Esteban, J4
Gimeno, C3
Barril, J3
Aragonés, A2
Climent, JM1
de la Cruz Pellín, M2
Pellín, Mde L1
Wong, KH1
Lim, WL1
Low, HK1
Miller, A1
Stevens, RC1
Rapaport, S1
Maroldo-Connelly, L1
Patterson, JB1
Bertz, R1
Rainey, PM3
Friedland, G4
Springer, S1
Buitrago, M1
Hunt, DP1
Sala, M2
Anguera, I2
Cervantes, M2
Rajah, V2
Douaihy, AB1
Jou, RJ1
Gorske, T1
Salloum, IM1
Thaker, HK1
Gil, M1
Chapinal, O1
Guma, JR1
Segura, F1
Faragon, JJ1
Piliero, PJ1
Turner, BJ3
Laine, C1
Yang, CP1
Hauck, WW2
Scholten, JN1
Driver, CR1
Munsiff, SS1
Kaye, K1
Rubino, MA1
Trim, C1
Amofa, J1
Highley, E1
Fujiwara, PI1
Scheer, R1
Palmer, NB2
Salcedo, J2
Miller, AL2
Winiarski, M1
Arno, P1
Rajs, J3
Petersson, A1
Thiblin, I1
Olsson-Mortlock, C1
Fredriksson, A1
Eksborg, S1
Grabowski, J2
Rhoades, H1
Stotts, A1
Cowan, K1
Kopecky, C1
Dougherty, A1
Moeller, FG1
Schmitz, J2
Usubiaga, MH1
Doebrick, C1
Haig, T1
Conway, B4
Prasad, J1
Reynolds, R1
Farley, J1
Jones, M1
Jutha, S1
Smith, N1
Mead, A3
DeVlaming, S4
Weidle, PJ3
Hader, S3
Moore, RD3
Mora, E1
Giménez, J1
Vilanova, E1
Morrow, K1
Costello, T1
Lucchini, A1
Barbaro, G1
Barbarini, G1
O'Shea, J1
Grinda, JM1
Brazille, P1
Bricourt, MO1
Mainardi, JL1
Gonzales-Canali, G1
Piketti, C1
Deloche, A1
Hammett, TM1
Wei, L1
Van, LK1
Donghua, M1
Ngu, D1
Hendrix, CW1
Wakeford, J1
Wire, MB1
Lou, Y1
Bigelow, GE5
Martinez, E1
Christopher, J1
Fuchs, EJ1
Snidow, JW1
Stocker, H1
Kruse, G1
Kreckel, P1
Herzmann, C1
Claus, J1
Jessen, H1
Cordes, C1
Hintsche, B1
Schlote, F1
Schneider, L1
Kurowski, M1
Baklan, Z1
Gorisek, JR1
Poljak, M1
Pisec, A1
Laurence, J1
Lançon, C1
Jaquet, I1
Labrune, N1
Bartolo, K1
De Stopeleire, C1
Auquier, P1
Fudala, PJ1
Palepu, A5
Horton, NJ1
Tibbetts, N1
Meli, S1
Vallalta, M1
Sahuquillo-Arce, E1
Salavert, M1
Lacruz, J1
Go, H1
Hill, J1
Hearn, KD1
O'Sullivan, LF1
Bargagli, AM1
Schifano, P1
Davoli, M2
Faggiano, F1
Perucci, CA1
Schroeder, JR1
Epstein, DH3
Highleyman, L1
Lollo, ND1
Delucchi, KL2
Andrews, L2
Schreibman, T1
Agarwala, S1
Daley, L1
Child, M1
O'Mara, E1
McKenzie, M1
Shield, DC1
Wolf, FA1
Key, RG1
Poshkus, M1
Clarke, J3
Negrín, MA1
Vázquez-Polo, FJ1
Graham, CH1
Meechan, JG1
Lloyd, JJ1
Ricketts, EP2
Cornelius, LJ1
Bishai, D1
Huettner, S1
Havens, JR1
Winiarski, MG1
Greene, LI1
Villanueva, M1
Farrell, M2
Ali, RL2
Shah, NG3
Galai, N4
Vlahov, D8
Villafranca, SW1
McKellar, JD1
Trafton, JA1
Humphreys, K1
Golz, JH1
Faílde Garrido, JM1
López Castro, J1
Fernández Rodríguez, V1
Fernández Rodríguez, R1
Warren, E1
Viney, R1
Shearer, J1
Shanahan, M1
Howard, AA1
Floris-Moore, M1
Joy, R1
Press, N1
Mullen, BA2
McCaul, ME2
Tang, YL1
Cubells, JF1
Brown, LS5
Kritz, S1
Chu, M1
Madray, C1
Lu, GH1
Wang, QY1
Zhu, M1
McCoy, CB1
Rodríguez Salgado, D1
Rodríguez Alvarez, M1
Seoane Pesqueira, G1
Cofrancesco, J1
Shah, N1
Ghanem, KG1
Dobs, AS1
Klein, RS2
Mayer, K1
Schuman, P1
Rompalo, AM1
Gelkopf, M2
Weizman, T1
Melamed, Y1
Adelson, M2
Bleich, A2
Lott, DC1
Strain, EC1
Johnson, RE1
Beitel, M1
Schuman-Olivier, Z1
Lollo, N1
Roth, G1
Gruber, V1
Kletter, E1
Batki, SL5
Barnett, P1
Hall, S1
Préau, M1
Kim, T1
Nunes, D1
Vidaver, J1
Alperen, J1
Saitz, R1
Moral Moral, P1
Rueda Soriano, J1
Tasias Pitarch, M1
Calbuig Alborch, JR1
Petrosillo, N1
Lisena, FP1
Chinello, P1
Haltiwanger, D1
Eldred, L1
Amass, L1
Jürgens, R1
Betteridge, G1
Semba, RD1
Mehta, SF1
Kirk, GD2
Cullen, W1
Stanley, J1
Langton, D1
Kelly, Y1
Bury, G2
Berk, SI1
Du, E1
Soloway, I1
Raffa, JD3
Grebely, J3
Tossonian, H1
Wong, T1
Viljoen, M2
Khara, M2
McLean, M2
Duncan, F2
Petkau, AJ2
Millson, P1
Challacombe, L1
Villeneuve, PJ1
Strike, CJ1
Fischer, B1
Myers, T1
Shore, R1
Federman, AD1
Lüthi, B1
Huttner, A1
Speck, RF1
Mueller, NJ1
Tossonian, HK2
Trotter, B1
Fraser, C1
Arroyo, E1
Valenzuela, B1
Portilla, J2
Climent-Grana, E1
Pérez-Ruixo, JJ1
Merino, E1
O'Driscoll, P1
Mehta, SH1
Ompad, DC1
Gern, R1
Karakiewicz, B1
Kozielec, T1
Brodowski, J1
Chlubek, D1
Noceń, I1
Starczewski, A1
Brodowska, A1
Laszczyńska, M1
Miller, CL1
Sarang, A1
Stuikyte, R1
Bykov, R1
van Beek, I1
Van Den Berg, C1
Smit, C1
Van Brussel, G1
Epperson, M1
Orellana, ER1
De, P1
Boivin, JF1
Platt, RW1
Jolly, AM1
Qian, HZ1
Cassell, HM1
Chen, K1
Qin, G1
Yin, L1
Schumacher, JE1
Shao, Y1
Fang, YX1
Zhao, LY1
Willner-Reid, J1
Belendiuk, KA1
Schmittner, J1
Ghitza, UE1
Yang, L1
Dai, F1
Ren, Z1
Qi, G1
Cheng, W1
Perlis, TE2
Kosten, TR3
Gardner, TJ1
Bao, YP1
Cruts, G1
Buster, M1
Vicente, J1
Deerenberg, I1
Van Laar, M1
Novick, DM3
Razali, SM1
Hanson, T1
Alessi, SM1
Markson, L1
Hauck, W1
Cocroft, J1
Fanning, T2
Battjes, RJ2
Pickens, RW2
Schilling, RF4
Abbott, PJ2
Weller, SB2
Walker, SR1
Hasson, AL1
Grella, CE5
Rawson, R1
Fugelstad, A3
Böttiger, M1
Gerhardsson de Verdier, M1
Nemoto, T2
Lehman, JS1
Allen, DM1
Green, TA1
Onorato, IM1
Johns, A1
Meandzija, B1
O'Connor, PG1
Fitzgerald, B1
Rounsaville, BJ2
Rapiti, E1
Anthony, JC1
Hadden, B1
Camí, J1
Feldman, N1
Mino, A1
Tignol, J1
Carpentier, J1
Bloch-Lainé, JF1
Hefez, S1
Boissonnas, A1
Ingold, FR1
Lowenstein, W1
Haas, C1
Durand, H1
Compton, WM1
Lamb, RJ2
Fletcher, BW1
Joe, GW6
Simpson, DD7
Bux, DA3
Iguchi, MY4
Wugalter, SE2
De Leon, G1
Staines, GL1
Sacks, S1
McKendrick, K1
Hilton, R1
Rees, V1
Gaughwin, MD2
Drake, S1
Swift, W2
Hall, W3
Ross, M2
Boccellari, AA1
Chambers, DB1
Dilley, JW1
Shore, MD1
Tauber, MA1
Moss, AR2
Osmond, DH1
King, VL2
Schmidt, CW1
Felch, LJ1
Gazaway, PM1
Blansfield, HN1
Wells, EA2
Clark, LL2
Jackson, TR2
Wrede, AF1
Peters, AD2
Reid, MM1
Griffin, SG1
Mastro, TD2
Weniger, BG1
Laosunthorn, V1
Uneklabh, T1
Uneklabh, C1
Limpakarnjanarat, K1
London, J1
Heitzmann, C1
Gibson, DR3
Morales, ES1
Dumontet, R1
Acree, M1
White, JM2
Dyer, KR1
Cormack, S1
Hsieh, SC1
Farley, TA2
Cartter, ML2
Wassell, JT2
Hadler, JL2
Rittmannsberger, H1
Ruschak, M1
Silberbauer, C1
Serpelloni, G1
Rezza, G2
Morganti, S1
Gomma, M1
Binkin, N1
Rota, MC1
Buning, E1
Hausser, D1
O'Hare, P1
Power, R1
O'Neill, WM1
Onen, TS1
Pivnick, A1
von Bardeleben, U1
Petitjean, S1
Natsch, C1
Ladewig, D2
Darke, S3
Brettle, RP2
Willocks, L1
Hamilton, BA1
Shaw, L1
Leen, CL1
Richardson, A1
Gore, SM1
Brook, JS1
Brook, DW1
Whiteman, M1
Roberto, J1
Masci, JR1
De Catalogne, J1
Amundsen, F1
Oertle, D1
Edelmann, R1
Ostewalder, J1
Vernazza, PL1
Galeazzi, RL1
Umbricht-Schneiter, A1
Ginn, DH1
Pabst, KM1
Weiss, SH1
Weston, CB1
Quirinale, J1
Battista, HJ1
Rössler, H1
Haller, R1
Kohler, H1
Riemer, Y1
Henn, R1
Hinterhuber, H1
Ottomanelli, G1
Becker-Boost, I1
Phlippen, R1
Turnbull, JE1
Su, KH1
McLellan, AT2
O'Brien, CP2
Druley, P1
Navaline, H1
DePhilippis, D2
Stolley, P1
Abrutyn, E1
Van den Hoek, JA1
Mientjes, GH1
Hsieh, S1
Danila, B1
O'Kelly, F1
Pomeroy, L1
Greenfield, L1
Camacho, LM3
Morrison, CL1
Ruben, SM1
Hartel, D1
Selwyn, PA5
Davenny, K1
Bartholomew, NG2
Cloud, MA1
Kent, H1
Ryan, CF1
Herbst, MD1
Manfredi, LB1
Jones, T1
O'Neill, K1
Baker, A2
Cooke, M1
Collins, E1
Heather, N2
Anglin, D1
Rodriguez, EM2
Mofenson, LM1
Chang, BH1
Rich, KC1
Fowler, MG1
Smeriglio, V1
Landesman, S1
Fox, HE1
Diaz, C1
Green, K1
Hanson, IC1
Saei, A1
Ward, J2
McGilchrist, CA1
Ferrando, SJ1
Wall, TL2
Stark, K1
Müller, R1
Bienzle, U1
Guggenmoos-Holzmann, I1
Dinwiddie, SH1
Cottler, L1
Compton, W1
Abdallah, AB1
Sawyer, RC1
Cobb, MN1
Colborn, DC1
Narang, PK1
Lidz, V2
French, JF1
Baxter, RC1
Platt, JJ1
Mader, U1
Matheson, PB1
Schoenbaum, E1
Greenberg, B1
Pliner, V1
Hahn, JA1
Vranizan, KM1
MacGowan, RJ2
Fichtner, RR1
Swanson, N1
Collier, C1
Kroliczak, A1
Cole, G1
Brackbill, RM1
Rugg, D1
Radkowski, M1
Werezyńska, T1
Kopicz-Kamińska, E1
Kuligowski, S1
Slusarczyk, J1
Annell, A1
Agren, G2
Tourian, K1
Alterman, A1
Rutherford, M1
Cacciola, JS1
McKay, JR1
Antela, A3
Casado, JL2
González, MJ1
Pérez, P1
Pérez-Elías, MJ2
Montilla, P1
Buzón, L1
Peyser, NP1
Willems, JC1
Delaney, HD1
Rhoades, HM1
Creson, D1
Elk, R1
Harris, RM1
Bausell, RB1
Scott, DE1
Hetherington, SE1
Kavanagh, KH1
Lurie, P1
Alcabes, P1
Bauer, LO1
Marsch, LA1
Hartel, DM1
Stein, GL1
Fleischman, AR1
Campos, M1
Broers, B1
Junet, C1
Bourquin, M1
Déglon, JJ2
Perrin, L1
Hirschel, B2
Mascovich, A1
Chesney, M1
Sindelar, JL1
Schottenfeld, R1
Stine, S1
Cooney, NL1
Rosenheck, RA1
Li, SH1
Anderson, JF1
Friedmann, PD1
Alexander, JA1
Jin, L1
D'Aunno, TA1
Stein, Z1
Saez, H1
el-Sadr, W1
Healton, C1
Mannheimer, S1
Messeri, P1
Scimeca, MM1
Van Devanter, N1
Zimmerman, R1
Betne, P1
Heelon, MW1
Meade, LB1
Chatham, LR2
Hiller, ML1
Rowan-Szal, GA2
Cooney, EL1
Otero, MJ1
Fuertes, A1
Sánchez, R1
Luna, G1
Newschaffer, CJ1
Pérez, K2
Bravo, MJ1
Antó, JM1
Alonso, J1
Broome, KM1
Langendam, MW2
van Brussel, GH2
Flynn, NM1
McCarthy, JJ1
Guerra-Romero, L1
Noguer, I1
Bolea, A1
Suárez, M1
Parras, F1
Isernhagen, K1
Geletko, SM1
Erickson, AD1
Farber, S1
O'Connor, A1
Copeland, AL1
Baño Rodrigo, MD1
Agujetas Rodríguez, M1
López García, ML1
Guillén Llera, JL1
Gute, P1
Nisius, G1
Miller, V1
Carlebach, A1
Bell, J1
Zador, D1
Bryan, AD1
Fisher, JD1
Fisher, WA1
Murray, DM1
Urdaneta, ME1
Maksad, J2
Sobota, M2
Hanna, L1
Markson, LE1
Schmidt, V1
Hayward, R1
Bodner, G1
Foleno, A1
Frye, V1
Chen, MH1
Hu, P1
Zule, WA1
Desmond, DP1
Troillet, N1
Telenti, A1
Baumann, P1
Decosterd, LA1
Eap, CB1
Zaric, GS1
Pinzani, V1
Faucherre, V1
Peyriere, H1
Blayac, JP1
Mitchell, SM1
Charles, C1
Thiede, H1
Hagan, H1
Murrill, CS1
Marmor, M2
Shore, RE1
Titus, S1
Stambolis, V1
Johnson, L1
Reynaud-Maurupt, C1
Gastaud, JA1
Pradier, C1
Obadia, Y1
Moatti, JP1
Fischer, G1
Cayol, V1
Corcos, M1
Clervoy, P1
Speranza, M1
Kidorf, MS1
Stoller, KB1
Boyle, BA1
Conover, C1
Ridzon, R1
Valway, S1
Schoenstadt, L1
McAuley, J1
Onorato, I1
Paul, W1
Raktham, S1
Sujarita, S1
Srisuwanvilai, LO1
Young, NL1
Wasi, C1
Subbarao, S1
Heyward, WL1
Esparza, L1
Tjia, J2
Reynolds, HE3
Gibbons, SE2
Barry, MG2
Back, DJ4
Richman, BL2
Flom, PL1
Rodés , A1
Meroño , M1
Casabona , J1
Llinares, R1
Belda, J1
Sánchez-Payá, J1
Isabel Manso, M1
de Estudio Protocolo-INH, G1
Fleming, GF1
McElnay, JC1
Hughes, CM1
Sheridan, J1
Strang, J2
Baker, R1
Bowers, M1
Fornataro, K1
Bartnof, HS1
Gaylord, G1
Kwiatkowski, CF1
Moreno, A1
Muñoz, V1
Dronda, F1
Navas, E1
Moreno, S1
Abel, S1
Agins, B1
Gerber, JG1
Rosenkranz, S1
Segal, Y1
Aberg, J1
D'Amico, R1
Mildvan, D1
Gulick, R1
Hughes, V1
Flexner, C1
Aweeka, F1
Hsu, A1
Gal, J1
Prendergast, ML1
Urada, D1
Podus, D1
Sethi, AK1
Gallant, JE1
Fontdevila, J1
Voisin, D1
Pitchell, P1
Craib, KJ1
Currie, S1
O'Shaughnessy, MV1
Schechter, MT1
Quang-Cantagrel, ND1
Wallace, MS1
Ashar, N1
Mathews, C1
Tian, S1
Guo, CJ1
Douglas, SD1
Ho, WZ1
Steffen, T1
Blättler, R1
Gutzwiller, F1
Zwahlen, M1
Lines, R1
Calvo, R1
Lukas, JC1
Rodriguez, M1
Carlos, MA1
Suarez, E1
Boffito, M1
Rossati, A1
Hoggard, PG1
Di Perri, G1
Reynolds, H1
Boyle, N1
Barry, M1
Iguchi, M1
Khalsa, J1
Genser, S1
Vocci, F1
Francis, H1
Bean, P1
Beck, M1
Mirmohammadsadegh, A1
Franz, B1
Blanke, J1
Hengge, UR1
Kay, RW1
Serraino, D1
Dawe, S1
Gerada, C1
Gachupin-Garcia, A1
Budner, NS1
Gill, K1
Nolimal, D2
Crowley, TJ2
Loimer, N2
Tschan, F1
Tueller, N1
Wenston, J1
Sotheran, JL1
Maslansky, R1
Stimson, G1
Mattick, R1
Dixon, J1
Schwartz, EL1
Brechbühl, AB1
Kahl, P1
Miller, MA1
Greenwood, J1
Vering, A1
Seeger, J1
Becker, S1
Halberstadt, E2
Bender, HG2
Chamot, E1
de Saussure, P1
Perrin, LH1
Amsel, Z1
Hartmann, L1
Jahn, K1
Beck, L1
Siddiqi, Q1
Freeman, RC1
Lipton, DS1
Wongsuwan, B1
Wongpanich, K1
Banks, SE1
Ajuluchukwu, D1
Werner, E1
Hollerer, E1
Pfersmann, V1
Schmid-Siegel, B1
Presslich, O1
Ochshorn, M1
Täschner, KL1
Schinke, SP1
Nichols, S1
Botvin, GJ1
Orlandi, MA1
Opravil, M1
Siegenthaler, W1
Lüthy, R1
Tokåker, PO1
Spångberg, L1
Pehrson, P1
Klee, H1
Faugier, J1
Hayes, C1
Morris, J1
Persico, AM1
Di Giannantonio, M1
Tempesta, E1
Böcker, FM1
Hofmeister-Wagner, WD1
Peters, M1
Streidl, C1
Radlbeck, J1
Wolk, J1
Guinan, JJ1
Macaskill, P1
Simpson, JM1
Chalmers, JW1
Walger, P2
Baumgart, P2
Wilke, G2
Kupfer, U2
von Eiff, M2
Dorst, KG2
Skogstad, M1
Williams, H1
Mullan, E1
O'Connor, JJ1
Kinsella, A1
Hartgers, C1
Buning, EC1
van Santen, GW1
Verster, AD1
Scheele, W1
Maude-Griffin, P1
DiPhilipis, D1
Chu, A1
Banks, S1
Primm, BJ1
Feingold, AR1
Iezza, A1
Satyadeo, M1
Colley, J1
Torres, R1
Shaw, JF1

Clinical Trials (40)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial (BRAVO)[NCT01936857]Phase 4281 participants (Actual)Interventional2015-07-31Completed
Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics[NCT04706624]640 participants (Anticipated)Interventional2020-11-02Active, not recruiting
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia[NCT02396979]Phase 4300 participants (Actual)Interventional2010-01-31Completed
Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China[NCT01647191]240 participants (Actual)Interventional2011-07-01Completed
A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail[NCT02334215]225 participants (Actual)Interventional2014-12-15Completed
Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs[NCT03282890]237 participants (Actual)Interventional2017-11-20Completed
Feasibility of an Interventional Project to Reduce HIV Incidence Among People Who Inject Drugs in Haiphong, Viet Nam[NCT02573948]603 participants (Actual)Observational2014-09-30Completed
DRIVE (DRug Use and Infections in ViEtnam) Project : Ending the HIV Epidemic Among Persons Who Inject Drugs in Hai Phong, Viet Nam[NCT03526939]5,546 participants (Actual)Observational2016-10-17Completed
Integrated Treatment and Prevention for People Who Inject Drugs: A Vanguard Study for a Network-based Randomized HIV Prevention Trial Comparing an Integrated Intervention Including Supported Antiretroviral Therapy to the Standard of Care[NCT02935296]Phase 31,281 participants (Actual)Interventional2015-02-28Completed
INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit to Link Persons Who Inject Drugs to Integrated Care and Prevention for Addiction, HIV, HCV and Primary Care[NCT04804072]450 participants (Anticipated)Interventional2021-06-02Enrolling by invitation
A Multiple-Dose Clinical Trial to Study the Effect of MK-1439 (Doravirine) on Methadone Pharmacokinetics[NCT02715700]Phase 114 participants (Actual)Interventional2015-09-28Completed
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Duloxetine and Methadone for the Treatment of HIV-Associated Painful Peripheral Neuropathy[NCT00863057]Phase 215 participants (Actual)Interventional2009-05-31Terminated (stopped due to Due to slow rate of enrollment, which compromised the ability to meet study objectives in a timely manner.)
Suboxone and Methadone for HIV Risk Reduction in Subutex Injectors[NCT01131273]Phase 368 participants (Actual)Interventional2010-06-30Completed
Starting Treatment With Agonist Replacement Therapies (START)[NCT00315341]Phase 41,269 participants (Actual)Interventional2006-04-30Completed
A Prospective, Single Arm, Open-label 96 Week Observational Trial of the Tolerability, Adherence and Efficacy of a Dolutegravir/Abacavir/Lamivudine Single Tablet Regimen in HIV-1 Antibody Positive People Living With HIV With a History of Injection Drug Us[NCT02659761]Phase 450 participants (Anticipated)Interventional2016-11-30Recruiting
[NCT01059747]500 participants (Anticipated)Observational2008-12-31Recruiting
Towards Ending HCV Infection Among Active Drug Users: a Community-based Intervention in Montpellier.[NCT04008927]554 participants (Actual)Interventional2020-09-18Completed
Towards HCV Elimination: Evaluation of an Integrated Model of HCV Care Targeting People Who Inject Drugs in Hai Phong, Vietnam[NCT03537196]Phase 4979 participants (Actual)Interventional2018-11-13Completed
Peer Supported Collaborative Care to Increase Engagement in Mental Health and Substance Use Disorder Care in HIV Care Settings[NCT04601064]400 participants (Anticipated)Interventional2022-04-20Recruiting
An Open-label, Randomised Pilot Study Comparing the Efficacy, Safety and Tolerability of Raltegravir With Protease Inhibitor-based Therapy in Treatment-naïve, HIV/Hepatitis C Co-infected Injecting Drug Users Receiving Methadone[NCT01105611]Phase 440 participants (Anticipated)Interventional2010-08-31Recruiting
A Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand[NCT00006327]Phase 32,500 participants Interventional1999-03-31Completed
HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs[NCT00084175]Phase 3630 participants Interventional2004-04-30Completed
Directly Observed Therapy for Community-Released HIV+ Prisoners[NCT00786396]151 participants (Actual)Interventional2004-07-31Completed
Phase 1b Single Dose Clinical Trial of a Novel Long-Acting Bispecific Antibody in People With HIV to Inform Development for HIV Pre- and Post-Exposure Prophylaxis[NCT05890963]Phase 120 participants (Anticipated)Interventional2023-11-28Recruiting
Efficacy of Drug and Risk Behavior Counseling Intervention Among Injecting Drug Users at Opioid Substitution Treatment[NCT03721380]118 participants (Actual)Interventional2012-05-14Completed
The Behavioral Activation for Chinese Substance Users (C-BA) Research Protocol[NCT03705143]90 participants (Actual)Interventional2018-06-04Completed
Integrating Buprenorphine Into the SFGH AIDS Program (Patient Evaluation Study)[NCT00263458]Phase 437 participants (Actual)Interventional2005-12-31Completed
Bictegravir in the Elderly Living With HIV: Impact of Polypharmacy and Multimorbidity (BICEP)[NCT05064020]162 participants (Anticipated)Observational2020-08-01Active, not recruiting
Entry Into Comprehensive Methadone Treatment Via Interim Maintenance[NCT00712036]230 participants (Actual)Interventional2008-06-30Completed
Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone in Human Subjects[NCT00504413]Phase 120 participants (Anticipated)Interventional2007-07-31Recruiting
HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence[NCT01369056]150 participants (Actual)Interventional2010-07-31Completed
Secondary HIV Prevention and Adherence Among HIV-infected Drug Users[NCT01741311]133 participants (Actual)Interventional2012-09-30Completed
A Randomized Community Intervention Trial on Reducing HIV Infection Among Drug Users Attending Methadone Maintenance Treatment(MMT) and Preventing Secondary Transmission From HIV Positive Clients to Their Sexual Partners in China[NCT01108614]Phase 312,000 participants (Anticipated)Interventional2009-06-30Recruiting
[NCT00292123]Phase 1200 participants (Actual)Interventional1999-06-30Completed
Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care[NCT01621711]504 participants (Actual)Interventional2011-03-31Active, not recruiting
Methadone Effects on Zidovudine (ZDV, AZT) Disposition[NCT00000800]Phase 115 participants InterventionalCompleted
A Pilot Randomized Comparative Effectiveness Clinical Trial of Buprenorphine vs. Methadone for the Treatment of Opioid Dependence in Pregnancy.[NCT03098407]55 participants (Actual)Interventional2017-04-20Completed
Women's Interagency HIV Study (WIHS)[NCT00000797]4,982 participants (Anticipated)Observational1994-10-31Active, not recruiting
The Effect of HIV Protease Inhibitors on the Stereospecific Metabolism of Methadone in HIV-Infected Subjects[NCT00000906]Phase 112 participants InterventionalCompleted
Pharmacokinetic Study of the Interaction of Azidothymidine and Methadone in Patients With AIDS and ARC[NCT00001008]18 participants InterventionalCompleted
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants in Receipt of Antiretroviral Therapy (ART)

Initiation of and retention on treatment with antiretroviral medications. (NCT01936857)
Timeframe: 12 months

InterventionParticipants (Count of Participants)
Buprenorphine/Naloxone108
Methadone Maintenance Therapy116

Number of Participants in Retention in HIV Care

HIV clinic visit in past 3 months (NCT01936857)
Timeframe: 12 months

InterventionParticipants (Count of Participants)
Buprenorphine/Naloxone111
Methadone Maintenance Therapy118

Participants With Heroin Use (Self-report)

(NCT01936857)
Timeframe: 12 months

InterventionParticipants (Count of Participants)
Buprenorphine/Naloxone64
Methadone Maintenance Therapy67

Participants With Heroin Use (Urine Drug Screen)

(NCT01936857)
Timeframe: 12 months

InterventionParticipants (Count of Participants)
Buprenorphine/Naloxone66
Methadone Maintenance Therapy72

Number of Participants With HIV Viral Suppression

HIV-1 RNA < 200 copies/mL (NCT01936857)
Timeframe: 12 months

,
InterventionParticipants (Count of Participants)
Viral suppression at baselineViral suppression at 12 months
Buprenorphine/Naloxone9774
Methadone Maintenance Therapy9299

Cost of Substance Abuse Services

Cost in US Dollars of substance abuse services on the modified Substance Abuse Services Cost Analysis Program (NCT02334215)
Timeframe: 12 months post-release from incarceration

InterventionUS Dollars (Mean)
Methadone Plus Patient Navigation3052
Methadone2377
Enhanced Treatment as Usual1884

Days of Hospitalization (Health Care Utilization) on the Economic Form 90 (EF-90)

Mean number of days hospitalized during the 12 months post-release from incarceration (NCT02334215)
Timeframe: 12 months post-release from incarceration

InterventionDays (Mean)
Methadone Plus Patient Navigation2.0
Methadone3.4
Enhanced Treatment as Usual1.2

Number of Participants With Arrests

Official data on participant arrests subsequent to release from index incarceration. (NCT02334215)
Timeframe: one year post-release from incarceration

InterventionParticipants (Count of Participants)
Methadone Plus Patient Navigation32
Methadone39
Enhanced Treatment as Usual36

Predicted Probability Derived From the General Linear Mixed Model of Entry Into Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form

Predicted probability derived from the general linear mixed model of self-reported entry into treatment for opioid use disorder following release from incarceration and being in treatment 30 days post-release (0= no entry in treatment; 1= entry in treatment). (NCT02334215)
Timeframe: 30 days post-release from incarceration

InterventionProbability (Least Squares Mean)
Methadone Plus Patient Navigation0.65
Methadone0.62
Enhanced Treatment as Usual0.225

Drug Risk Score on the Risk Assessment Battery (RAB)

Drug Risk Scale Score on the Risk Assessment Battery. The scale's range goes from 0 to 22. Higher score represents greater frequency of drug risk behaviors (NCT02334215)
Timeframe: Baseline and 6, and 12 months post-release from incarceration

,,
Interventionscore on a scale (Least Squares Mean)
Baseline6 month post-release from incarceration12 month post-release
Enhanced Treatment as Usual3.112.161.03
Methadone2.431.811.35
Methadone Plus Patient Navigation2.301.52.50

Environmental Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)

Environmental domain score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. A higher score represents a better quality of life. (NCT02334215)
Timeframe: 1, 3, 6, and 12 months post-release from incarceration

,,
Interventionscore on a scale (Least Squares Mean)
Baseline1 months post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual54.965.163.757.259.3
Methadone54.663.655.160.659.4
Methadone Plus Patient Navigation48.056.151.959.054.8

Mean Number of Days of Criminal Activity in the Past 30 Days Reported by Participants on the Addiction Severity Index (ASI)

Mean number of days reported by participants of their criminal activity during the 30 days preceding the Addiction Severity Index interviews (NCT02334215)
Timeframe: 1, 3, 6, and 12 months post-release from incarceration

,,
InterventionDays (Least Squares Mean)
1 month post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual8.2210.5911.4910.18
Methadone8.189.359.749.97
Methadone Plus Patient Navigation5.229.799.246.88

Mean Number of Days of Illicit Opioid Use Reported by Participants in the Past 30 Days

Mean number of participant self-reported days of heroin use in the 30 days preceding the interview on the Addiction Severity Index (ASI) (NCT02334215)
Timeframe: 1, 3, 6, and 12 months post-release from incarceration

,,
InterventionDays (Least Squares Mean)
1 month post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual14.8816.1815.4215.35
Methadone12.0715.1514.0214.70
Methadone Plus Patient Navigation8.6613.4613.5612.35

Overall Quality of Life Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)

Self report quality of life as reported by participants following release from their index incarceration on a scale from 1 to 5. A higher score is a better outcome. (NCT02334215)
Timeframe: 1, 3, 6, and 12 month post-release from incarceration

,,
Interventionunits on a scale (Least Squares Mean)
Baseline1 month post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual3.13.403.573.533.45
Methadone2.83.563.463.583.43
Methadone Plus Patient Navigation2.73.493.153.513.29

Participant Self-reported Mean Number of Days of Cocaine Use in the Past 30 Days

Participant self-reported mean number of days of cocaine use in the 30 days preceding the interview on the Addiction Severity Index (ASI) (NCT02334215)
Timeframe: 1, 3, 6, and 12 months post-release from incarceration

,,
InterventionDays (Least Squares Mean)
1 month post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual11.0111.9411.9412.63
Methadone9.0511.3213.5714.46
Methadone Plus Patient Navigation5.958.8310.749.60

Physical Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)

The score on the Physical Domain Scale of the World Health Organization Quality of Life Scale-BREF (WHOQOL-BREF). The scales range is from 0 to 100. The higher score represents better quality of life. (NCT02334215)
Timeframe: 1, 3, 6, and 12 months post-incarceration

,,
Interventionscore on a scale (Least Squares Mean)
Baseline1 months post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual57.168.767.361.260.3
Methadone58.362.260.166.363.8
Methadone Plus Patient Navigation54.662.860.368.663.1

Predicted Probability Derived From Generalized Linear Mixed Model of Meeting Opioid Use Disorder Criteria as Determined by the Modified Composite International Diagnostic Interview (CIDI)

Predicted probability derived from the Generalized Linear Mixed Model of meeting the Data and Statistical Manual - 5 criteria for Opioid Use Disorder in response to modified CIDI interview (0= does not meet criteria; 1= meets criteria). (NCT02334215)
Timeframe: one month period prior to the 3, 6, and 12 month post-release from incarceration

,,
InterventionProbability (Least Squares Mean)
3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual0.760.770.59
Methadone0.700.590.77
Methadone Plus Patient Navigation0.660.510.54

Predicted Probability Derived From the Generalized Linear Mixed Model of Being Retained in Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form

Predicted Probability derived from the Generalized Linear Mixed of self-reported enrolled in treatment for Opioid Use Disorder at the time of the follow-up interview (0=not enrolled; 1=enrolled). (NCT02334215)
Timeframe: 12 months post-release from incarceration

,,
InterventionProbability (Least Squares Mean)
1 month post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual.26.19.24.29
Methadone.56.47.52.27
Methadone Plus Patient Navigation.63.57.52.40

Predicted Probability Derived From the Generalized Linear Mixed Model of Meeting Cocaine Use Disorder Criteria in the Past 30 Days

Predicted Probability Derived from the Generalized Linear Mixed Model meeting Data and Statistical Manual - 5 criteria for Cocaine Use Disorder on the modified Composite International Diagnostic Interview (CIDI) (0=Does not meet criteria; 1=meets criteria). (NCT02334215)
Timeframe: 3, 6, and 12 months post-release from incarceration

,,
InterventionProbability (Least Squares Mean)
3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual.32.36.30
Methadone.32.35.40
Methadone Plus Patient Navigation.20.22.32

Predicted Probability Derived From the Generalized Linear Mixed Model of Opioid Urine Test Positive Results Over Time

Predicted probability derived from the generalized linear mixed model opioid positive urine tests (0= negative; 1- positive) for heroin, oxycodone, methadone, or buprenorphine -- excluding the latter two positives when they results from prescribed medications to treat opioid use disorder) (NCT02334215)
Timeframe: 1, 3, 6, and 12 months post-release from incarceration

,,
InterventionProbability (Least Squares Mean)
1 month post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual0.660.730.710.59
Methadone0.720.720.630.71
Methadone Plus Patient Navigation0.700.590.490.46

Psychological Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)

Scale score on the Psychological Domain on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life. (NCT02334215)
Timeframe: 1, 3, 6, and 12 months post-release from incarceration

,,
Interventionscore on a scale (Least Squares Mean)
Baseline1 month post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual55.966.766.664.864.4
Methadone56.964.061.263.961.8
Methadone Plus Patient Navigation56.865.562.664.962.0

Sex Risk Score on the Risk Assessment Battery (RAB)

Sex Risk Score on the Risk Assessment Battery (RAB). Higher scores represents greater risk. The score ranges from 0 to 18. (NCT02334215)
Timeframe: Baseline and 6, and 12 months post-release from incarceration

,,
Interventionscore on a scale (Least Squares Mean)
Baseline6 months post-release12 month post-release
Enhanced Treatment as Usual4.684.274.17
Methadone4.783.944.61
Methadone Plus Patient Navigation4.523.933.78

Social Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)

Social domain scale score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life. (NCT02334215)
Timeframe: 1, 3, 6, and 12 month post-release from incarceration

,,
Interventionscore on a scale (Least Squares Mean)
Baseline1 month post-release from incarceration3 months post-release from incarceration6 months post-release from incarceration12 months post-release from incarceration
Enhanced Treatment as Usual51.364.966.458.859.1
Methadone57.757.562.463.355.4
Methadone Plus Patient Navigation56.963.660.963.356.6

HCV Seroconversion

Number of new HCV infection among HCV negative (at RDS) cohort participants over 1 year period (NCT02573948)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
HCV Negative Cohort Participants18

HIV Incidence

HIV incidence was calculated by 100person/year. With zero conversion, we choose 2.5% unilateral confidence interval. (NCT02573948)
Timeframe: 52 weeks

Interventioninfections per 100 person-years (Number)
HIV Negative Cohort Participants0

HIV Seroconversion

Number of new HIV infection among HIV negative (at RDS) cohort participants over 1 year period. (NCT02573948)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
HIV Negative Cohort Participants0

Incidence of HCV Infection

The HCV incidence was calculated by 100person/year (NCT02573948)
Timeframe: 52 weeks

Interventioninfections per 100 person-years (Number)
HCV Negative Cohort Participants19.4

Number of Cohort Participants Attending the Last Follow-up Visit at W52

Number of participants who were followed up and not lost to follow-up after enrolment into cohort. (NCT02573948)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
PWID Cohort194

Area Under the Concentration-Time Curve From Zero to 24 Hours After Dosing (AUC0-24) of R-Methadone

The AUC0-24 of the R- methadone enantiomer was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by liquid chromatographic-tandem mass spectrometric (LC-MS/MS) detection. The lower limit of quantification (LLoQ) was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

Interventionng*hr/mL/mg (Geometric Mean)
Maintenance Methadone55.8
Maintenance Methadone + Doravirine53.2

AUC0-24 of S-Methadone

The AUC0-24 of the S- methadone enantiomer was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

Interventionng*hr/mL/mg (Geometric Mean)
Maintenance Methadone52.0
Maintenance Methadone + Doravirine50.8

AUC0-24 of Total Methadone

The AUC0-24 of total methadone was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

Interventionng*hr/mL/mg (Geometric Mean)
Maintenance Methadone109
Maintenance Methadone + Doravirine105

C24 of S-Methadone

The C24 of the S- methadone enantiomer was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: 24 hours postdose on Day 1 and Day 6

Interventionng/mL/mg (Geometric Mean)
Maintenance Methadone1.51
Maintenance Methadone + Doravirine1.47

C24 of Total Methadone

The C24 of total methadone was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: 24 hours postdose on Day 1 and Day 6

Interventionng/mL/mg (Geometric Mean)
Maintenance Methadone3.48
Maintenance Methadone + Doravirine3.34

Cmax of S-Methadone

The Cmax of the S- methadone enantiomer was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

Interventionng/mL/mg (Geometric Mean)
Maintenance Methadone3.77
Maintenance Methadone + Doravirine3.67

Cmax of Total Methadone

The Cmax of total methadone was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

Interventionng/mL/mg (Geometric Mean)
Maintenance Methadone7.19
Maintenance Methadone + Doravirine7.01

Maximum Plasma Concentration (Cmax) of R-Methadone

The Cmax of the R- methadone enantiomer was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

Interventionng/mL/mg (Geometric Mean)
Maintenance Methadone3.41
Maintenance Methadone + Doravirine3.33

Plasma Concentration at 24 Hours After Dosing (C24) of R-Methadone

The C24 of the R- methadone enantiomer was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: 24 hours postdose on Day 1 and Day 6

Interventionng/mL/mg (Geometric Mean)
Maintenance Methadone1.91
Maintenance Methadone + Doravirine1.82

Time to Maximum Plasma Concentration (Tmax) of R-Methadone

The Tmax of the R- methadone enantiomer was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

InterventionHours (Median)
Maintenance Methadone2.00
Maintenance Methadone + Doravirine2.01

Tmax of S-Methadone

The Tmax of the S- methadone enantiomer was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

InterventionHours (Median)
Maintenance Methadone1.99
Maintenance Methadone + Doravirine2.00

Tmax of Total Methadone

The Tmax of total methadone was determined on Day 1 (methadone alone) and on Day 6 (methadone + doravirine). Plasma samples collected for methadone assay were analyzed for R- and S-methadone concentrations by Pharma Medica Research Inc. (Ontario, Canada). The analytical method used liquid-liquid extraction for analyte isolation followed by LC-MS/MS detection. The LLoQ was 0.0250 ng/mL for each enantiomer. The analytical range was 0.0250 - 15.0 ng/mL. (NCT02715700)
Timeframe: Predose and 0.5, 1, 1.5, 2, 3, 4, 6, 12, 16, and 24 hours postdose on Day 1 and Day 6

InterventionHours (Median)
Maintenance Methadone2.00
Maintenance Methadone + Doravirine2.01

Emotional Functioning as Measured by the Center for Epidemiologic Studies Depression Scale (CES-D)

The CES-D is a 20-item self-report rating inventory measuring characteristic attitudes and symptoms of depression. Participants were asked to score each item: (0) Rarely, (1) Occasionally, (2) Sometimes, and (3) Most of time. Some items are multiplied by -1 to change direction. The overall CES-D score is simply the sum of 20 items. The highest possible total CES-D score is 48, and the lowest possible score is -12. The total CES-D score is considered missing if more than 4 items are not answered. (NCT00863057)
Timeframe: At the fourth treatment week of each treatment period

InterventionScores on a scale (Mean)
Duloxetine and Methadone13.8
Duloxetine and Methadone Placebo13.8
Duloxetine Placebo and Methadone13.3
Duloxetine Placebo and Methadone Placebo13.3

Maximum Tolerated Dose of Duloxetine and Methadone

(NCT00863057)
Timeframe: During each treatment period

Interventionmg (Number)
Methadone30
Duloxetine60

Mean Nighttime Pain Measure on an 11-point Likert Scale

"Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=''No pain to 10=''Pain as bad as you can imagine.~Participants were given pain diaries at weeks 0, 5, 10, and 15. They started the diary 7 days prior to their clinic visits at weeks 0, 4, 9, 14, and 19. During the 7 days, each morning, they recorded their pain level due to neuropathy by circling the number that best described their neuropathy pain on average during the night time." (NCT00863057)
Timeframe: Over the fourth treatment week of each treatment period

InterventionScores on a scale (Mean)
Duloxetine and Methadone5.20
Duloxetine and Methadone Placebo5.82
Duloxetine Placebo and Methadone5.90
Duloxetine Placebo and Methadone Placebo6.10

Number of Participants With 30% or More Improvement in Mean Pain Score on an 11-point Likert Scale

"Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=''No pain to 10=''Pain as bad as you can imagine at baseline and over the fourth treatment week of each treatment period.~The % of improvement was calculated as (x-y)/x,where x was the MPI score at baseline, and y was the MPI score at the end of each treatment stage." (NCT00863057)
Timeframe: At Baseline and over the fourth treatment week of each treatment period

Interventionparticipants (Number)
Duloxetine and Methadone2
Duloxetine and Methadone Placebo2
Duloxetine Placebo and Methadone2
Duloxetine Placebo and Methadone Placebo2

Number of Participants With 50% or More Improvement in Mean Pain Score on an 11-point Likert Scale

"Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=''No pain to 10=''Pain as bad as you can imagine at baseline and over the fourth treatment week of each treatment period.~The % of improvement was calculated as (x-y)/x,where x was the MPI score at baseline, and y was the MPI score at the end of each treatment stage." (NCT00863057)
Timeframe: At Baseline and over the fourth treatment week of each treatment period

Interventionparticipants (Number)
Duloxetine and Methadone2
Duloxetine and Methadone Placebo2
Duloxetine Placebo and Methadone1
Duloxetine Placebo and Methadone Placebo2

Number of Participants With Treatment-emergent Grade 2 to 4 Adverse Events

The DAIDS Table for Grading the Severity of Adult and Pediatric Adverse Events (DAIDS AE Grading Table), Version 1.0, December 2004 was used (see the link to the grading table in Protocol Section) (NCT00863057)
Timeframe: From study entry to end of study at week 20 or premature study discontinuation

InterventionParticipants (Count of Participants)
Duloxetine and Methadone5
Duloxetine and Methadone Placebo4
Duloxetine Placebo and Methadone6
Duloxetine Placebo and Methadone Placebo5

Pain-related Interference Measured by the Brief Pain Inventory (BPI) Interference Items

"The BPI interference scale measured level of interference with the following seven items:~General activity~Mood~Walking ability~Normal work~Relations with other people~Sleep~Enjoyment of life~Interference scales range from 0='Does not interfere' to 10='Completely interferes'. The overall BPI score is the mean of seven item with the minimum and maximal scores of 0 and 70, respectively." (NCT00863057)
Timeframe: At the fourth week of each treatment period

InterventionScores on a scale (Median)
Duloxetine and Methadone3.14
Duloxetine and Methadone Placebo4.14
Duloxetine Placebo and Methadone3.64
Duloxetine Placebo and Methadone Placebo3.14

Weekly Mean Pain Score Derived From Self-reported Average Daily Pain Intensity on an 11-point Likert Scale

"Pain was measured on an 11-point Likert numerical rating scale, ranging from 0=''No pain to 10=''Pain as bad as you can imagine.~Participants were given pain diaries at weeks 0, 5, 10, and 15. They started the diary 7 days prior to their clinic visits at weeks 0, 4, 9, 14, and 19. During the 7 days, each morning, they recorded their pain level due to neuropathy by circling the number that best described their neuropathy pain on average over the past 24 hours." (NCT00863057)
Timeframe: During the fourth treatment week of each treatment period

InterventionScores on a scale (Mean)
Duloxetine and Methadone5.20
Duloxetine and Methadone Placebo5.91
Duloxetine Placebo and Methadone6.20
Duloxetine Placebo and Methadone Placebo5.70

Patient and Clinician Global Impression of Change (PGIC and CGIC) on a 7-point Likert Scale

"The GIC scale is a validated instrument that consists of seven verbal descriptors on a 7-point scale:~Very much improved~Much improved~Minimally improved~No change~Minimally worse~Much worse~Very much worse~Participants were carefully instructed to consider the impact of study treatments on their level of neuropathic pain intensity during the baseline phase of the study." (NCT00863057)
Timeframe: At the fourth treatment week of each treatment period

,,,
Interventionparticipants (Number)
PGIC - Very much improvedPGIC - Much improvedPGIC - Minimally improvedPGIC - No changePGIC - Much worseCGIC - Very much improvedCGIC - Much improvedCGIC - Minimally improvedCGIC - No changeCGIC - Much worse
Duloxetine and Methadone1423014140
Duloxetine and Methadone Placebo0146011180
Duloxetine Placebo and Methadone1242113330
Duloxetine Placebo and Methadone Placebo1144011341

Use of Rescue Medication (Acetaminophen)

(NCT00863057)
Timeframe: During each treatment period and the subsequent cross-over (or final study week) period

,,,
Interventionparticipants (Number)
Treatment period (1-4, 6-9, 11-14, 16-19 weeks)Cross-over period (5, 10, 15, 20 weeks)
Duloxetine and Methadone01
Duloxetine and Methadone Placebo00
Duloxetine Placebo and Methadone01
Duloxetine Placebo and Methadone Placebo21

Hepatic Safety

"Participants were categorized according liver transaminase (ALT, AST) levels in blood comparing the baseline sample to any and all subsequent samples in the following manner:~A: both ALT and AST started at less than or equal to two times the ULN and remained at two times or less ULN throughout the study~B: either ALT or AST started at less than or equal to 2 x ULN and at any point in study exceeded 2 x ULN~C: Either ALT or AST started > 2 x ULN, decreased (both ALT and AST) to < 2 x ULN, and remained < 2 x ULN~D: Either ALT or AST started > 2 x ULN and remained above 2 x ULN throughout the study" (NCT00315341)
Timeframe: 24 Weeks

,
Interventionparticipants (Number)
ALT - A (low, stays low)ALT - B (low, goes high)ALT - C (high, goes low, stays low)ALT - D (high, stays high)AST - A (low, stay low)AST - B (low, goes high)AST - C (high, goes low, stays low)AST - D (high, stays high)
Buprenorphine/Nx278414172913739
Methadone318621103285418

Reviews

76 reviews available for methadone and HIV Coinfection

ArticleYear
Side Effects of Chronic Methadone Use in Opioid Addiction: A Scoping Review on Hematological Derangements.
    Current drug safety, 2023, Volume: 18, Issue:2

    Topics: Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Methadone; Opioid-Related D

2023
The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV.
    Current HIV/AIDS reports, 2019, Volume: 16, Issue:5

    Topics: Analgesics, Opioid; Buprenorphine; Cardiovascular Diseases; HIV Infections; Humans; Inflammation; Me

2019
Opioid substitution therapy for people living in German prisons-inequality compared with civic sector.
    Harm reduction journal, 2019, 12-21, Volume: 16, Issue:1

    Topics: Delivery of Health Care; Female; Germany; Healthcare Disparities; Hepatitis C, Chronic; HIV Infectio

2019
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Methadone maintenance therapy service components linked to improvements in HIV care cascade outcomes: A systematic review of trials and observational studies.
    Drug and alcohol dependence, 2021, 01-01, Volume: 218

    Topics: Adult; Delivery of Health Care; Female; HIV Infections; Humans; Male; Methadone; Observational Studi

2021
Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean, and Black people: a systematic review.
    JBI evidence synthesis, 2021, Volume: 19, Issue:8

    Topics: Cohort Studies; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Randomized Control

2021
Serotonin syndrome due to co-administration of linezolid and methadone.
    Le infezioni in medicina, 2017, Sep-01, Volume: 25, Issue:3

    Topics: Adult; Anti-HIV Agents; Drug Synergism; Drug Therapy, Combination; HIV Infections; Humans; Linezolid

2017
Medications for Treatment of Opioid Use Disorder among Persons Living with HIV.
    Current HIV/AIDS reports, 2019, Volume: 16, Issue:1

    Topics: Buprenorphine; HIV Infections; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Treatment Ou

2019
Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned.
    Journal of clinical pharmacology, 2019, Volume: 59, Issue:8

    Topics: Analgesics, Opioid; Antiviral Agents; Cytochrome P-450 CYP2B6; Drug Interactions; Hepatitis C; HIV I

2019
A randomized controlled trial to evaluate the relative efficacy of the addition of a psycho-social intervention to standard-of-care services in reducing attrition and improving attendance among first-time users of methadone maintenance treatment in China.
    AIDS and behavior, 2013, Volume: 17, Issue:6

    Topics: Adult; China; Female; Heroin Dependence; HIV Infections; Humans; Male; Medication Adherence; Methado

2013
Mitigating the risk of HIV infection with opioid substitution treatment.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; Comorbidity; Evidence-Based Medicine; Harm Red

2013
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.
    Expert review of clinical pharmacology, 2013, Volume: 6, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Anti-Retroviral Agents; Buprenorphine; Drug

2013
Review on the demographic and social impact of methadone-medication therapy on Malaysian patients.
    Pakistan journal of pharmaceutical sciences, 2013, Volume: 26, Issue:4

    Topics: Adult; Cross-Sectional Studies; Employment; Female; Hepatitis C; HIV Infections; Humans; Malaysia; M

2013
Oculomotor disturbances in HIV-positive individuals treated with methadone.
    Postepy higieny i medycyny doswiadczalnej (Online), 2014, Dec-04, Volume: 68

    Topics: Anti-Retroviral Agents; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Drug Interactions; H

2014
Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.
    The Annals of pharmacotherapy, 2015, Volume: 49, Issue:7

    Topics: Analgesics, Opioid; Antiviral Agents; Coinfection; Drug Interactions; Hepatitis C; HIV Infections; H

2015
Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.
    Current HIV research, 2016, Volume: 14, Issue:5

    Topics: AIDS Dementia Complex; Analgesics, Opioid; Blood-Brain Barrier; Buprenorphine; Cell Movement; HIV In

2016
Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 10-15, Volume: 63, Issue:8

    Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; CD4 Lymphocyte Count;

2016
Drug addiction in China.
    Annals of the New York Academy of Sciences, 2008, Volume: 1141

    Topics: Adolescent; Adult; Alcoholism; China; Female; Health Policy; HIV Infections; Humans; Illicit Drugs;

2008
A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
    European addiction research, 2009, Volume: 15, Issue:2

    Topics: Buprenorphine; Heroin Dependence; HIV Infections; Humans; International Cooperation; Methadone; Nalt

2009
The implications of medication development in the treatment of substance use disorders in developing countries.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Comorbidity; Developing Countries; Disul

2009
Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review.
    Addiction (Abingdon, England), 2010, Volume: 105, Issue:2

    Topics: Buprenorphine; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Methadone; Narcotics;

2010
[Utility of atazanavir in special populations].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 17

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardi

2008
[Etravirine in first-line therapy].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27 Suppl 2

    Topics: Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Interactions; Drug Res

2009
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
    Lancet (London, England), 2010, Mar-20, Volume: 375, Issue:9719

    Topics: Africa; Anti-Retroviral Agents; Buprenorphine; Europe; HIV Infections; Humans; Methadone; Middle Eas

2010
Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    The International journal on drug policy, 2010, Volume: 21, Issue:5

    Topics: Alcoholism; Analgesics, Opioid; Health Services Accessibility; HIV Infections; Humans; Iran; Methado

2010
Methadone, buprenorphine, and street drug interactions with antiretroviral medications.
    Current HIV/AIDS reports, 2010, Volume: 7, Issue:3

    Topics: Analgesics, Opioid; Anti-HIV Agents; Buprenorphine; Drug Interactions; HIV Infections; Humans; Illic

2010
Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.
    Lancet (London, England), 2010, Jul-31, Volume: 376, Issue:9738

    Topics: Anti-HIV Agents; Anti-Retroviral Agents; Buprenorphine; China; Cost-Benefit Analysis; Developing Cou

2010
Drug treatment as HIV prevention: expanding treatment options.
    Current HIV/AIDS reports, 2010, Volume: 7, Issue:4

    Topics: Alcoholism; Buprenorphine; Clinical Protocols; Drug Users; Health Promotion; HIV Infections; Humans;

2010
Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.
    Life sciences, 2011, May-23, Volume: 88, Issue:21-22

    Topics: Anti-HIV Agents; Buprenorphine; Cocaine; Drug Interactions; Female; HIV Infections; Humans; Methadon

2011
Evolution of information-driven HIV/AIDS policies in China.
    International journal of epidemiology, 2010, Volume: 39 Suppl 2

    Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; Blood Donors; China; Condoms; Counseling

2010
Oral substitution treatment of injecting opioid users for prevention of HIV infection.
    The Cochrane database of systematic reviews, 2011, Aug-10, Issue:8

    Topics: Administration, Oral; Buprenorphine; HIV Infections; Humans; Methadone; Narcotics; Opioid-Related Di

2011
HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
    BMC infectious diseases, 2012, Jun-08, Volume: 12

    Topics: China; Coinfection; Hepatitis C; HIV Infections; Methadone; Opiate Substitution Treatment; Prevalenc

2012
Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
    Drug and alcohol dependence, 2012, Dec-01, Volume: 126, Issue:3

    Topics: Adult; Age Factors; China; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Narcotics;

2012
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.
    BMJ (Clinical research ed.), 2012, Oct-03, Volume: 345

    Topics: Confounding Factors, Epidemiologic; Disease Transmission, Infectious; HIV Infections; Humans; Methad

2012
A triple threat. HIV, mental illness and chemical addiction.
    Advance for nurse practitioners, 2002, Volume: 10, Issue:9

    Topics: Female; HIV Infections; Humans; Mental Disorders; Methadone; Substance-Related Disorders

2002
Triple diagnosis: dual diagnosis and HIV disease, part 2.
    The AIDS reader, 2003, Volume: 13, Issue:8

    Topics: Anti-HIV Agents; Attitude to Health; Continuity of Patient Care; Cooperative Behavior; Diagnosis, Du

2003
Drug interactions associated with HAART: focus on treatments for addiction and recreational drugs.
    The AIDS reader, 2003, Volume: 13, Issue:9

    Topics: Antiretroviral Therapy, Highly Active; Drug Interactions; HIV Infections; Humans; Illicit Drugs; Met

2003
Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.
    Addiction (Abingdon, England), 2005, Volume: 100, Issue:2

    Topics: Buprenorphine; Drug Evaluation; Health Services Accessibility; HIV Infections; Humans; Methadone; Na

2005
Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-01, Volume: 41 Suppl 1

    Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; Drug Evaluation; Drug

2005
Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.
    Journal of general internal medicine, 2006, Volume: 21, Issue:2

    Topics: HIV Infections; Humans; Methadone; Narcotics; Substance Abuse, Intravenous

2006
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.
    Journal of acquired immune deficiency syndromes (1999), 2006, Apr-15, Volume: 41, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Anti-HIV Agents; Buprenorphine; Drug Interac

2006
Opiate addiction in China: current situation and treatments.
    Addiction (Abingdon, England), 2006, Volume: 101, Issue:5

    Topics: Buprenorphine; China; Clonidine; Drugs, Chinese Herbal; HIV Infections; Humans; Methadone; Naltrexon

2006
The medical management of opioid dependence in HIV primary care settings.
    Current HIV/AIDS reports, 2006, Volume: 3, Issue:4

    Topics: Anti-HIV Agents; Buprenorphine; HIV Infections; Humans; Methadone; Narcotic Antagonists; Narcotics;

2006
Initial strategies for integrating buprenorphine into HIV care settings in the United States.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Dec-15, Volume: 43 Suppl 4

    Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; Centers for Disease Control and Prevention, U.

2006
Buprenorphine use: the international experience.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Dec-15, Volume: 43 Suppl 4

    Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; Comorbidity; Female; Follow-Up Studies; Global

2006
Prisoners who inject drugs: public health and human rights imperatives.
    Health and human rights, 2005, Volume: 8, Issue:2

    Topics: AIDS Serodiagnosis; Global Health; Hepatitis C; HIV Infections; Human Rights; Humans; International

2005
Implementation of harm reduction in Central and Eastern Europe and Central Asia.
    The International journal on drug policy, 2007, Volume: 18, Issue:2

    Topics: Asia, Central; Community Networks; Europe; Harm Reduction; HIV Infections; Humans; Methadone; Narcot

2007
Rapid scale up of harm reduction in China.
    The International journal on drug policy, 2007, Volume: 18, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; China; Disease Outbreaks; Drug and Narcotic Control; Government

2007
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
    The International journal on drug policy, 2007, Volume: 18, Issue:4

    Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; HIV Infections; Humans; Methadone; Narcotics;

2007
Comparison of drug abuse in Germany and China.
    Acta pharmacologica Sinica, 2007, Volume: 28, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; China; Drug and Narcotic Control; Geography; Germany; Hepatitis

2007
Drug abuse in China: past, present and future.
    Cellular and molecular neurobiology, 2008, Volume: 28, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; China; Disease Outbreaks; Forecasting; History, 19th Century; Hi

2008
Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.
    Addiction (Abingdon, England), 2008, Volume: 103, Issue:6

    Topics: Analgesics, Opioid; Antiviral Agents; Delivery of Health Care, Integrated; Hepatitis C, Chronic; HIV

2008
Opiate treatments.
    Addiction (Abingdon, England), 1994, Volume: 89, Issue:11

    Topics: Combined Modality Therapy; Follow-Up Studies; HIV Infections; Humans; Methadone; Opioid-Related Diso

1994
[Do substitution treatments reduce the incidence of human immunodeficiency virus infections in intravenous heroin addicts? Review of pertinent literature].
    Annales de medecine interne, 1994, Volume: 145 Suppl 3

    Topics: Acquired Immunodeficiency Syndrome; Buprenorphine; Codeine; Female; Heroin Dependence; HIV Infection

1994
Assessing HIV prevention among injecting drug users in European Community countries: a review.
    Sozial- und Praventivmedizin, 1994, Volume: 39 Suppl 1

    Topics: Adolescent; Adult; AIDS Serodiagnosis; Counseling; Europe; Female; HIV Infections; HIV Seroprevalenc

1994
Cocaine, dopamine and the endogenous opioid system.
    Journal of addictive diseases, 1996, Volume: 15, Issue:4

    Topics: Animals; Brain; Cocaine; Dopamine; Gene Expression Regulation; HIV Infections; Humans; Methadone; Na

1996
Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.
    AIDS (London, England), 1998, Volume: 12 Suppl A

    Topics: HIV Infections; Humans; Methadone; Needle-Exchange Programs; Program Evaluation; Risk Factors; Subst

1998
The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.
    Addiction (Abingdon, England), 1998, Volume: 93, Issue:4

    Topics: Crime; HIV Infections; Humans; Methadone; Narcotics; Opioid-Related Disorders; Risk-Taking

1998
Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users.
    AIDS (London, England), 1999, Oct-01, Volume: 13, Issue:14

    Topics: Case-Control Studies; Cohort Studies; HIV Infections; Humans; Methadone; Narcotics; Prospective Stud

1999
[Preventing HIV infection: an exercise in evaluating scientific evidence in public health].
    Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17 Suppl 2

    Topics: Adult; Anti-HIV Agents; Biological Products; Clinical Trials as Topic; Evidence-Based Medicine; Fema

1999
[Special problems of HIV-positive women who are either drug abusers or on methadone replacement therapy].
    Zentralblatt fur Gynakologie, 1999, Volume: 121, Issue:11

    Topics: Cocaine; Drug Administration Schedule; Female; Germany; Heroin; HIV Infections; HIV Protease Inhibit

1999
Drug abuse treatment as an HIV prevention strategy: a review.
    Drug and alcohol dependence, 2000, Apr-01, Volume: 59, Issue:1

    Topics: Clinical Trials as Topic; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Methadone;

2000
A risk-benefit analysis of methadone maintenance treatment.
    Drug safety, 2000, Volume: 22, Issue:3

    Topics: Analgesics, Opioid; Heroin Dependence; HIV Infections; Humans; Methadone; Quality of Life; Risk Asse

2000
Antiretroviral therapy for drug users.
    International journal of STD & AIDS, 2000, Volume: 11, Issue:10

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Drug Therapy, Combination

2000
[Pregnancy and drug abuse: current situation and therapeutic strategies].
    Annales de medecine interne, 2000, Volume: 151 Suppl B

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Female; Fetal Growth Retardation; Hepatit

2000
Caring for diverse populations of HIV-infected patients.
    The AIDS reader, 2001, Volume: 11, Issue:1

    Topics: Anti-HIV Agents; Child; Drug Interactions; Female; Guidelines as Topic; HIV Infections; Humans; Meth

2001
Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs.
    Journal of consulting and clinical psychology, 2001, Volume: 69, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Health Education; HIV Infections; Huma

2001
Efavirenz therapy in drug users.
    HIV medicine, 2000, Volume: 1 Suppl 1

    Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; Drug T

2000
The challenging interactions between antiretroviral agents and addiction drugs.
    American clinical laboratory, 2002, Volume: 21, Issue:3

    Topics: Antiretroviral Therapy, Highly Active; Drug Interactions; HIV Infections; Humans; Illicit Drugs; Met

2002
Drug injecting and HIV infection: new directions for social science research.
    The International journal of the addictions, 1992, Volume: 27, Issue:2

    Topics: Cross-Cultural Comparison; Health Knowledge, Attitudes, Practice; HIV Infections; HIV Seroprevalence

1992
Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research.
    British journal of addiction, 1992, Volume: 87, Issue:3

    Topics: Heroin Dependence; HIV Infections; Humans; Methadone; Needle Sharing; Risk Factors; Sexual Behavior;

1992
[Drug abuse, pregnancy and HIV infection].
    Der Gynakologe, 1991, Volume: 24, Issue:6

    Topics: Adult; AIDS Serodiagnosis; Contraception Behavior; Female; HIV Infections; Humans; Methadone; Opport

1991
In vivo and in vitro studies of opiates and cellular immunity in narcotic addicts.
    Advances in experimental medicine and biology, 1991, Volume: 288

    Topics: Adult; Antibody Formation; Cells, Cultured; Cytotoxicity, Immunologic; Disease Susceptibility; Endor

1991
[Do we need a methadone maintenance program?].
    Der Nervenarzt, 1991, Volume: 62, Issue:9

    Topics: HIV Infections; Humans; Methadone; Opioid-Related Disorders; Risk Factors; Substance Abuse, Intraven

1991
HIV and harm reduction for injection drug users.
    AIDS (London, England), 1991, Volume: 5, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Behavior; Equipment Contamination; Health Education; HIV Infecti

1991
[Treatment of drug-dependent patients with methadone. 2: AIDS prevention by drug substitution?].
    Fortschritte der Medizin, 1991, Feb-20, Volume: 109, Issue:5

    Topics: Europe; Follow-Up Studies; Heroin Dependence; HIV Infections; HIV Seroprevalence; Humans; Methadone;

1991

Trials

87 trials available for methadone and HIV Coinfection

ArticleYear
Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam.
    The International journal on drug policy, 2022, Volume: 100

    Topics: Analgesics, Opioid; Buprenorphine; HIV Infections; Humans; Male; Methadone; Opiate Substitution Trea

2022
An adaptive design to screen, treat, and retain people with opioid use disorders who use methamphetamine in methadone clinics (STAR-OM): study protocol of a clinical trial.
    Trials, 2022, Apr-23, Volume: 23, Issue:1

    Topics: Adolescent; Amphetamine-Related Disorders; COVID-19; HIV Infections; Humans; Methadone; Methamphetam

2022
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.
    Journal of substance abuse treatment, 2022, Volume: 142

    Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Hepatitis C; HIV Infections; Humans;

2022
Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.
    BMC infectious diseases, 2022, Nov-11, Volume: 22, Issue:1

    Topics: Analgesics, Opioid; HIV Infections; Humans; Malaysia; Male; Methadone; Opiate Substitution Treatment

2022
Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study.
    AIDS research and therapy, 2022, 12-14, Volume: 19, Issue:1

    Topics: HIV Infections; Humans; Mental Disorders; Methadone; Qualitative Research; Social Stigma; Substance-

2022
Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study.
    AIDS research and therapy, 2022, 12-14, Volume: 19, Issue:1

    Topics: HIV Infections; Humans; Mental Disorders; Methadone; Qualitative Research; Social Stigma; Substance-

2022
Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study.
    AIDS research and therapy, 2022, 12-14, Volume: 19, Issue:1

    Topics: HIV Infections; Humans; Mental Disorders; Methadone; Qualitative Research; Social Stigma; Substance-

2022
Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study.
    AIDS research and therapy, 2022, 12-14, Volume: 19, Issue:1

    Topics: HIV Infections; Humans; Mental Disorders; Methadone; Qualitative Research; Social Stigma; Substance-

2022
DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.
    BMC infectious diseases, 2019, Sep-05, Volume: 19, Issue:1

    Topics: Adult; Awareness; China; Cluster Analysis; Drug Users; Efficiency, Organizational; Female; Health Kn

2019
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
HIV-Risk Behavior Among Adults with Opioid Use Disorder During 12 Months Following Pre-trial Detention: Results from a Randomized Trial of Methadone Treatment.
    AIDS and behavior, 2021, Volume: 25, Issue:4

    Topics: Adult; Baltimore; HIV Infections; Humans; Methadone; Opioid-Related Disorders; Risk-Taking

2021
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial.
    The lancet. HIV, 2021, Volume: 8, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; CD4 Lymphocyte Count;

2021
Outcomes of Methadone Maintenance Therapy Combined with Rilpivirine/Efavirenz in Treatment-Naive HIV-Infected Patients.
    Current HIV research, 2021, Volume: 19, Issue:4

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; HIV-1; Humans; Methadone; Pro

2021
Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.
    Contemporary clinical trials, 2017, Volume: 59

    Topics: Adult; Behavior Therapy; Evidence-Based Practice; Female; HIV Infections; Humans; Malaysia; Male; Me

2017
Alcohol use disorders are associated with increased HIV risk behaviors in cocaine-dependent methadone patients.
    Journal of substance abuse treatment, 2017, Volume: 83

    Topics: Adult; Alcoholism; Behavior Therapy; Cocaine-Related Disorders; Comorbidity; Female; HIV Infections;

2017
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Lancet (London, England), 2018, 09-01, Volume: 392, Issue:10149

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Feasibility Studies;

2018
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Lancet (London, England), 2018, 09-01, Volume: 392, Issue:10149

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Feasibility Studies;

2018
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Lancet (London, England), 2018, 09-01, Volume: 392, Issue:10149

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Feasibility Studies;

2018
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Lancet (London, England), 2018, 09-01, Volume: 392, Issue:10149

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Feasibility Studies;

2018
HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients.
    Journal of acquired immune deficiency syndromes (1999), 2019, 02-01, Volume: 80, Issue:2

    Topics: Adult; Anti-HIV Agents; Female; Health Surveys; HIV Infections; Humans; Interviews as Topic; Male; M

2019
Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid-dependent, human immunodeficiency virus seronegative participants.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:8

    Topics: Adult; Anti-HIV Agents; Buprenorphine, Naloxone Drug Combination; Cross-Over Studies; Drug Interacti

2019
Effect of rilpivirine on the pharmacokinetics of methadone in HIV-Infected Chinese patients.
    Expert review of clinical pharmacology, 2019, Volume: 12, Issue:6

    Topics: Adult; Anti-HIV Agents; Area Under Curve; Asian People; Dose-Response Relationship, Drug; Drug Inter

2019
Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone.
    Clinical pharmacology in drug development, 2020, Volume: 9, Issue:2

    Topics: Adult; Analgesics, Opioid; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combinatio

2020
Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia.
    HIV research & clinical practice, 2019, Volume: 20, Issue:1

    Topics: Adult; Behavior Therapy; Clinical Trials as Topic; HIV Infections; Humans; Malaysia; Male; Methadone

2019
"Damaging what wasn't damaged already": psychological tension and antiretroviral adherence among HIV-infected methadone-maintained drug users.
    AIDS care, 2013, Volume: 25, Issue:11

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Directly Observed Therapy; Eva

2013
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.
    Pain medicine (Malden, Mass.), 2013, Volume: 14, Issue:7

    Topics: Adult; Aged; Analgesics; Analgesics, Opioid; Comorbidity; Cross-Over Studies; Double-Blind Method; D

2013
A randomized controlled trial of the community-friendly health recovery program (CHRP) among high-risk drug users in treatment.
    AIDS and behavior, 2013, Volume: 17, Issue:9

    Topics: Adult; Female; Health Behavior; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Male;

2013
Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Drug and alcohol dependence, 2013, Dec-01, Volume: 133, Issue:2

    Topics: Adult; Buprenorphine; Female; Georgia (Republic); Hepatitis C; HIV Infections; Humans; Male; Methado

2013
HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.
    Journal of acquired immune deficiency syndromes (1999), 2014, Jul-01, Volume: 66, Issue:3

    Topics: Adult; Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Naloxone; Narcot

2014
Faster entry into HIV care among HIV-infected drug users who had been in drug-use treatment programs.
    Drug and alcohol dependence, 2016, Aug-01, Volume: 165

    Topics: Adolescent; Adult; Demography; Drug Users; Female; Health Services Accessibility; HIV Infections; Hu

2016
Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders.
    Drug and alcohol dependence, 2008, Nov-01, Volume: 98, Issue:1-2

    Topics: Adult; Behavior Therapy; Black People; Cocaine-Related Disorders; Female; Follow-Up Studies; Hispani

2008
Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
    Drug and alcohol dependence, 2009, Jan-01, Volume: 99, Issue:1-3

    Topics: Adolescent; Adult; Aged; Buprenorphine; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; HIV

2009
Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior.
    The journal of behavioral health services & research, 2009, Volume: 36, Issue:2

    Topics: Adult; Aged; Crime; Heroin Dependence; HIV Infections; Humans; Longitudinal Studies; Methadone; Meth

2009
Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV.
    Drug and alcohol dependence, 2009, Feb-01, Volume: 100, Issue:1-2

    Topics: Adult; Anti-Retroviral Agents; Delivery of Health Care; Drug Costs; Female; Follow-Up Studies; HIV I

2009
Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
    Addiction (Abingdon, England), 2009, Volume: 104, Issue:2

    Topics: Adult; AIDS Vaccines; Amphetamine-Related Disorders; Double-Blind Method; Female; HIV; HIV Infection

2009
Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men.
    Journal of substance abuse treatment, 2009, Volume: 37, Issue:2

    Topics: Adult; Follow-Up Studies; Health Education; Health Knowledge, Attitudes, Practice; HIV Infections; H

2009
Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.
    Contemporary clinical trials, 2009, Volume: 30, Issue:5

    Topics: Ambulatory Care Facilities; Analgesics, Opioid; Anti-HIV Agents; Directly Observed Therapy; Female;

2009
Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment.
    Addiction (Abingdon, England), 2010, Volume: 105, Issue:1

    Topics: Adult; Alcohol Drinking; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Logi

2010
Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2010, Volume: 87, Issue:4

    Topics: Anti-Retroviral Agents; Buprenorphine; Buprenorphine, Naloxone Drug Combination; CD4 Lymphocyte Coun

2010
Impact of interim methadone maintenance on HIV risk behaviors.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2010, Volume: 87, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV Infections; Humans; Male; Methadone; Middle A

2010
Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.
    Drug and alcohol dependence, 2011, Jan-15, Volume: 113, Issue:2-3

    Topics: Antiretroviral Therapy, Highly Active; Directly Observed Therapy; Female; HIV Infections; Humans; Ma

2011
Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
    AIDS research and human retroviruses, 2011, Volume: 27, Issue:5

    Topics: Adult; Amino Acid Substitution; Analgesics, Opioid; Anti-HIV Agents; Directly Observed Therapy; Drug

2011
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
    Drug and alcohol dependence, 2011, Jun-01, Volume: 115, Issue:3

    Topics: Adult; China; Counseling; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Mal

2011
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
    Drug and alcohol dependence, 2011, Jun-01, Volume: 115, Issue:3

    Topics: Adult; China; Counseling; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Mal

2011
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
    Drug and alcohol dependence, 2011, Jun-01, Volume: 115, Issue:3

    Topics: Adult; China; Counseling; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Mal

2011
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
    Drug and alcohol dependence, 2011, Jun-01, Volume: 115, Issue:3

    Topics: Adult; China; Counseling; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Mal

2011
The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.
    Journal of acquired immune deficiency syndromes (1999), 2011, Mar-01, Volume: 56 Suppl 1

    Topics: Ambulatory Care; Buprenorphine; Buprenorphine, Naloxone Drug Combination; HIV Infections; Humans; Me

2011
Conducting peer outreach to migrants: outcomes for drug treatment patients.
    Journal of immigrant and minority health, 2012, Volume: 14, Issue:2

    Topics: Adult; Community-Institutional Relations; Emigrants and Immigrants; Female; Hispanic or Latino; HIV

2012
Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:10

    Topics: Adult; Analysis of Variance; China; Female; HIV Infections; Humans; Male; Methadone; Narcotic Antago

2011
Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:9

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Directly Observed The

2011
Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.
    Journal of addiction medicine, 2012, Volume: 6, Issue:2

    Topics: Adult; Baltimore; Combined Modality Therapy; Counseling; Crisis Intervention; Dose-Response Relation

2012
Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance.
    Journal of substance abuse treatment, 2012, Volume: 43, Issue:4

    Topics: Adult; Anti-HIV Agents; Delivery of Health Care, Integrated; Directly Observed Therapy; Feasibility

2012
Modified directly observed therapy (MDOT) for injection drug users with HIV disease.
    The American journal on addictions, 2002,Fall, Volume: 11, Issue:4

    Topics: Adult; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; Drug Interactions; Femal

2002
Effects of HIV triple therapy on methadone levels.
    The American journal on addictions, 2002,Fall, Volume: 11, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Cross-Sectional Studie

2002
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Drug and alcohol dependence, 2003, Apr-01, Volume: 69, Issue:3

    Topics: Administration, Oral; Adrenergic alpha-Agonists; Adult; Buprenorphine; Clonidine; Dose-Response Rela

2003
Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:5

    Topics: Adolescent; Adult; Blood Pressure; Cocaine; Cocaine-Related Disorders; Cognitive Behavioral Therapy;

2004
Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Journal of substance abuse treatment, 2004, Volume: 26, Issue:2

    Topics: Adult; Analgesics, Opioid; Behavior Therapy; Cocaine-Related Disorders; Condoms; Costs and Cost Anal

2004
Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Journal of substance abuse treatment, 2004, Volume: 26, Issue:2

    Topics: Adult; Analgesics, Opioid; Behavior Therapy; Cocaine-Related Disorders; Condoms; Costs and Cost Anal

2004
Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Journal of substance abuse treatment, 2004, Volume: 26, Issue:2

    Topics: Adult; Analgesics, Opioid; Behavior Therapy; Cocaine-Related Disorders; Condoms; Costs and Cost Anal

2004
Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Journal of substance abuse treatment, 2004, Volume: 26, Issue:2

    Topics: Adult; Analgesics, Opioid; Behavior Therapy; Cocaine-Related Disorders; Condoms; Costs and Cost Anal

2004
Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison.
    Canadian HIV/AIDS policy & law review, 2003, Volume: 8, Issue:3

    Topics: Canada; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Incidence; Methadone; New South Wale

2003
Directly observed therapy for the management of HIV-infected patients in a methadone program.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jun-01, Volume: 38 Suppl 5

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cocaine-Related Disord

2004
Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jun-01, Volume: 38 Suppl 5

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Directly Observed Therapy; Drug Thera

2004
Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects.
    Pharmacotherapy, 2004, Volume: 24, Issue:9

    Topics: Adult; Anti-HIV Agents; Area Under Curve; Carbamates; Confidence Intervals; Drug Administration Sche

2004
Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11

    Topics: Adult; Aged; Analgesics, Opioid; Anti-HIV Agents; Area Under Curve; Dose-Response Relationship, Drug

2004
HIV and intimate partner violence among methadone-maintained women in New York City.
    Social science & medicine (1982), 2005, Volume: 61, Issue:1

    Topics: Adolescent; Adult; Domestic Violence; Female; Heroin Dependence; HIV Infections; Humans; Longitudina

2005
Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence.
    Addictive behaviors, 2006, Volume: 31, Issue:5

    Topics: Adult; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; H

2006
Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial.
    AIDS care, 2005, Volume: 17, Issue:8

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Diagnosis, Dual (Psychiatry); Female;

2005
Social contextual factors associated with entry into opiate agonist treatment among injection drug users.
    The American journal of drug and alcohol abuse, 2005, Volume: 31, Issue:4

    Topics: Adult; Female; HIV Infections; Humans; Male; Methadone; Narcotics; Needle-Exchange Programs; Prospec

2005
Value for money in drug treatment: economic evaluation of prison methadone.
    Drug and alcohol dependence, 2006, Sep-15, Volume: 84, Issue:2

    Topics: Costs and Cost Analysis; Health Expenditures; Hepatitis C; Heroin Dependence; HIV Infections; Humans

2006
Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-01, Volume: 42, Issue:11

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Directly Observ

2006
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
    Journal of substance abuse treatment, 2006, Volume: 31, Issue:2

    Topics: Adult; Buprenorphine; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Hum

2006
A controlled study of a spirituality-focused intervention for increasing motivation for HIV prevention among drug users.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 2006, Volume: 18, Issue:4

    Topics: Adult; Analysis of Variance; Cohort Studies; Confidence Intervals; Female; HIV Infections; Humans; M

2006
Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.
    Drug and alcohol dependence, 2007, Apr-17, Volume: 88, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Monitoring; Female; Heroin Depen

2007
Adherence and retention of female injection drug users in a phase III clinical trial in inner city Baltimore.
    The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:1

    Topics: Adult; Baltimore; Demography; Female; Follow-Up Studies; Hepatitis C; HIV Infections; Humans; Methad

2007
Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment.
    Clinical therapeutics, 2007, Volume: 29, Issue:1

    Topics: Administration, Oral; Adult; Analgesics, Opioid; Antiviral Agents; Area Under Curve; Cross-Over Stud

2007
Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program.
    Journal of acquired immune deficiency syndromes (1999), 2007, Jul-01, Volume: 45, Issue:3

    Topics: Administration, Oral; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count;

2007
Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients.
    Addictive behaviors, 2008, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Aged; Cocaine-Related Disorders; Counseling; Female; Heroin Dependence; HIV Infec

2008
Psychiatric disorders of opioid addicts entering treatment: preliminary data.
    Journal of addictive diseases, 1994, Volume: 13, Issue:3

    Topics: Adult; Antisocial Personality Disorder; Comorbidity; Cross-Sectional Studies; Depressive Disorder; F

1994
Case management within a methadone maintenance program. A research demonstration project for HIV risk reduction.
    Journal of case management, 1994,Winter, Volume: 3, Issue:4

    Topics: HIV Infections; Humans; Los Angeles; Managed Care Programs; Methadone; Patient Care Planning; Risk F

1994
Therapeutic community methods in methadone maintenance (Passages): an open clinical trial.
    Drug and alcohol dependence, 1995, Volume: 37, Issue:1

    Topics: Adult; Cocaine; Comorbidity; Crime; Day Care, Medical; Female; Heroin Dependence; HIV Infections; Hu

1995
Psychoeducational group approach: HIV risk reduction in drug users.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 1994, Volume: 6, Issue:2

    Topics: Adult; Ambulatory Care; Combined Modality Therapy; Female; Follow-Up Studies; Health Behavior; Healt

1994
Providing medical care to methadone clinic patients: referral vs on-site care.
    American journal of public health, 1994, Volume: 84, Issue:2

    Topics: Female; Health Services; HIV Infections; Humans; Hypertension; Male; Methadone; Referral and Consult

1994
Evaluation of a cognitive-behavioural intervention for pregnant injecting drug users at risk of HIV infection.
    Addiction (Abingdon, England), 1996, Volume: 91, Issue:8

    Topics: Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Health Kn

1996
Threshold models in a methadone programme evaluation.
    Statistics in medicine, 1996, Oct-30, Volume: 15, Issue:20

    Topics: Australia; Benzodiazepines; Cocaine; Heroin; HIV Infections; Humans; Methadone; Models, Statistical;

1996
Changes in HIV risk behavior among injecting drug users: the impact of 21 versus 90 days of methadone detoxification.
    AIDS (London, England), 1996, Volume: 10, Issue:14

    Topics: Analgesics, Opioid; Follow-Up Studies; HIV Infections; Humans; Methadone; Risk-Taking; Substance Abu

1996
Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment.
    The American journal of drug and alcohol abuse, 1997, Volume: 23, Issue:1

    Topics: Adult; Case Management; Cocaine; Combined Modality Therapy; Comorbidity; Crack Cocaine; Female; Foll

1997
[The effect of discontinuing intravenous opiate injections and methadone treatment on the status of the immune system in narcotic abusers with HIV].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1996, Volume: 51, Issue:23-26

    Topics: Adult; CD4-CD8 Ratio; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Narcotics;

1996
Community reinforcement approach in the treatment of opiate addicts.
    The American journal of drug and alcohol abuse, 1998, Volume: 24, Issue:1

    Topics: Behavior Therapy; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Humans; Male; Methad

1998
Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.
    American journal of public health, 1998, Volume: 88, Issue:1

    Topics: Adult; Behavior Therapy; Female; HIV Infections; Humans; Illicit Drugs; Male; Methadone; Middle Aged

1998
An intervention for changing high-risk HIV behaviors of African American drug-dependent women.
    Research in nursing & health, 1998, Volume: 21, Issue:3

    Topics: Adult; Black or African American; Female; Health Behavior; HIV Infections; Humans; Methadone; Narcot

1998
Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Aug-15, Volume: 18, Issue:5

    Topics: Administration, Oral; Adult; Anti-HIV Agents; Area Under Curve; Biological Availability; Female; Her

1998
Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    The American journal of psychiatry, 1999, Volume: 156, Issue:1

    Topics: Adult; Cocaine-Related Disorders; Cost-Benefit Analysis; Day Care, Medical; Female; Follow-Up Studie

1999
Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users.
    Antiviral therapy, 1998, Volume: 3 Suppl 4

    Topics: Adult; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; H

1998
The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.
    British journal of clinical pharmacology, 2001, Volume: 51, Issue:3

    Topics: Adult; Alkynes; Analgesics, Opioid; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Infe

2001
Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes.
    AIDS (London, England), 2001, May-25, Volume: 15, Issue:8

    Topics: Female; HIV Infections; HIV Protease Inhibitors; Humans; Injections, Intravenous; Male; Methadone; N

2001
Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401.
    Journal of acquired immune deficiency syndromes (1999), 2001, Jun-01, Volume: 27, Issue:2

    Topics: Adult; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Meth

2001
Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Apr-15, Volume: 34, Issue:8

    Topics: Adult; Analgesics, Opioid; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Human

2002
A controlled trial of methadone maintenance in a population of intravenous drug users in Bangkok: implications for prevention of HIV.
    The International journal of the addictions, 1991, Volume: 26, Issue:12

    Topics: Adult; Heroin Dependence; HIV Infections; Humans; Methadone; Substance Abuse, Intravenous; Thailand;

1991

Other Studies

589 other studies available for methadone and HIV Coinfection

ArticleYear
Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study.
    Drug and alcohol dependence, 2021, 10-01, Volume: 227

    Topics: Anti-HIV Agents; Anti-Retroviral Agents; Benzoxazines; Constitutive Androstane Receptor; HIV Infecti

2021
Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV.
    AIDS and behavior, 2022, Volume: 26, Issue:3

    Topics: Analgesics, Opioid; Cohort Studies; HIV Infections; Humans; Methadone; Opiate Substitution Treatment

2022
Use of methamphetamine and alcohol among people with opioid use disorder and HIV in Vietnam: a qualitative study.
    BMC public health, 2021, 09-22, Volume: 21, Issue:1

    Topics: HIV Infections; Humans; Male; Methadone; Methamphetamine; Opioid-Related Disorders; Vietnam

2021
Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.
    Journal of substance abuse treatment, 2022, Volume: 136

    Topics: HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Prisoners; Prisons; Substance Abus

2022
Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
    The International journal on drug policy, 2022, Volume: 101

    Topics: Female; HIV Infections; Humans; Kyrgyzstan; Male; Methadone; Opioid-Related Disorders; Prisoners; Pr

2022
Assessing the Temporality Between Transitions onto Opioid Agonist Therapy and Engagement with Antiretroviral Therapy in a Cohort of HIV-Positive People Who Use Opioids Daily.
    AIDS and behavior, 2022, Volume: 26, Issue:6

    Topics: Analgesics, Opioid; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related

2022
Surge of HIV, tuberculosis and COVID feared amid war in Ukraine.
    Nature, 2022, Volume: 603, Issue:7902

    Topics: Anti-HIV Agents; Armed Conflicts; COVID-19; HIV Infections; Humans; Immunization Programs; Male; Mea

2022
Familial support in integrated treatment with antiretroviral therapy and medications for opioid use disorder in Vietnam: A qualitative study.
    Substance abuse, 2022, Volume: 43, Issue:1

    Topics: Analgesics, Opioid; Buprenorphine; HIV Infections; Humans; Methadone; Opiate Substitution Treatment;

2022
Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study.
    Harm reduction journal, 2022, 05-25, Volume: 19, Issue:1

    Topics: Adult; Cohort Studies; Female; HIV Infections; Humans; Kyrgyzstan; Male; Methadone; Reproducibility

2022
Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection.
    Journal of leukocyte biology, 2022, Volume: 112, Issue:4

    Topics: Analgesics, Opioid; Cross-Sectional Studies; Cytokines; HIV Infections; Humans; Immunoglobulin G; In

2022
Assisted Partner Services for People Who Inject Drugs: Index Characteristics Associated With Untreated HIV in Partners.
    Journal of acquired immune deficiency syndromes (1999), 2022, 11-01, Volume: 91, Issue:3

    Topics: Drug Users; Female; HIV Infections; Humans; Kenya; Male; Methadone; Sexual Partners; Substance Abuse

2022
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution.
    Expert review of anti-infective therapy, 2022, Volume: 20, Issue:11

    Topics: Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Im

2022
Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study.
    Harm reduction journal, 2022, 09-29, Volume: 19, Issue:1

    Topics: Drug Users; Hepatitis C; HIV Infections; Humans; Methadone; Myanmar; Substance Abuse, Intravenous; S

2022
The risk assessment of relapse among newly enrolled participants in methadone maintenance treatment: A group-LASSO based Bayesian network study.
    Frontiers in public health, 2022, Volume: 10

    Topics: Bayes Theorem; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Retrospective Studi

2022
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.
    Harm reduction journal, 2023, 02-23, Volume: 20, Issue:1

    Topics: Adult; Cohort Studies; COVID-19; Cross-Sectional Studies; Drug Users; Female; Harm Reduction; HIV In

2023
Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study.
    Addiction science & clinical practice, 2023, 03-27, Volume: 18, Issue:1

    Topics: Analgesics, Opioid; Female; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Opioid

2023
A new collaborative care approach toward hepatitis C elimination in marginalized populations.
    Journal of infection and public health, 2023, Volume: 16, Issue:8

    Topics: Antiviral Agents; Hepacivirus; Hepatitis C; HIV Infections; Humans; Methadone; Substance Abuse, Intr

2023
Double counting of clients using services in Iran: implications for assessing the reach of harm reduction programs.
    Harm reduction journal, 2023, 08-16, Volume: 20, Issue:1

    Topics: Harm Reduction; HIV Infections; Humans; Iran; Methadone; Sexually Transmitted Diseases

2023
Challenges to Providing Integrated HIV Prevention in Substance Use Treatment Settings: Frontline Staff Perspectives on HIV and Sex-Related, Education, Communication and Stigma.
    Substance use & misuse, 2023, Volume: 58, Issue:14

    Topics: Acquired Immunodeficiency Syndrome; Communication; HIV Infections; Humans; Methadone; Substance-Rela

2023
Life-time HIV testing among people who inject drugs in Iran: results from the National Rapid Assessment and Response survey.
    Frontiers in public health, 2023, Volume: 11

    Topics: Adult; Drug Users; Female; HIV Infections; HIV Testing; Humans; Iran; Male; Methadone; Substance Abu

2023
[Aging in a methadone maintenance program. A perspective from the framework of social determinants of health].
    Revista espanola de salud publica, 2019, Aug-26, Volume: 93

    Topics: Adult; Age of Onset; Aging; Comorbidity; Female; Hepatitis C; HIV Infections; Humans; Life Expectanc

2019
Polysubstance Use among Patients Enrolling in Methadone Maintenance Treatment Program in a Vietnam Province with Drug-Driven HIV Epidemic.
    International journal of environmental research and public health, 2019, 09-06, Volume: 16, Issue:18

    Topics: Adult; Alcohol Drinking; Ambulatory Care Facilities; Cross-Sectional Studies; Epidemics; Female; HIV

2019
Optimising opioid substitution therapy in the prison environment.
    International journal of prisoner health, 2019, 12-05, Volume: 15, Issue:4

    Topics: Age Factors; Buprenorphine; Comorbidity; Continuity of Patient Care; Delayed-Action Preparations; Dr

2019
Predictors of Medication Utilization for Opioid Use Disorder Among Medicaid-Insured HIV Patients in New York.
    The American journal on addictions, 2020, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Drug Utilization; Fem

2020
HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study.
    BMC public health, 2020, Mar-30, Volume: 20, Issue:1

    Topics: Adult; Analgesics, Opioid; Anti-Retroviral Agents; Buprenorphine; Continuity of Patient Care; Female

2020
Factors Affecting Changes of Cluster of Differentiation 4 Cell Counts Among Human Immunodeficiency Virus-positive People Who Inject Heroin and Receive Methadone Maintenance Treatment.
    Journal of addiction medicine, 2020, Volume: 14, Issue:6

    Topics: Cell Count; Cell Differentiation; Heroin; HIV; HIV Infections; Humans; Longitudinal Studies; Methado

2020
Adherence among HIV-positive injection drug users undergoing methadone treatment in Taiwan.
    BMC psychiatry, 2020, 07-02, Volume: 20, Issue:1

    Topics: Drug Users; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Taiwan

2020
No Increase in HIV Drug Resistance Mutations among Injecting Drug Users on Methadone Maintenance Therapy: A Prospective Cohort Study.
    Current HIV research, 2020, Volume: 18, Issue:5

    Topics: Adult; China; Cohort Studies; Drug Resistance; Drug Users; Female; HIV; HIV Infections; Humans; Main

2020
Methadone Inhibits Viral Restriction Factors and Facilitates HIV Infection in Macrophages.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Biomarkers; Cells, Cultured; Chemokine CCL4; Gene Expression Regulation; HIV Infections; HIV-1; Host

2020
Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
    Harm reduction journal, 2020, 10-01, Volume: 17, Issue:1

    Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Buprenorphine; Drug Overdose; Female; Health Services Ac

2020
Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment.
    Drug and alcohol dependence, 2021, 02-01, Volume: 219

    Topics: Adolescent; Adult; Analgesics, Opioid; Cross-Sectional Studies; Female; HIV Infections; Homosexualit

2021
Imperfect progress: treatment options for opioid dependence.
    The lancet. HIV, 2021, Volume: 8, Issue:2

    Topics: Buprenorphine; HIV Infections; Humans; Maintenance; Methadone; Naloxone; Nitriles; Opioid-Related Di

2021
Reducing Risky Drug Use Behaviors by Enrolling Syringe Exchange Registrants in Methadone Maintenance.
    Substance use & misuse, 2021, Volume: 56, Issue:4

    Topics: Baltimore; HIV Infections; Humans; Methadone; Needle-Exchange Programs; Pharmaceutical Preparations;

2021
Sexual-risk reduction following the referral of syringe exchange registrants to methadone maintenance: Impact of gender and drug use.
    Journal of substance abuse treatment, 2021, Volume: 124

    Topics: Baltimore; Female; HIV Infections; Humans; Methadone; Pharmaceutical Preparations; Referral and Cons

2021
Examining common mental health disorders in people living with HIV on methadone maintenance therapy in Hanoi, Vietnam.
    Harm reduction journal, 2021, 04-23, Volume: 18, Issue:1

    Topics: Cross-Sectional Studies; HIV Infections; Humans; Mental Health; Methadone; Opiate Substitution Treat

2021
Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam.
    Journal of substance abuse treatment, 2022, Volume: 134

    Topics: Analgesics, Opioid; Buprenorphine; HIV Infections; Humans; Methadone; Opiate Substitution Treatment;

2022
Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention.
    Journal of substance abuse treatment, 2021, Volume: 129

    Topics: Anti-HIV Agents; HIV Infections; Humans; Methadone; New Jersey; Pre-Exposure Prophylaxis; Social Sti

2021
Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV.
    Journal of substance abuse treatment, 2022, Volume: 132

    Topics: Buprenorphine; Cohort Studies; HIV Infections; Humans; Methadone; Opioid-Related Disorders

2022
Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study.
    BMC infectious diseases, 2021, Jul-21, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Ambulatory Care Facilities; Cross-Sectional Studies; Drug Users; Female; Health K

2021
Participation in methadone programs improves antiretroviral uptake and HIV viral suppression among people who inject drugs in Kenya.
    Journal of substance abuse treatment, 2022, Volume: 134

    Topics: Adult; Cross-Sectional Studies; Drug Users; Female; HIV Infections; Humans; Kenya; Methadone; Substa

2022
Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency.
    Viruses, 2021, 07-27, Volume: 13, Issue:8

    Topics: Buprenorphine; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Methadone; Morphine; Nocicept

2021
Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcome.
    PloS one, 2017, Volume: 12, Issue:3

    Topics: ADAM10 Protein; Adult; Amyloid Precursor Protein Secretases; Antigens, CD; Cadherins; Female; Heroin

2017
Tobacco and alcohol use among drug users receiving methadone maintenance treatment: a cross-sectional study in a rural prefecture of Yunnan Province, Southwest China.
    BMJ open, 2017, 03-30, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Aged; Alcohol Drinking; Analgesics, Opioid; China; Cross-Sectional Studies; Hepat

2017
HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study.
    AIDS care, 2017, Volume: 29, Issue:12

    Topics: Adult; Analgesics, Opioid; Anti-Retroviral Agents; Coinfection; Comorbidity; Dose-Response Relations

2017
Re-entry and related predictors among HIV-infected clients receiving methadone maintenance treatment in Guangdong province, China.
    Bioscience trends, 2017, Jul-24, Volume: 11, Issue:3

    Topics: Adult; China; Employment; Female; HIV Infections; Humans; Male; Marital Status; Methadone; Multivari

2017
Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis.
    The International journal on drug policy, 2017, Volume: 45

    Topics: Adult; British Columbia; Drug and Narcotic Control; Female; Health Care Reform; HIV Infections; Huma

2017
Interest in use of mHealth technology in HIV prevention and associated factors among high-risk drug users enrolled in methadone maintenance program.
    AIDS care, 2017, Volume: 29, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adult; Cell Phone; Cross-Sectional Studies; Delivery of Health C

2017
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Journal of medical economics, 2017, Volume: 20, Issue:7

    Topics: Buprenorphine; Cost-Benefit Analysis; Crime; Health Services; Hepatitis C; HIV Infections; Humans; M

2017
The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam.
    PloS one, 2017, Volume: 12, Issue:5

    Topics: Anti-Retroviral Agents; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Likelihood Functio

2017
Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
    AIDS and behavior, 2018, Volume: 22, Issue:4

    Topics: Adult; Aged; Ambulatory Care Facilities; Connecticut; Cross-Sectional Studies; Drug Users; Female; H

2018
Expanding co-payment for methadone maintenance services in Vietnam: the importance of addressing health and socioeconomic inequalities.
    BMC health services research, 2017, 07-12, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Analgesics, Opioid; Cross-Sectional Studies; Deductibles and Coinsurance; Female;

2017
Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    BMJ open, 2017, Jul-13, Volume: 7, Issue:7

    Topics: Adolescent; Adult; China; Coinfection; Cross-Sectional Studies; Female; Hepatitis C; Hepatitis C Ant

2017
Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.
    The International journal on drug policy, 2017, Volume: 48

    Topics: Adult; Buprenorphine; Cohort Studies; Delivery of Health Care, Integrated; Dose-Response Relationshi

2017
Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.
    Drug and alcohol dependence, 2017, 10-01, Volume: 179

    Topics: Administration, Intravenous; Cohort Studies; Comprehensive Health Care; Female; Heroin; HIV Infectio

2017
Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.
    Drug and alcohol dependence, 2017, 10-01, Volume: 179

    Topics: Administration, Intravenous; Cohort Studies; Comprehensive Health Care; Female; Heroin; HIV Infectio

2017
Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.
    Drug and alcohol dependence, 2017, 10-01, Volume: 179

    Topics: Administration, Intravenous; Cohort Studies; Comprehensive Health Care; Female; Heroin; HIV Infectio

2017
Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions.
    Drug and alcohol dependence, 2017, 10-01, Volume: 179

    Topics: Administration, Intravenous; Cohort Studies; Comprehensive Health Care; Female; Heroin; HIV Infectio

2017
Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic.
    Addiction science & clinical practice, 2017, 08-22, Volume: 12, Issue:1

    Topics: Adult; Age Factors; Ambulatory Care Facilities; Continuity of Patient Care; Electronic Health Record

2017
Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China.
    Scientific reports, 2017, 09-13, Volume: 7, Issue:1

    Topics: Adult; China; Comorbidity; Cross-Sectional Studies; Drug Users; Female; HIV Infections; Humans; Male

2017
Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine.
    The International journal on drug policy, 2017, Volume: 49

    Topics: Budgets; Buprenorphine; Drug Users; Health Policy; HIV Infections; Humans; Methadone; Narcotics; Opi

2017
Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program.
    BMC public health, 2017, 09-30, Volume: 17, Issue:1

    Topics: Adult; China; Cohort Studies; Coinfection; Drug Users; Female; Hepatitis C; HIV Infections; Humans;

2017
Opiate use inhibits TLR9 signaling pathway in vivo: possible role in pathogenesis of HIV-1 infection.
    Scientific reports, 2017, 10-12, Volume: 7, Issue:1

    Topics: Analgesics, Opioid; Antiviral Agents; Blotting, Western; CD4-Positive T-Lymphocytes; Cells, Cultured

2017
Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania.
    Addiction science & clinical practice, 2017, 10-18, Volume: 12, Issue:1

    Topics: Anti-HIV Agents; Attitude of Health Personnel; Female; Health Services Accessibility; HIV Infections

2017
[TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case].
    The Pan African medical journal, 2017, Volume: 28

    Topics: AIDS-Related Opportunistic Infections; Coinfection; Female; Heroin Dependence; HIV Infections; Human

2017
Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study.
    Substance abuse treatment, prevention, and policy, 2018, 01-10, Volume: 13, Issue:1

    Topics: China; Cross-Sectional Studies; Hepatitis C; HIV Infections; Humans; Methadone; Models, Biological;

2018
The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential.
    Social science & medicine (1982), 2018, Volume: 201

    Topics: Adult; Evidence-Based Practice; Female; Health Promotion; HIV Infections; Humans; Kenya; Male; Metha

2018
Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis.
    Drug and alcohol dependence, 2018, 04-01, Volume: 185

    Topics: Adult; Analgesics, Opioid; Canada; Cohort Studies; Coinfection; Female; Food Supply; Hepatitis C; HI

2018
Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.
    AIDS and behavior, 2018, Volume: 22, Issue:8

    Topics: Adult; Analgesics, Opioid; Biobehavioral Sciences; Condoms; Feasibility Studies; Female; HIV Infecti

2018
Methadone dosing in patients on ritonavir-boosted-based highly active antiretroviral therapy.
    Medicina clinica, 2019, 02-15, Volume: 152, Issue:4

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytochrome P-450 CYP3A Inhibitors; Drug Dosa

2019
Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
    Addictive behaviors, 2018, Volume: 85

    Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Comorbidity; Connecticut; Female; HIV Infections; Humans

2018
Mortality rate in patients on methadone treatment and infected with the human immunodeficiency virus and/or the hepatitis C virus.
    Adicciones, 2019, Jan-01, Volume: 31, Issue:1

    Topics: Adult; Female; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middle Aged;

2019
Factors Associated with Substance Use and Sexual Behavior among Drug Users in Three Mountainous Provinces of Vietnam.
    International journal of environmental research and public health, 2018, 08-31, Volume: 15, Issue:9

    Topics: Adult; Cross-Sectional Studies; Drug Users; HIV Infections; Humans; Logistic Models; Male; Methadone

2018
Risk factors for kidney disease among HIV-1 positive persons in the methadone program.
    Clinical and experimental nephrology, 2019, Volume: 23, Issue:3

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Drug Therapy, Combination; Female; Glomerular Filtration

2019
Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    International journal of prisoner health, 2018, 09-10, Volume: 14, Issue:3

    Topics: Adult; Female; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Kyrgyzstan; Male;

2018
Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
    Journal of acquired immune deficiency syndromes (1999), 2018, 11-01, Volume: 79, Issue:3

    Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Anti-HIV Agents; Buprenorphine; Cities; Cross-Sectional

2018
Methadone Maintenance Treatment Reduces the Vulnerability of Drug Users on HIV/AIDS in Vietnamese Remote Settings: Assessing the Changes in HIV Knowledge, Perceived Risk, and Testing Uptake after a 12-Month Follow-Up.
    International journal of environmental research and public health, 2018, 11-16, Volume: 15, Issue:11

    Topics: Adult; Counseling; Drug Users; Follow-Up Studies; Health Knowledge, Attitudes, Practice; HIV Infecti

2018
Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety.
    AIDS and behavior, 2019, Volume: 23, Issue:8

    Topics: Adult; Antiretroviral Therapy, Highly Active; Cross-Sectional Studies; HIV; HIV Infections; Humans;

2019
Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention.
    Addiction science & clinical practice, 2019, 01-28, Volume: 14, Issue:1

    Topics: Adult; Anti-Retroviral Agents; Attitude of Health Personnel; Female; Health Care Rationing; Health S

2019
Integrated and differentiated methadone and HIV care for people who use drugs: a qualitative study in Kenya with implications for implementation science.
    Health policy and planning, 2019, Mar-01, Volume: 34, Issue:2

    Topics: Adult; Anti-Retroviral Agents; Attitude of Health Personnel; Delivery of Health Care, Integrated; Fe

2019
Evaluating the Integrated Methadone and Anti-Retroviral Therapy Strategy in Tanzania Using the RE-AIM Framework.
    International journal of environmental research and public health, 2019, 02-28, Volume: 16, Issue:5

    Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Delivery of Health Care; Drug Therapy, Combination; Fema

2019
Employment Cessation, Long Term Labour Market Engagement and HIV Infection Risk Among People Who Inject Drugs in an Urban Canadian Setting.
    AIDS and behavior, 2019, Volume: 23, Issue:12

    Topics: Adult; Canada; Cohort Studies; Employment; Female; HIV Infections; Housing; Humans; Illicit Drugs; L

2019
Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.
    Harm reduction journal, 2019, 04-29, Volume: 16, Issue:1

    Topics: Adult; Age Factors; Analgesics, Opioid; Antiviral Agents; Cambodia; Coinfection; Ethnicity; Female;

2019
Participation pattern of methadone users and its association with social connection and HIV status: Analyses of electronic health records data.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Adult; Algorithms; Case-Control Studies; Electronic Health Records; Female; HIV Infections; HIV Sero

2019
Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China.
    Harm reduction journal, 2019, 05-27, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Aged; Amphetamine-Related Disorders; Analgesics, Opioid; China; Female; Focus Gro

2019
Using Social Media to Enhance Provider Network for HIV and Harm Reduction Service Integration in Vietnam.
    AIDS and behavior, 2019, Volume: 23, Issue:11

    Topics: Adult; Anti-Retroviral Agents; Attitude of Health Personnel; Delivery of Health Care, Integrated; Ha

2019
Changes in Substance Abuse and HIV Risk Behaviors over 12-Month Methadone Maintenance Treatment among Vietnamese Patients in Mountainous Provinces.
    International journal of environmental research and public health, 2019, 07-08, Volume: 16, Issue:13

    Topics: Adult; Counseling; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Opiate Substitution

2019
Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection.
    Pharmacotherapy, 2019, Volume: 39, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Benzodiazepines; Cause of Death; CD4 Ly

2019
Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    HIV medicine, 2019, Volume: 20, Issue:9

    Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Canada; Delivery of Health Care; Drug Users; Female; HIV

2019
High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.
    Addictive behaviors, 2013, Volume: 38, Issue:4

    Topics: Adult; Analgesics, Opioid; Criminals; Female; Health Knowledge, Attitudes, Practice; Hepatitis B; He

2013
Prevention. Opiate substitute therapy reduces HIV transmission.
    AIDS policy & law, 2012, Volume: 28, Issue:2

    Topics: HIV Infections; Humans; Methadone; Opioid-Related Disorders; Substance Abuse, Intravenous

2012
Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
    Drug and alcohol dependence, 2013, Sep-01, Volume: 132, Issue:1-2

    Topics: Adolescent; Adult; Ethnicity; HIV Infections; Humans; Kaplan-Meier Estimate; Malaysia; Male; Methado

2013
Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.
    Journal of the International Neuropsychological Society : JINS, 2013, Volume: 19, Issue:4

    Topics: Adult; Cognition Disorders; Cohort Studies; Female; HIV Infections; Humans; Male; Methadone; Middle

2013
Opioid substitution: improving cost-efficiency.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Cost-Benefit Analysis; HIV Infections; Humans; International Cooperation; Methadone; Opiate Substitu

2013
Scaling up opioid dependence treatment in low- and middle-income settings.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Cost-Benefit Analysis; Counseling; Developing Countries; Global Health; Harm Reduction; Hepatitis C;

2013
Opioid treatment in Ukraine risks losing momentum.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Buprenorphine; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Diso

2013
New treatment gives hope to East Africa's drug users.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Healthcare Financing; Heroin Dependence; HIV Infections; Humans; International Cooperation; Methadon

2013
Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; China; Female; HIV Infections; Humans; Mal

2013
Implementing methadone maintenance treatment in prisons in Malaysia.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Adult; Female; Harm Reduction; Health Plan Implementation; HIV Infections; Humans; Malaysia; Male; M

2013
Human resource development and capacity-building during China's rapid scale-up of methadone maintenance treatment services.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Capacity Building; China; Health Personnel; HIV Infections; Humans; Methadone; Opiate Substitution T

2013
Methadone maintenance treatment in Spain: the success of a harm reduction approach.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Community Health Services; Harm Reduction; Heroin Dependence; HIV Infections; Humans; Legislation, D

2013
Factors associated with mortality of HIV-positive clients receiving methadone maintenance treatment in China.
    The Journal of infectious diseases, 2013, Aug-01, Volume: 208, Issue:3

    Topics: Adolescent; Adult; China; Cohort Studies; Female; HIV Infections; Humans; Male; Methadone; Middle Ag

2013
HIV prevention, treatment, and care for people who inject drugs.
    The Journal of infectious diseases, 2013, Aug-01, Volume: 208, Issue:3

    Topics: Female; HIV Infections; Humans; Male; Methadone; Opiate Substitution Treatment; Substance-Related Di

2013
Relationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot study.
    Substance use & misuse, 2013, Volume: 48, Issue:9

    Topics: Adult; Female; HIV Infections; Humans; Male; Menopause; Methadone; Middle Aged; Narcotics; Opiate Su

2013
Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data.
    Annals of internal medicine, 2013, May-21, Volume: 158, Issue:10

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Retroviral Agents; Heart Arrest; HIV Infections

2013
HIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, China.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Adult; Asian People; China; Female; Hepatitis C; HIV Infections; Humans; Male; Mass Screening; Metha

2013
Willingness to pay for methadone maintenance treatment in Vietnamese epicentres of injection-drug-driven HIV infection.
    Bulletin of the World Health Organization, 2013, Jul-01, Volume: 91, Issue:7

    Topics: Female; Financing, Personal; HIV Infections; Humans; Male; Methadone; Narcotics; Opiate Substitution

2013
Effectiveness and feasibility study of routine HIV rapid testing in an urban methadone maintenance treatment program.
    The American journal of drug and alcohol abuse, 2013, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Aged; Ambulatory Care Facilities; Counseling; Feasibility Studies; Female; HIV In

2013
The trajectory of methadone maintenance treatment in Nepal.
    The International journal on drug policy, 2013, Volume: 24, Issue:6

    Topics: Administration, Oral; Analgesics, Opioid; Cost-Benefit Analysis; Developing Countries; Drug and Narc

2013
Higher methadone doses are associated with lower mortality in patients of opioid dependence in Taiwan.
    Journal of psychiatric research, 2013, Volume: 47, Issue:10

    Topics: Adult; Female; Follow-Up Studies; HIV Infections; Humans; Male; Methadone; Middle Aged; Mortality; O

2013
Health care service utilization and associated factors among heroin users in northern Taiwan.
    Addictive behaviors, 2013, Volume: 38, Issue:11

    Topics: Adult; Ambulatory Care; Cross-Sectional Studies; Female; Hepatitis B, Chronic; Hepatitis C, Chronic;

2013
Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:8

    Topics: Adult; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV Infections; Humans; Linear Models;

2013
Editorial commentary: the methadone menace.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:8

    Topics: Female; HIV Infections; Humans; Long QT Syndrome; Male; Methadone; Opioid-Related Disorders

2013
Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.
    AIDS and behavior, 2014, Volume: 18, Issue:4

    Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Canada; CD4 Lymphocyte Count; Female; HIV Infections; Hu

2014
Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV/AIDS.
    The International journal on drug policy, 2013, Volume: 24, Issue:6

    Topics: Adult; Analgesics, Opioid; Cost Savings; Cost-Benefit Analysis; Cross-Sectional Studies; Drug Users;

2013
HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
    Sexually transmitted infections, 2013, Volume: 89 Suppl 3

    Topics: Adult; Age Distribution; Analgesics, Opioid; Condoms; Enzyme-Linked Immunosorbent Assay; Female; Har

2013
HIV and hepatitis C virus test uptake at methadone clinics in Southern China: opportunities for expanding detection of bloodborne infections.
    BMC public health, 2013, Sep-30, Volume: 13

    Topics: Adult; China; Cross-Sectional Studies; Drug Users; Female; Hepatitis C; HIV Infections; Humans; Male

2013
Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China--a prospective study.
    Harm reduction journal, 2013, Oct-10, Volume: 10

    Topics: Adult; China; Female; Hepatitis C, Chronic; HIV Infections; Humans; Male; Medication Adherence; Meth

2013
High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Adult; Analgesics, Opioid; China; Coinfection; Comorbidity; Female; Hepatitis C; HIV Infections; Hum

2013
Policy implementation of methadone maintenance treatment and HIV infection: evidence from Hubei province, China.
    Substance abuse treatment, prevention, and policy, 2013, Nov-05, Volume: 8

    Topics: China; Health Plan Implementation; Health Policy; HIV Infections; Humans; Methadone; Opiate Substitu

2013
HIV prevalence and related risk behaviours among female sex workers in Iran: results of the national biobehavioural survey, 2010.
    Sexually transmitted infections, 2013, Volume: 89 Suppl 3

    Topics: Adolescent; Adult; Age Distribution; Analgesics, Opioid; Condoms; Enzyme-Linked Immunosorbent Assay;

2013
Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment.
    The International journal on drug policy, 2014, Volume: 25, Issue:1

    Topics: Delivery of Health Care, Integrated; HIV Infections; Humans; Mental Health Services; Methadone; Opia

2014
[Current situation related to antiretroviral therapy and related influential factors on HIV infected injection drug users in the methadone maintenance treatment clinics].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2013, Volume: 34, Issue:8

    Topics: Adult; Antiretroviral Therapy, Highly Active; China; Female; HIV Infections; Humans; Male; Methadone

2013
Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan.
    BioMed research international, 2013, Volume: 2013

    Topics: Adult; Alleles; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Bi

2013
Long-term effects of methadone maintenance treatment with different psychosocial intervention models.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adult; China; Counseling; Female; Follow-Up Studies; Hepatitis C; HIV; HIV Infections; Humans; Male;

2014
Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response.
    Drug and alcohol dependence, 2014, Apr-01, Volume: 137

    Topics: Adult; Female; Follow-Up Studies; HIV Infections; Humans; Longitudinal Studies; Male; Methadone; Opi

2014
Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adult; Analgesics, Opioid; Coinfection; Follow-Up Studies; Hepacivirus; Hepatitis C; Hepatitis C Ant

2014
The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China.
    BMC infectious diseases, 2014, Mar-10, Volume: 14

    Topics: Adult; China; Coinfection; Drug Users; Female; Geography, Medical; Hepatitis C; HIV Infections; Huma

2014
Continued drug use during methadone treatment in China: a retrospective analysis of 19,026 service users.
    Journal of substance abuse treatment, 2014, Volume: 47, Issue:1

    Topics: China; Female; HIV Infections; Humans; Male; Methadone; Narcotics; Opiate Substitution Treatment; Op

2014
Situation-specific factors predicting nonadherence to methadone maintenance treatment: a cross-sectional study using the case-crossover design in Guangzhou, China.
    AIDS care, 2014, Volume: 26 Suppl 1

    Topics: Adult; Aged; China; Cross-Over Studies; Drug Users; Female; Health Services Accessibility; HIV Infec

2014
[Study on the adherence and related determinants among HIV-positive clients under methadone maintenance treatment in Dali,Yunnan province from 2005 to 2013].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2014, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiretroviral Therapy, Highly Active; Child; Child, Pre

2014
Evaluation of state opioid substitution treatment program in Georgia.
    Georgian medical news, 2014, Issue:229

    Topics: Adult; Aged; Alcoholism; Buprenorphine; Female; Georgia (Republic); Government Programs; Hepatitis B

2014
Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Sep-01, Volume: 59, Issue:5

    Topics: Adult; Cohort Studies; Female; HIV Infections; Humans; Incidence; Kaplan-Meier Estimate; Male; Medic

2014
Editorial commentary: successful methadone delivery in East Africa and its global implications.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Sep-01, Volume: 59, Issue:5

    Topics: Female; HIV Infections; Humans; Male; Medication Adherence; Methadone; Opiate Substitution Treatment

2014
"In their perception we are addicts": social vulnerabilities and sources of support for men released from drug treatment centers in Vietnam.
    The International journal on drug policy, 2014, Volume: 25, Issue:5

    Topics: Adult; Drug Users; Harm Reduction; HIV Infections; Humans; Interviews as Topic; Male; Mandatory Prog

2014
Prevalence and factors associated with HIV infection among injection drug users at methadone clinics in Taipei, Taiwan.
    BMC public health, 2014, Jul-04, Volume: 14

    Topics: Adolescent; Adult; Ambulatory Care Facilities; Drug Overdose; Drug Users; Female; HIV Infections; Ho

2014
[A case-control study on the causes of new HIV infection among heroin addicts attendees at the methadone maintenance treatment clinics].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2014, Volume: 35, Issue:4

    Topics: Adult; Case-Control Studies; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Humans; M

2014
The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance.
    International journal of behavioral medicine, 2015, Volume: 22, Issue:2

    Topics: Adult; Antiretroviral Therapy, Highly Active; Depression; Female; HIV Infections; Humans; Male; Medi

2015
Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis.
    Harm reduction journal, 2014, Aug-18, Volume: 11

    Topics: Adult; Emigrants and Immigrants; Ethnicity; Female; HIV Infections; Humans; Male; Methadone; Narcoti

2014
Risk reduction with buprenorphine-naloxone and methadone: patient's choice.
    Journal of acquired immune deficiency syndromes (1999), 2014, Dec-15, Volume: 67, Issue:5

    Topics: Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Opio

2014
Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
    Journal of acquired immune deficiency syndromes (1999), 2014, Dec-15, Volume: 67, Issue:5

    Topics: Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Opio

2014
Methadone maintenance therapy and HIV counseling and testing are associated with lower frequency of risky behaviors among injection drug users in China.
    Substance use & misuse, 2015, Volume: 50, Issue:1

    Topics: Adolescent; Adult; AIDS Serodiagnosis; China; Counseling; Cross-Sectional Studies; Female; HIV Infec

2015
Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand.
    Drug and alcohol review, 2015, Volume: 34, Issue:1

    Topics: Adult; Cross-Sectional Studies; Female; Health Policy; HIV Infections; Humans; Logistic Models; Male

2015
Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care.
    The International journal on drug policy, 2015, Volume: 26, Issue:1

    Topics: Adult; Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Opiate Substitution Treatment

2015
Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China.
    AIDS research and human retroviruses, 2015, Volume: 31, Issue:1

    Topics: Adult; Anti-HIV Agents; China; Data Collection; Female; HIV Infections; Humans; Male; Methadone; Mid

2015
The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection.
    Journal of substance abuse treatment, 2015, Volume: 51

    Topics: Adult; Anti-HIV Agents; Buprenorphine; Cocaine; Cocaine-Related Disorders; Drug Interactions; Female

2015
Who uses methadone services in China? Monitoring the world's largest methadone programme.
    Addiction (Abingdon, England), 2015, Volume: 110 Suppl 1

    Topics: Adult; Analgesics, Opioid; China; Cohort Studies; Database Management Systems; Drug Users; Female; H

2015
Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
    Drug and alcohol dependence, 2015, Apr-01, Volume: 149

    Topics: Adult; Attitude; Heroin; HIV Infections; Humans; Indonesia; Male; Methadone; Narcotics; Needle Shari

2015
Health service utilization of heroin abusers: a retrospective cohort study.
    Addictive behaviors, 2015, Volume: 45

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Cohort Studies; Comorbidity; Educational Status; Emergency

2015
Is the promise of methadone Kenya's solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study.
    BMJ open, 2015, Mar-06, Volume: 5, Issue:3

    Topics: Adult; Female; Harm Reduction; Heroin Dependence; HIV Infections; Hope; Humans; Incidence; Interview

2015
HIV-gp120 and physical dependence to buprenorphine.
    Drug and alcohol dependence, 2015, May-01, Volume: 150

    Topics: Animals; Buprenorphine; HIV Envelope Protein gp120; HIV Infections; Male; Methadone; Opioid-Related

2015
Factors associated with methadone treatment duration: a Cox regression analysis.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adult; Demography; Female; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Male; Methadone;

2015
[Impact of antiretroviral therapy on drug-using and high risk sexual behaviors among HIV-positive methadone maintenance treatment clients: a qualitative study].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2015, Volume: 36, Issue:1

    Topics: Adult; China; Condoms; Female; HIV Infections; Humans; Male; Methadone; Needle Sharing; Opiate Subst

2015
[Prevalence and network-characteristics of risky sexual behaviors among clients receiving methadone maintenance treatment at clinics in Taizhou prefecture of Zhejiang province].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2015, Volume: 36, Issue:1

    Topics: Adult; China; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Methadone; Opiate Subst

2015
Comparison of outcomes after 3-month methadone maintenance treatment between heroin users with and without HIV infection: a 3-month follow-up study.
    Harm reduction journal, 2015, May-08, Volume: 12

    Topics: Adult; Depression; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Humans; Male; Metha

2015
Implementation and Operational Research: Linkage to Care Among Methadone Clients Living With HIV in Dar es Salaam, Tanzania.
    Journal of acquired immune deficiency syndromes (1999), 2015, Jun-01, Volume: 69, Issue:2

    Topics: Adult; Female; Health Services; HIV Infections; Humans; Male; Methadone; Opiate Substitution Treatme

2015
Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients.
    International journal of cardiology, 2015, Sep-01, Volume: 194

    Topics: Adult; Chemokine CXCL10; Chemokines; Electrocardiography; Female; Hepatitis C; Heroin Dependence; HI

2015
Effect of integrating HIV and addiction care for non-engaging HIV-infected opiate-dependent patients.
    Irish journal of medical science, 2016, Volume: 185, Issue:3

    Topics: Adult; Cohort Studies; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Opiate Substitu

2016
Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
    Drug and alcohol dependence, 2015, Aug-01, Volume: 153

    Topics: Adult; Buprenorphine; Case-Control Studies; Coinfection; Female; Hepatitis C; HIV Infections; Humans

2015
Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.
    Journal of addictive diseases, 2015, Volume: 34, Issue:2-3

    Topics: Baltimore; Buprenorphine; Counseling; Criminal Behavior; Health Services Accessibility; Health Servi

2015
Simeprevir-induced severe withdrawal syndrome in an HIV/HCV coinfected patient on long-term maintenance methadone therapy.
    European journal of clinical pharmacology, 2015, Volume: 71, Issue:8

    Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Interactions; Hepatitis C

2015
Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.
    The International journal on drug policy, 2016, Volume: 27

    Topics: Adolescent; Adult; Attitude of Health Personnel; China; Cross-Sectional Studies; Feasibility Studies

2016
Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study.
    BMJ open, 2015, Aug-21, Volume: 5, Issue:8

    Topics: Adult; Analgesics, Opioid; China; Drug Users; Female; Follow-Up Studies; Hepatitis C; HIV Infections

2015
[Impacts of antiretroviral treatment on drug use and high risk sexual behaviors among HIV-positive MMT clients].
    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2015, Volume: 49, Issue:6

    Topics: Anti-HIV Agents; China; Condoms; Cross-Sectional Studies; HIV Infections; HIV Seropositivity; Humans

2015
[A study on the risk and its determinants of HIV transmission by syringe sharing among HIV-positive drug users].
    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2015, Volume: 49, Issue:6

    Topics: Aged; Case-Control Studies; Drug Users; HIV Infections; Humans; Male; Methadone; Needle Sharing; Pre

2015
Preference of methadone maintenance patients for the integrative and decentralized service delivery models in Vietnam.
    Harm reduction journal, 2015, Sep-17, Volume: 12

    Topics: Adult; Comorbidity; Cross-Sectional Studies; Female; Harm Reduction; Health Services Accessibility;

2015
Quality of life and its determinants for heroin addicts receiving a methadone maintenance program: Comparison with matched referents from the general population.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:9

    Topics: Adult; Comorbidity; Databases, Factual; Female; Heroin Dependence; HIV Infections; Humans; Male; Met

2016
Methadone treatment in primary care.
    The lancet. HIV, 2015, Volume: 2, Issue:10

    Topics: Female; HIV Infections; Humans; Male; Methadone; Narcotics; Substance Abuse, Intravenous

2015
Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study.
    The lancet. HIV, 2015, Volume: 2, Issue:10

    Topics: Adult; British Columbia; Cohort Studies; Female; HIV Infections; Humans; Incidence; Maintenance Chem

2015
Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center.
    AIDS and behavior, 2016, Volume: 20, Issue:5

    Topics: Adult; Antiretroviral Therapy, Highly Active; Comorbidity; Female; HIV Infections; Humans; Longitudi

2016
Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission.
    Addiction (Abingdon, England), 2015, Volume: 110, Issue:12

    Topics: Buprenorphine; Health Services Accessibility; HIV Infections; Humans; Methadone; Narcotic Antagonist

2015
Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response.
    Harm reduction journal, 2015, Oct-16, Volume: 12

    Topics: Adult; Cohort Studies; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Humans; Male; M

2015
Patient Satisfaction with Methadone Maintenance Treatment in Vietnam: A Comparison of Different Integrative-Service Delivery Models.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Adult; Ambulatory Care Facilities; Cross-Sectional Studies; Delivery of Health Care, Integrated; Dru

2015
[Prevalence of HIV and HCV infections in patients receiving methadone maintenance treatment in Kaiyuan, Yunnan].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2015, Volume: 36, Issue:8

    Topics: China; Coinfection; Drug Users; Hepatitis C; HIV Infections; Humans; Methadone; Opiate Substitution

2015
[Factors influencing access to methadone maintenance treatment among injecting drug users attending antiretroviral treatment clinics in two counties, Yunnan province].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2016, Volume: 37, Issue:1

    Topics: Adult; China; Demography; Drug Users; Educational Status; Female; Health Services Accessibility; HIV

2016
"Can't you initiate me here?": Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania.
    The International journal on drug policy, 2016, Volume: 30

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Female; Health Knowledge, Attitudes, Practice; Health Service

2016
Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups.
    AIDS and behavior, 2016, Volume: 20, Issue:9

    Topics: Adolescent; Adult; Condoms; Counseling; Follow-Up Studies; HIV Infections; Humans; Male; Mass Screen

2016
Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania.
    The International journal on drug policy, 2016, Volume: 30

    Topics: Adult; Female; Harm Reduction; Health Services Accessibility; Heroin Dependence; HIV Infections; Hum

2016
Types and Characteristics of Childhood Sexual Abuse: How Do They Matter in HIV Sexual Risk Behaviors Among Women in Methadone Treatment in New York City?
    Substance use & misuse, 2016, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Adult Survivors of Child Abuse; Female; HIV Infections; Humans; Methadone; New Yo

2016
Towards "evidence-making intervention" approaches in the social science of implementation science: The making of methadone in East Africa.
    The International journal on drug policy, 2016, Volume: 30

    Topics: Evidence-Based Practice; Health Policy; Heroin Dependence; HIV Infections; Humans; Kenya; Methadone;

2016
Drug addiction stigma in relation to methadone maintenance treatment by different service delivery models in Vietnam.
    BMC public health, 2016, Mar-08, Volume: 16

    Topics: Adult; Cross-Sectional Studies; Drug Users; Female; Health Services Administration; HIV Infections;

2016
Characteristics of U.S. Substance Abuse Treatment Facilities Offering HIV Services: Results From a National Survey.
    Psychiatric services (Washington, D.C.), 2016, 06-01, Volume: 67, Issue:6

    Topics: Delivery of Health Care; Health Services Accessibility; HIV Infections; Humans; Logistic Models; Met

2016
Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.
    AIDS and behavior, 2016, Volume: 20, Issue:12

    Topics: Adult; Aftercare; Attitude; Female; Follow-Up Studies; HIV Infections; Humans; Intention; Interview,

2016
Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania.
    The International journal on drug policy, 2016, Volume: 30

    Topics: Adult; Cohort Studies; Dose-Response Relationship, Drug; Heroin Dependence; HIV Infections; Humans;

2016
Methadone Maintenance Treatment Promotes Referral and Uptake of HIV Testing and Counselling Services amongst Drug Users and Their Partners.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: Adolescent; Adult; AIDS Serodiagnosis; Counseling; Cross-Sectional Studies; Female; HIV Infections;

2016
Finding what works: identification of implementation strategies for the integration of methadone maintenance therapy and HIV services in Vietnam.
    Implementation science : IS, 2016, Apr-20, Volume: 11

    Topics: Health Plan Implementation; Health Services Accessibility; HIV Infections; Humans; Interviews as Top

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.
    The International journal on drug policy, 2016, Volume: 32

    Topics: Delivery of Health Care; Europe; Gross Domestic Product; Harm Reduction; Health Care Costs; Health E

2016
[Related factors and interaction on high-risk sexual behaviors among patients under the methadone maintenance treatment].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2016, Volume: 37, Issue:6

    Topics: China; Hepatitis B Vaccines; HIV Infections; Humans; Male; Methadone; Risk Factors; Sexual Behavior;

2016
[HCV infection status and related risk factors in drug users under HIV sentinel surveillance in Henan province, 2011-2015].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2016, Volume: 37, Issue:6

    Topics: China; Cross-Sectional Studies; Drug Users; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Hum

2016
Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV.
    BMJ case reports, 2016, Jul-11, Volume: 2016

    Topics: Adult; Analgesics, Opioid; Canada; Female; Harm Reduction; HIV Infections; Hospitalization; Humans;

2016
HIV seroconversion and risk factors among drug users receiving methadone maintenance treatment in China: A qualitative study.
    Drug and alcohol dependence, 2016, Oct-01, Volume: 167

    Topics: Adult; China; Counseling; Drug Users; Female; HIV Infections; Humans; Male; Methadone; Needle Sharin

2016
Heroin addiction, methadone, and HIV in China.
    The lancet. Psychiatry, 2016, Volume: 3, Issue:9

    Topics: China; Drug Users; Heroin Dependence; HIV Infections; Humans; Methadone; Needle-Exchange Programs; S

2016
Effectiveness of Methadone Maintenance Therapy and Improvement in Quality of Life Following a Decade of Implementation.
    Journal of substance abuse treatment, 2016, Volume: 69

    Topics: Adult; Follow-Up Studies; Hepatitis B; Heroin Dependence; HIV Infections; Humans; Interpersonal Rela

2016
Client Acceptability for Integrating Antiretroviral Therapy in Methadone Maintenance Therapy Clinics in Sichuan, China.
    Substance use & misuse, 2017, 01-02, Volume: 52, Issue:1

    Topics: Adult; Anti-Retroviral Agents; China; Cross-Sectional Studies; Female; Heroin Dependence; HIV Infect

2017
Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
    Drug and alcohol dependence, 2016, Nov-01, Volume: 168

    Topics: Adult; Analgesics, Opioid; Canada; Cocaine; Cocaine-Related Disorders; Crack Cocaine; Female; HIV In

2016
First Report of Gender Based Violence as a Deterrent to Methadone Access Among Females Who Use Heroin in Dar es Salaam, Tanzania.
    AIDS and behavior, 2017, Volume: 21, Issue:7

    Topics: Adolescent; Adult; Analgesics, Opioid; Case-Control Studies; Child; Female; Gender-Based Violence; H

2017
NPS and the methadone queue: Spillages of space and time.
    The International journal on drug policy, 2017, Volume: 40

    Topics: Adult; Central Nervous System Stimulants; Female; HIV Infections; Humans; Interviews as Topic; Male;

2017
Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study.
    Drug and alcohol dependence, 2017, Jan-01, Volume: 170

    Topics: Adult; Anti-Retroviral Agents; China; Female; HIV Infections; Humans; Male; Methadone; Middle Aged;

2017
Willingness to Use Pre-Exposure Prophylaxis (PrEP): An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model among High-Risk Drug Users in Treatment.
    AIDS and behavior, 2017, Volume: 21, Issue:5

    Topics: Adult; Behavior Therapy; Cross-Sectional Studies; Drug Users; Female; Health Education; HIV Infectio

2017
Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment.
    AIDS and behavior, 2017, Volume: 21, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adult; Cell Phone; Connecticut; Delivery of Health Care; Drug Us

2017
Hepatitis C in a Mobile Low-Threshold Methadone Program.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:6

    Topics: Adult; Aged; Alcohol-Related Disorders; Coinfection; Comorbidity; Cross-Sectional Studies; Drug User

2017
Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.
    Harm reduction journal, 2017, 02-14, Volume: 14, Issue:1

    Topics: Adult; China; Cities; Comorbidity; Condoms; Female; Harm Reduction; HIV Infections; Humans; Male; Me

2017
Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.
    Drug and alcohol dependence, 2017, Apr-01, Volume: 173

    Topics: Adult; Cross-Sectional Studies; Female; HIV Infections; Homosexuality, Male; Humans; Male; Methadone

2017
Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
    Drug and alcohol dependence, 2017, Apr-01, Volume: 173

    Topics: Adult; Buprenorphine; Cross-Sectional Studies; Delivery of Health Care, Integrated; Female; Health S

2017
Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).
    European addiction research, 2008, Volume: 14, Issue:3

    Topics: Adult; Catchment Area, Health; Cohort Studies; Comorbidity; Demography; Diagnosis, Dual (Psychiatry)

2008
Effect of methadone treatment on incarceration rates among injection drug users.
    European addiction research, 2008, Volume: 14, Issue:3

    Topics: Adult; Age Factors; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Humans; Incidence;

2008
Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Aug-01, Volume: 47, Issue:3

    Topics: Adult; Atazanavir Sulfate; Drug Therapy, Combination; Electrocardiography; HIV Infections; HIV Prote

2008
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
    Addiction (Abingdon, England), 2008, Volume: 103, Issue:9

    Topics: Adolescent; Adult; Aged; Buprenorphine; Developing Countries; Female; HIV Infections; Humans; Male;

2008
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Addiction (Abingdon, England), 2008, Volume: 103, Issue:11

    Topics: Adult; Antiretroviral Therapy, Highly Active; Buprenorphine; Epidemiologic Studies; Female; HIV Infe

2008
Implementation of drug substitution therapy in Georgia.
    Central European journal of public health, 2008, Volume: 16, Issue:3

    Topics: Georgia (Republic); Harm Reduction; Hepatitis C; HIV Infections; Humans; Methadone; Narcotics; Psych

2008
Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program.
    Journal of substance abuse treatment, 2009, Volume: 37, Issue:1

    Topics: Adult; Analgesics, Opioid; Antiviral Agents; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination

2009
Incarceration and drug use patterns among a cohort of injection drug users.
    Addiction (Abingdon, England), 2009, Volume: 104, Issue:1

    Topics: Adult; Epidemiologic Methods; Female; HIV Infections; Humans; Institutionalization; Law Enforcement;

2009
The effect of methadone maintenance on positive outcomes for opiate injection drug users.
    Journal of substance abuse treatment, 2009, Volume: 37, Issue:2

    Topics: Adult; Colorado; Female; Follow-Up Studies; HIV Infections; Humans; Logistic Models; Male; Methadone

2009
Tribute to Peter Lee, pioneer of methadone treatment in Hong Kong.
    The International journal on drug policy, 2009, Volume: 20, Issue:2

    Topics: Analgesics, Opioid; History, 20th Century; HIV Infections; Hong Kong; Humans; Male; Methadone; Opioi

2009
Gender Differences Among In- and Out-of-Treatment Opioid-Addicted Individuals.
    The American journal of drug and alcohol abuse, 2009, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Age of Onset; Analgesics, Opioid; Baltimore; Cocaine-Related Disorders; Crime; Fe

2009
An 18-year follow-up of patients admitted to methadone treatment for the first time.
    Journal of addictive diseases, 2009, Volume: 28, Issue:1

    Topics: Adolescent; Adult; Cause of Death; Criminology; Diagnosis, Dual (Psychiatry); Female; Follow-Up Stud

2009
Self-efficacy and depression as mediators of the relationship between pain and antiretroviral adherence.
    AIDS care, 2009, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Depressive Disorder; Female; HIV Infections; Humans; Male;

2009
Multilevel analysis of HIV related risk behaviors among heroin users in a low prevalence community.
    BMC public health, 2009, May-12, Volume: 9

    Topics: Adult; Age Factors; Analgesics, Opioid; Cross-Sectional Studies; Drug Users; Heroin Dependence; HIV

2009
Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Nov-01, Volume: 49, Issue:9

    Topics: Adult; Antiretroviral Therapy, Highly Active; Buprenorphine; Female; HIV Infections; Humans; Male; M

2009
Syringe exchange, injecting and intranasal drug use.
    Addiction (Abingdon, England), 2010, Volume: 105, Issue:1

    Topics: Administration, Intranasal; Attitude to Health; HIV Infections; Humans; Methadone; Narcotics; Needle

2010
Integration of methadone maintenance treatment and HIV care for injecting drug users: a cohort study in Bandung, Indonesia.
    Acta medica Indonesiana, 2009, Volume: 41 Suppl 1

    Topics: Adult; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Opiate Substitution Treat

2009
Heroin-assisted treatment in Switzerland: a case study in policy change.
    Addiction (Abingdon, England), 2010, Volume: 105, Issue:1

    Topics: Cohort Studies; Drug and Narcotic Control; Germany; Harm Reduction; Health Plan Implementation; Hero

2010
Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine.
    The International journal on drug policy, 2010, Volume: 21, Issue:3

    Topics: Adult; Behavior, Addictive; Buprenorphine; Employment; Feasibility Studies; Female; HIV Infections;

2010
Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.
    The International journal on drug policy, 2010, Volume: 21, Issue:2

    Topics: Developing Countries; Disease Outbreaks; Harm Reduction; Health Services Accessibility; HIV Infectio

2010
Age and HIV sexual risk among women in methadone treatment.
    AIDS and behavior, 2011, Volume: 15, Issue:1

    Topics: Adult; Age Distribution; Condoms; Female; HIV Infections; Humans; Interpersonal Relations; Logistic

2011
Disproportionate and increasing burden of HIV infection among men who have sex with men in Slovenia: surveillance data for 1999-2008.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2009, Nov-26, Volume: 14, Issue:47

    Topics: Adolescent; Adult; Anonymous Testing; Bisexuality; Comorbidity; Condoms; Cross-Sectional Studies; He

2009
No differences in quality of life between men and women undergoing HIV antiretroviral treatment. Impact of demographic, clinical and psychosocial factors.
    AIDS care, 2009, Volume: 21, Issue:8

    Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; Female; Hepatitis C, Chronic; HIV Infections; Human

2009
[Burden of disease and level of patient's medical care in substitution treatment for opiates].
    Medizinische Klinik (Munich, Germany : 1983), 2009, Dec-15, Volume: 104, Issue:12

    Topics: Adult; Asthma; Comorbidity; Cooperative Behavior; Cost of Illness; Cross-Sectional Studies; Female;

2009
A longitudinal study of incarceration and HIV risk among methadone maintained men and their primary female partners.
    AIDS and behavior, 2011, Volume: 15, Issue:2

    Topics: Adult; Aged; Female; HIV Infections; Humans; Interviews as Topic; Longitudinal Studies; Male; Methad

2011
Menopause symptom attribution among midlife women in methadone treatment.
    Social work in health care, 2010, Volume: 49, Issue:1

    Topics: Adult; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Health Surveys; HIV I

2010
Examining the temporal relationship between criminal justice involvement and sexual risk behaviors among drug-involved men.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2010, Volume: 87, Issue:2

    Topics: Criminal Law; HIV Infections; Humans; Interviews as Topic; Logistic Models; Male; Methadone; Middle

2010
HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005.
    Journal of substance abuse treatment, 2010, Volume: 38, Issue:4

    Topics: Ambulatory Care; Cross-Sectional Studies; Data Collection; Directive Counseling; HIV Infections; Hum

2010
Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province, China.
    AIDS care, 2010, Volume: 22, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Ambulatory Care Facilities; China; Harm Reduction; Health

2010
Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
    Addiction (Abingdon, England), 2010, Volume: 105, Issue:5

    Topics: Adult; Anti-HIV Agents; British Columbia; Epidemiologic Methods; Female; HIV Infections; Humans; Mal

2010
Assessing criminal justice involvement as an indicator of human immunodeficiency virus risk among women in methadone treatment.
    Journal of substance abuse treatment, 2010, Volume: 38, Issue:4

    Topics: Adult; Data Collection; Female; HIV Infections; Humans; Logistic Models; Methadone; Middle Aged; New

2010
Select barriers to harm-reduction services for IDUs in eastern Europe.
    Central European journal of public health, 2009, Volume: 17, Issue:4

    Topics: Age Factors; Confidentiality; Europe, Eastern; Fees and Charges; Harm Reduction; Health Services Acc

2009
Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2010, Volume: 87, Issue:4

    Topics: Adult; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Iran; Male; Methadone; Narcoti

2010
Commentary on Uhlmann et al. (2010): managing HIV in drug users--the huge gap remaining between evidence and international policy and practice.
    Addiction (Abingdon, England), 2010, Volume: 105, Issue:5

    Topics: Anti-HIV Agents; Evidence-Based Medicine; Health Policy; HIV Infections; Humans; International Coope

2010
Prevention of HIV transmission among intravenous drug users.
    Lancet (London, England), 2010, May-22, Volume: 375, Issue:9728

    Topics: France; HIV Infections; Humans; Methadone; Needle-Exchange Programs; Substance Abuse, Intravenous

2010
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
    Antiviral therapy, 2010, Volume: 15, Issue:3

    Topics: Anti-HIV Agents; Central Nervous System Agents; Cohort Studies; Comorbidity; Drug Interactions; Drug

2010
Evidence based policy for illicit [corrected] drugs.
    BMJ (Clinical research ed.), 2010, Jul-01, Volume: 341

    Topics: Evidence-Based Medicine; Health Policy; HIV Infections; Humans; Methadone; Narcotics; Opioid-Related

2010
Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.
    BMJ (Clinical research ed.), 2010, Jul-01, Volume: 341

    Topics: Adult; Epidemiologic Methods; Female; HIV Infections; Humans; Male; Methadone; Narcotics; Opioid-Rel

2010
No opiate substitutes for the masses of IDUs.
    Science (New York, N.Y.), 2010, Jul-09, Volume: 329, Issue:5988

    Topics: Female; Harm Reduction; HIV Infections; Humans; Male; Methadone; Methadyl Acetate; Narcotics; Needle

2010
Law enforcement and drug treatment: a culture clash.
    Science (New York, N.Y.), 2010, Jul-09, Volume: 329, Issue:5988

    Topics: Buprenorphine; Female; Harm Reduction; HIV Infections; Humans; Law Enforcement; Male; Methadone; Nar

2010
A peer-led mobile outreach program and increased utilization of detoxification and residential drug treatment among female sex workers who use drugs in a Canadian setting.
    Drug and alcohol dependence, 2011, Jan-01, Volume: 113, Issue:1

    Topics: Canada; Community-Institutional Relations; Female; Health Education; HIV Infections; Humans; Methado

2011
Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study.
    Addiction (Abingdon, England), 2010, Volume: 105, Issue:12

    Topics: Anti-Retroviral Agents; Attitude to Health; Buprenorphine; Cohort Studies; Depression; Female; Franc

2010
Scaling up the national methadone maintenance treatment program in China: achievements and challenges.
    International journal of epidemiology, 2010, Volume: 39 Suppl 2

    Topics: China; Crime; Health Education; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Methadone; N

2010
Quantitatively monitoring AIDS policy implementation in China.
    International journal of epidemiology, 2010, Volume: 39 Suppl 2

    Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; CD4 Lymphocyte Count; China; Health Poli

2010
Development of a unified web-based national HIV/AIDS information system in China.
    International journal of epidemiology, 2010, Volume: 39 Suppl 2

    Topics: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Anti-Retroviral Agents; China; Counseling; D

2010
Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
    Journal of acquired immune deficiency syndromes (1999), 2011, Jan-01, Volume: 56, Issue:1

    Topics: Antiretroviral Therapy, Highly Active; Directly Observed Therapy; HIV Infections; Humans; Medication

2011
Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy.
    Drug and alcohol dependence, 2011, Jul-01, Volume: 116, Issue:1-3

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV

2011
[Impact of methadone maintenance treatment on HIV risk behaviors of heroin drug users].
    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2010, Volume: 44, Issue:11

    Topics: Adult; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Opiate Substitution Treat

2010
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
    Journal of acquired immune deficiency syndromes (1999), 2011, Mar-01, Volume: 56 Suppl 1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; Buprenorphine, Naloxon

2011
[Pneumonia and bacteremia due to Neisseria mucosa in a human immunodeficient virus seropositive patient parenteral drug abuser].
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:3

    Topics: Adult; Bacteremia; Heart Valve Prosthesis Implantation; Heroin Dependence; HIV Infections; Humans; I

2011
Commentary: reaching women drug users with methadone treatment and other HIV prevention services in Tehran.
    Journal of public health policy, 2011, Volume: 32, Issue:2

    Topics: Ambulatory Care Facilities; Analgesics, Opioid; Female; HIV Infections; Humans; Iran; Methadone; Opi

2011
The establishment of a methadone treatment clinic for women in Tehran, Iran.
    Journal of public health policy, 2011, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Ambulatory Care Facilities; Analgesics, Opioid; Female; Harm Reduction; Hepatitis

2011
Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
    PLoS medicine, 2011, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Cost-Benefit Analysis; Epidemics; Harm Reduction; Health

2011
Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    The International journal on drug policy, 2011, Volume: 22, Issue:3

    Topics: Adult; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; Harm Reduction; HIV Infections

2011
Methadone maintenance therapy as evidence based drug abuse planning in developed countries: can developing countries afford and learn from this experience?
    East African journal of public health, 2010, Volume: 7, Issue:1

    Topics: Developed Countries; Developing Countries; Evidence-Based Medicine; Female; Health Planning; HIV Inf

2010
Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:8

    Topics: Adult; Aged; Drug Users; Epidemiologic Methods; Female; Harm Reduction; Heroin Dependence; HIV Infec

2011
Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment.
    Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2011, Volume: 42, Issue:1

    Topics: Antiretroviral Therapy, Highly Active; Depression; Female; HIV Infections; Humans; Male; Medication

2011
Ageing with HIV: medication use and risk for potential drug-drug interactions.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9

    Topics: Adult; Aged; Aging; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiovascular Agents; C

2011
Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS.
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2012, Volume: 21, Issue:4

    Topics: Adult; Cohort Studies; Female; HIV Infections; HIV Seropositivity; Humans; Longitudinal Studies; Mal

2012
HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users.
    AIDS care, 2012, Volume: 24, Issue:2

    Topics: Adult; China; Cross-Sectional Studies; Female; HIV Infections; Humans; Libido; Male; Medication Adhe

2012
Associations between political/civic participation and HIV drug injection risk.
    The American journal of drug and alcohol abuse, 2011, Volume: 37, Issue:6

    Topics: Adult; Community Participation; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Needle

2011
A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences.
    Addictive behaviors, 2011, Volume: 36, Issue:12

    Topics: Adult; Aged, 80 and over; Female; Follow-Up Studies; Hepatitis B; Hepatitis C; Heroin Dependence; HI

2011
Characteristics of Iranian women seeking drug treatment.
    Journal of women's health (2002), 2011, Volume: 20, Issue:11

    Topics: Adolescent; Adult; Analysis of Variance; Female; Health Status; Hepatitis C; HIV Infections; Humans;

2011
Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam.
    AIDS care, 2012, Volume: 24, Issue:3

    Topics: Adult; Cohort Studies; Cost-Benefit Analysis; Female; HIV Infections; HIV Seropositivity; Humans; Ma

2012
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.
    Maturitas, 2011, Volume: 70, Issue:3

    Topics: Adult; Age Factors; Body Mass Index; Bone Density; Bone Resorption; Female; Hepatitis C; HIV Infecti

2011
Studying up harm reduction policy: the office as an assemblage.
    The International journal on drug policy, 2011, Volume: 22, Issue:6

    Topics: Administrative Personnel; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combinatio

2011
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study.
    European journal of medical research, 2011, Oct-10, Volume: 16, Issue:10

    Topics: Adenine; Adult; Analgesics, Opioid; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female;

2011
Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.
    Journal of acquired immune deficiency syndromes (1999), 2012, Apr-01, Volume: 59, Issue:4

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; British Columbia; Female; HIV Infecti

2012
Studies confirm effectiveness of harm reduction for people who inject drugs.
    HIV/AIDS policy & law review, 2011, Volume: 15, Issue:3

    Topics: Harm Reduction; HIV Infections; Humans; Methadone; Needle-Exchange Programs; Substance Abuse, Intrav

2011
Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2012, Volume: 89, Issue:2

    Topics: Adolescent; Adult; Attitude of Health Personnel; Child; Delivery of Health Care; Drug Users; Female;

2012
HIV sex-risk behaviors among in- versus out-of-treatment heroin-addicted adults.
    The American journal of drug and alcohol abuse, 2012, Volume: 38, Issue:4

    Topics: Adult; Cohort Studies; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Humans; Longitu

2012
Essentiality of HIV testing and education for effective HIV control in the national pilot harm reduction program: the Taiwan experience.
    The Kaohsiung journal of medical sciences, 2012, Volume: 28, Issue:2

    Topics: Harm Reduction; Health Education; HIV Infections; Humans; Methadone; Needle-Exchange Programs; Taiwa

2012
Methadone maintenance treatment: disciplining the 'addict'.
    Health and history, 2011, Volume: 13, Issue:2

    Topics: Attitude to Health; Australia; Crime; Drug Users; Health Policy; Heroin Dependence; History, 20th Ce

2011
[Mortality of HIV infected clients treated with methadone maintenance treatment in Yili Kazakh autonomous prefecture].
    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2011, Volume: 45, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; China; Female; HIV Infection

2011
[Study on incidence of HIV infection among heroin addicts receiving methadone maintenance treatment in Dehong prefecture, Yunnan province].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2011, Volume: 32, Issue:12

    Topics: Adolescent; Adult; Aged; China; Drug Users; Female; Heroin Dependence; HIV Infections; HIV Seroposit

2011
A harm reduction paradox: comparing China's policies on needle and syringe exchange and methadone maintenance.
    The International journal on drug policy, 2012, Volume: 23, Issue:4

    Topics: China; Harm Reduction; Health Policy; HIV Infections; Humans; Methadone; Needle-Exchange Programs; O

2012
Methadone maintenance therapy outcomes in Iran.
    Substance use & misuse, 2012, Volume: 47, Issue:7

    Topics: Adaptation, Psychological; Adult; Case-Control Studies; Crime; Harm Reduction; HIV Infections; Human

2012
In control?: Ukrainian opiate substitution treatment patients strive for a voice in their treatment.
    Substance use & misuse, 2012, Volume: 47, Issue:5

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Users; Female; Health Services Accessibility; HIV Inf

2012
Self-efficacy and HIV risk behaviors among heroin users in Taiwan.
    Journal of studies on alcohol and drugs, 2012, Volume: 73, Issue:3

    Topics: Adult; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heroin Dependence; HIV Infection

2012
Predictors of relationship power among drug-involved women.
    AIDS and behavior, 2012, Volume: 16, Issue:6

    Topics: Adult; Ambulatory Care; Analgesics, Opioid; Decision Making; Dominance-Subordination; Female; HIV In

2012
Depression, Testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV Infection.
    AIDS and behavior, 2012, Volume: 16, Issue:8

    Topics: Adult; Cross-Sectional Studies; Depression; Female; HIV Infections; Humans; Hypogonadism; Iran; Logi

2012
Harm reduction and "clean" community: can Viet Nam have both?
    Harm reduction journal, 2012, Jul-09, Volume: 9

    Topics: Female; Harm Reduction; Health Policy; Health Promotion; HIV Infections; Humans; Male; Methadone; Ne

2012
HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.
    The American journal of drug and alcohol abuse, 2012, Volume: 38, Issue:6

    Topics: Adult; AIDS Serodiagnosis; Cross-Sectional Studies; Female; Hepatitis C; HIV Infections; HIV Seroneg

2012
The dual pathway of professional attitude among health care workers serving HIV/AIDS patients and drug users.
    AIDS care, 2013, Volume: 25, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Attitude of Health Personnel; Drug Users; Female; Harm Re

2013
Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study.
    The International journal on drug policy, 2012, Volume: 23, Issue:5

    Topics: Adolescent; Adult; Cost-Benefit Analysis; Female; Health Policy; HIV Infections; Humans; Indonesia;

2012
Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Journal of substance abuse treatment, 2013, Volume: 44, Issue:2

    Topics: Administration, Intranasal; Adult; Drug Overdose; Female; HIV Infections; Humans; Male; Massachusett

2013
Methadone maintenance treatment in China: perceived challenges from the perspectives of service providers and patients.
    Journal of public health (Oxford, England), 2013, Volume: 35, Issue:2

    Topics: Adult; Attitude of Health Personnel; Attitude to Health; China; Female; Focus Groups; Health Service

2013
Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.
    AIDS and behavior, 2013, Volume: 17, Issue:1

    Topics: Adaptation, Psychological; Adolescent; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte

2013
HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, China.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Adult; China; Female; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middl

2012
The role of opioid substitution treatment in reducing HIV transmission.
    BMJ (Clinical research ed.), 2012, Oct-03, Volume: 345

    Topics: HIV Infections; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Substance Abuse, Intrav

2012
High prevalence of HIV, syphilis and HCV, and low methadone maintenance treatment in a migrant population in Beijing.
    Journal of addiction medicine, 2012, Volume: 6, Issue:4

    Topics: Adult; China; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Health Services Acc

2012
Methadone prescribing is to be reviewed in Scotland as user numbers continue to rise.
    BMJ (Clinical research ed.), 2012, Oct-09, Volume: 345

    Topics: Attitude of Health Personnel; Heroin Dependence; HIV Infections; Humans; Methadone; Practice Pattern

2012
The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users.
    Global public health, 2012, Volume: 7, Issue:10

    Topics: Analgesics, Opioid; Cost-Benefit Analysis; Heroin; HIV Infections; Humans; Methadone; Monte Carlo Me

2012
Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
    BMC public health, 2012, Dec-11, Volume: 12

    Topics: Adult; Coinfection; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Hepatitis C;

2012
Opioid substitution therapy is associated with decreased HIV transmission among people who inject drugs.
    Evidence-based medicine, 2013, Volume: 18, Issue:5

    Topics: HIV Infections; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Substance Abuse, Intrav

2013
[Characteristics of heroin dependent patients admitted to a methadone treatment program].
    Medicina clinica, 2014, Jan-21, Volume: 142, Issue:2

    Topics: Adolescent; Adult; Comorbidity; Cross-Sectional Studies; Educational Status; Female; Hepatitis B, Ch

2014
When grammars collide: Harm reduction, drug detention and the challenges of international policy reform efforts in Vietnam.
    Global public health, 2013, Volume: 8 Suppl 1

    Topics: Harm Reduction; HIV Infections; Humans; International Agencies; Interviews as Topic; Methadone; Narc

2013
Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users.
    AIDS patient care and STDs, 2002, Volume: 16, Issue:6

    Topics: Adult; CD4 Lymphocyte Count; Cognition Disorders; Educational Status; Female; HIV Infections; HIV-1;

2002
Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment.
    Journal of addictive diseases, 2002, Volume: 21, Issue:4

    Topics: Adult; Comorbidity; Hepatitis C; HIV Infections; HIV-1; Humans; Methadone; New York; Substance Abuse

2002
Methadone maintenance expands inside federal prisons.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2002, Nov-12, Volume: 167, Issue:10

    Topics: Analgesics, Opioid; Canada; Hepatitis C; HIV Infections; Human Rights; Humans; Methadone; Opioid-Rel

2002
Relationships between childhood abuse and neglect experience and HIV risk behaviors among methadone treatment drop-outs.
    Child abuse & neglect, 2002, Volume: 26, Issue:12

    Topics: Adaptation, Psychological; Adult; Child; Child Abuse; Female; HIV Infections; Humans; Male; Methadon

2002
Beliefs about methadone in an inner-city methadone clinic.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2002, Volume: 79, Issue:4

    Topics: Adult; Attitude to Health; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middl

2002
Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence.
    Substance use & misuse, 2002, Volume: 37, Issue:14

    Topics: Adult; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Female; Health Knowledge, A

2002
Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users.
    HIV medicine, 2003, Volume: 4, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Crime; Cross-Sectional St

2003
DAAT may work where DOT model fell short. Good results for drugs issued by methadone clinics.
    AIDS alert, 2003, Volume: 18, Issue:1

    Topics: Anti-HIV Agents; Directly Observed Therapy; HIV Infections; Humans; Methadone; Patient Compliance; P

2003
What's new for injection drug users with HIV infection?
    Sexually transmitted infections, 2003, Volume: 79, Issue:2

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Disease Outbreaks; Drug Interactions; Health

2003
Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment.
    Drug and alcohol dependence, 2003, May-21, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Aged; Chi-Square Distribution; Confidence Intervals; Female; HIV Infections; Huma

2003
The impact of methadone treatment on registered convictions and arrests in HIV-positive and HIV-negative men and women with one or more treatment periods.
    Drug and alcohol review, 2003, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Confidence Intervals; Female; HIV Infections; Humans; Male; Methadone; Opioid-Rel

2003
[Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment].
    Medicina clinica, 2003, May-31, Volume: 120, Issue:20

    Topics: Adult; Analgesics, Opioid; Cohort Studies; Female; Hepatitis C; HIV Infections; Humans; Male; Methad

2003
Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users.
    Journal of substance abuse treatment, 2003, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; HIV Infections; Hong Kong; Humans; Male; Methado

2003
Healthy choice = healthy live series outlines. "Sex, drugs and HIV" and microbicides.
    Survival news (Atlanta, Ga.), 2003

    Topics: Anti-HIV Agents; Anti-Infective Agents; Cannabis; Drug Interactions; Health Promotion; HIV Infection

2003
Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir.
    Journal of acquired immune deficiency syndromes (1999), 2003, Aug-15, Volume: 33, Issue:5

    Topics: Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Methado

2003
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Aug-15, Volume: 37, Issue:4

    Topics: HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Methadone; Narcotics; Opioid-Related Dis

2003
Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2003, Volume: 80, Issue:3

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Connecticut; Directly Observed T

2003
Torsade de pointes due to methadone.
    Annals of internal medicine, 2003, Aug-19, Volume: 139, Issue:4

    Topics: Adult; Analgesics, Opioid; HIV Infections; Humans; Male; Methadone; Torsades de Pointes

2003
The relationship between drug abuse and sexual performance among women on methadone. Heightening the risk of sexual intimate violence and HIV.
    Addictive behaviors, 2003, Volume: 28, Issue:8

    Topics: Adult; Female; Focus Groups; HIV Infections; Humans; Interviews as Topic; Libido; Male; Methadone; M

2003
Response to Clark et al. Assessing limiting factors to the acceptance of antiretroviral therapy n a large cohort of injecting drug users. HIV Med 2003;4:33-37.
    HIV medicine, 2003, Volume: 4, Issue:4

    Topics: Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Ireland; Life Style; Methadone; Patie

2003
QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.
    The American journal of cardiology, 2003, Oct-15, Volume: 92, Issue:8

    Topics: Adult; Analgesics, Opioid; Antiretroviral Therapy, Highly Active; Dose-Response Relationship, Drug;

2003
Pharmacokinetic drug interactions with nevirapine.
    Journal of acquired immune deficiency syndromes (1999), 2003, Volume: 34 Suppl 1

    Topics: Drug Interactions; Herbal Medicine; HIV Infections; HIV Protease Inhibitors; Humans; Methadone; Nevi

2003
Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Dec-15, Volume: 37 Suppl 5

    Topics: Adult; Delivery of Health Care; Emergencies; Female; HIV Infections; HIV Seronegativity; HIV Seropos

2003
Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Dec-15, Volume: 37, Issue:12

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; HIV; HIV Infectio

2003
Alberta gets a second methadone clinic.
    Canadian HIV/AIDS policy & law review, 2002, Volume: 7, Issue:2-3

    Topics: Alberta; HIV Infections; Humans; Methadone; Substance Abuse Treatment Centers; Substance Abuse, Intr

2002
Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population.
    AIDS patient care and STDs, 2003, Volume: 17, Issue:12

    Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Mental Disorders; Methadone; New York

2003
Nutritional status of deceased illicit drug addicts in Stockholm, Sweden--a longitudinal medicolegal study.
    Journal of forensic sciences, 2004, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Age Distribution; Amphetamine; Body Mass Index; Cannabis; Cocaine; Dopamine Uptak

2004
Detection of clinical interactions between methadone and anti-retroviral compounds using an enantioselective capillary electrophoresis for methadone analysis.
    Toxicology letters, 2004, Jun-15, Volume: 151, Issue:1

    Topics: Adult; Anti-Retroviral Agents; Cocaine; Drug Interactions; Electrophoresis, Capillary; Heroin; HIV;

2004
HIV/AIDS in China. Changing course to break the HIV-heroin connection.
    Science (New York, N.Y.), 2004, Jun-04, Volume: 304, Issue:5676

    Topics: Acquired Immunodeficiency Syndrome; China; Harm Reduction; Heroin Dependence; HIV Infections; Humans

2004
HIV, STD and hepatitis prevention among women in methadone maintenance: a qualitative and quantitative needs assessment.
    AIDS care, 2004, Volume: 16, Issue:4

    Topics: Adult; Aged; Analgesics, Opioid; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Methadone;

2004
Methadone and QT prolongation in HIV-infected patients.
    The American journal of cardiology, 2004, Jul-01, Volume: 94, Issue:1

    Topics: Analgesics, Opioid; HIV Infections; Humans; Long QT Syndrome; Methadone; Torsades de Pointes

2004
Highly active antiretroviral therapy among HIV-infected people with alcohol and substance misuse problems: the impact of substance abuse treatment.
    Addiction (Abingdon, England), 2004, Volume: 99, Issue:8

    Topics: Alcoholism; Antiretroviral Therapy, Highly Active; Directly Observed Therapy; HIV Infections; Humans

2004
Pulmonary homograft endocarditis after Ross procedure.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:2

    Topics: Adult; Ampicillin; Aortic Valve; Bioprosthesis; Combined Modality Therapy; Drug Therapy, Combination

2004
Opiate agonist maintenance treatment for injecting drug user peer educators.
    Addiction (Abingdon, England), 2004, Volume: 99, Issue:10

    Topics: Buprenorphine; HIV Infections; Humans; Methadone; Narcotics; Patient Education as Topic; Peer Group;

2004
Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
    Wiener klinische Wochenschrift, 2004, Volume: 116 Suppl 2

    Topics: Adult; Age Factors; Cross-Sectional Studies; Female; Flaviviridae Infections; GB virus C; Hepatitis

2004
Stroke and anemia in HIV/AIDS.
    The AIDS reader, 2004, Volume: 14, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anemia; Antiretroviral Therapy, Highly Active

2004
[The profile of drug addicts attending the Sainte Marguerite University Hospital in Marseille analysis of the active file from 1996 to 2001].
    Presse medicale (Paris, France : 1983), 2004, Oct-23, Volume: 33, Issue:18 Suppl

    Topics: Adult; Age Distribution; Buprenorphine; Cohort Studies; Drug Overdose; Female; France; Hallucinogens

2004
Substance abuse treatment and hospitalization among a cohort of HIV-infected individuals with alcohol problems.
    Alcoholism, clinical and experimental research, 2005, Volume: 29, Issue:3

    Topics: Adult; Alcoholism; CD4 Lymphocyte Count; Cohort Studies; Female; Halfway Houses; HIV Infections; Hos

2005
[Oral pain and loss of teeth in a 36-year-old woman].
    Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Debr

2005
Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users.
    AIDS (London, England), 2005, May-20, Volume: 19, Issue:8

    Topics: Anti-Retroviral Agents; HIV Infections; Humans; Methadone; Narcotics; Patient Compliance; Prospectiv

2005
Intimate partner violence and monogamy among women in methadone treatment.
    AIDS and behavior, 2005, Volume: 9, Issue:2

    Topics: Adult; Assertiveness; Domestic Violence; Fear; Female; HIV Infections; Humans; Methadone; Middle Age

2005
Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Drug and alcohol dependence, 2005, Aug-01, Volume: 79, Issue:2

    Topics: Adult; Age Factors; Female; HIV Infections; Humans; Italy; Male; Methadone; Narcotics; Opioid-Relate

2005
Drug interactions and anti-HIV therapy.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 2005,Summer, Volume: 17, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anticholesteremic Agents; Contraceptives, Or

2005
Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction.
    AIDS (London, England), 2005, Oct-14, Volume: 19, Issue:15

    Topics: Adult; Atazanavir Sulfate; Drug Administration Schedule; Drug Interactions; Female; HIV Infections;

2005
Linkage with methadone treatment upon release from incarceration: a promising opportunity.
    Journal of addictive diseases, 2005, Volume: 24, Issue:3

    Topics: Crime; Health Services Needs and Demand; Hepatitis B; Hepatitis C; HIV Infections; Humans; Long-Term

2005
Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane.
    Health economics, 2006, Volume: 15, Issue:4

    Topics: Anti-Retroviral Agents; Bayes Theorem; Cost-Benefit Analysis; HIV Infections; Humans; Methadone; Out

2006
Dental management of patients taking methadone.
    Dental update, 2005, Volume: 32, Issue:8

    Topics: Dental Care; Dental Caries; Hepatitis C; HIV Infections; Humans; Methadone; Narcotics; Opioid-Relate

2005
Psychiatric diagnoses in a sample of HIV-infected people of color in methadone treatment.
    Community mental health journal, 2005, Volume: 41, Issue:4

    Topics: Adult; Black or African American; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders

2005
Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.
    Drug and alcohol dependence, 2006, Jun-28, Volume: 83, Issue:2

    Topics: Adult; Baltimore; Cohort Studies; Female; HIV Infections; Humans; Ill-Housed Persons; Incidence; Lon

2006
Predictors of retention in methadone programs: a signal detection analysis.
    Drug and alcohol dependence, 2006, Jul-27, Volume: 83, Issue:3

    Topics: Adult; California; Combined Modality Therapy; Comorbidity; Counseling; Dose-Response Relationship, D

2006
[HIV and drug users: current trends].
    MMW Fortschritte der Medizin, 2005, Apr-25, Volume: 147 Spec No 1

    Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Comorbidity; Dose-Resp

2005
[HIV-1 infection, use of drugs and neuropsychologic efficiency].
    Anales de medicina interna (Madrid, Spain : 1984), 2005, Volume: 22, Issue:12

    Topics: Adult; Cognition; Female; HIV Infections; HIV-1; Humans; Male; Methadone; Narcotics; Neuropsychologi

2005
HIV infection and bone mineral density in middle-aged women.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Apr-01, Volume: 42, Issue:7

    Topics: Adult; Black People; Body Mass Index; Bone Density; Bone Remodeling; Cohort Studies; Cross-Sectional

2006
Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Drug and alcohol dependence, 2006, Sep-15, Volume: 84, Issue:2

    Topics: Adult; Anti-Retroviral Agents; British Columbia; Cohort Studies; Comorbidity; Demography; Female; Fo

2006
Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
    Journal of substance abuse treatment, 2006, Volume: 30, Issue:4

    Topics: Adult; Anti-HIV Agents; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Middle Aged; N

2006
HIV sexual risk behaviors among injection drug users in Shanghai.
    Drug and alcohol dependence, 2006, Volume: 82 Suppl 1

    Topics: Adult; Catchment Area, Health; China; Cross-Sectional Studies; Demography; Female; Hepatitis B; Hepa

2006
Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2006, Volume: 19, Issue:2

    Topics: Adult; Chi-Square Distribution; Heterosexuality; HIV Infections; HIV Seropositivity; Humans; Male; M

2006
The effects of illicit drug use and HIV infection on sex hormone levels in women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:5

    Topics: Adult; Alcohol Drinking; CD4 Lymphocyte Count; Crack Cocaine; Cross-Sectional Studies; Estradiol; Fe

2006
HIV/AIDS: Latin America & Caribbean. Puerto Rico: rich port, poor port.
    Science (New York, N.Y.), 2006, Jul-28, Volume: 313, Issue:5786

    Topics: Acquired Immunodeficiency Syndrome; Delivery of Health Care; Disease Outbreaks; Female; Health Servi

2006
Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    The Israel journal of psychiatry and related sciences, 2006, Volume: 43, Issue:2

    Topics: Ambulatory Care; Female; Hepatitis C; HIV Infections; Humans; Israel; Male; Mental Disorders; Methad

2006
Intravenous drug use and HIV: evidence for action now.
    Lancet (London, England), 2006, Sep-30, Volume: 368, Issue:9542

    Topics: HIV Infections; Humans; Methadone; Narcotics; Needle-Exchange Programs; Substance Abuse, Intravenous

2006
HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching.
    Behavior modification, 2006, Volume: 30, Issue:6

    Topics: Antiretroviral Therapy, Highly Active; Drug Monitoring; Guidelines as Topic; Heroin Dependence; HIV

2006
[Health related quality of life among HIV-HCV co-infected patients].
    Revue d'epidemiologie et de sante publique, 2006, Volume: 54 Spec No 1

    Topics: Adult; Anti-Retroviral Agents; Buprenorphine; Cohort Studies; Counseling; Data Interpretation, Stati

2006
Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problems.
    Journal of substance abuse treatment, 2006, Volume: 31, Issue:4

    Topics: Adult; Alcoholism; Cohort Studies; Combined Modality Therapy; Comorbidity; Cross-Sectional Studies;

2006
[Torsade de Pointes in patient infected with human immunodeficiency virus and treated with methadone].
    Anales de medicina interna (Madrid, Spain : 1984), 2006, Volume: 23, Issue:8

    Topics: HIV Infections; Humans; Male; Methadone; Middle Aged; Narcotics; Torsades de Pointes

2006
QTc prolongation in human immunodeficiency virus-infected persons.
    Archives of internal medicine, 2006, Nov-13, Volume: 166, Issue:20

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Electrocardiography; Female; HIV Infections; Humans; Long

2006
Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    The European journal of general practice, 2007, Volume: 13, Issue:1

    Topics: Adult; Aged; Family Practice; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Illicit Drug

2007
Controlling HIV among injecting drug users: the current status of harm reduction.
    HIV/AIDS policy & law review, 2006, Volume: 11, Issue:2-3

    Topics: Harm Reduction; Health Policy; HIV Infections; Humans; Methadone; Needles; Substance Abuse, Intraven

2006
The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Drug and alcohol dependence, 2007, Jul-10, Volume: 89, Issue:2-3

    Topics: Amphetamine-Related Disorders; Antiretroviral Therapy, Highly Active; Benzodiazepines; Cocaine-Relat

2007
Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 2007, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Analgesics, Opioid; Female; HIV Infections; Humans; Logistic Models; Male; Methad

2007
Primary care affiliations of adults in a methadone program with onsite care.
    Journal of addictive diseases, 2007, Volume: 26, Issue:1

    Topics: Adult; Ambulatory Care; Cardiovascular Diseases; Continuity of Patient Care; Diabetes Mellitus; Drug

2007
Methadone-induced Torsade de pointes after stopping lopinavir-ritonavir.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:5

    Topics: Analgesics, Opioid; Anti-Retroviral Agents; Drug Administration Schedule; Drug Combinations; Drug In

2007
Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily.
    European journal of clinical pharmacology, 2007, Volume: 63, Issue:7

    Topics: Adult; Analgesics, Opioid; Analysis of Variance; Anti-HIV Agents; Area Under Curve; Drug Interaction

2007
Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users.
    Addiction (Abingdon, England), 2007, Volume: 102, Issue:5

    Topics: Adolescent; Adult; Analgesics, Opioid; Female; HIV Infections; Humans; Illicit Drugs; Male; Methadon

2007
Serum magnesium concentration in drug-addicted patients.
    Magnesium research, 2007, Volume: 20, Issue:1

    Topics: Adult; Female; HIV Infections; Humans; Magnesium; Male; Methadone; Middle Aged; Poland; Reference Va

2007
A humble service that has delivered public health good.
    Public health, 2007, Volume: 121, Issue:11

    Topics: Health Policy; HIV Infections; Hong Kong; Humans; Methadone; Public Health; Substance-Related Disord

2007
A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
    The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:4

    Topics: Adult; Age Factors; Amphetamine-Related Disorders; British Columbia; Cocaine-Related Disorders; Comm

2007
Case study: accessible primary health care--a foundation to improve health outcomes for people who inject drugs.
    The International journal on drug policy, 2007, Volume: 18, Issue:4

    Topics: Anti-HIV Agents; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Methadone; Narc

2007
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Addiction (Abingdon, England), 2007, Volume: 102, Issue:9

    Topics: Adult; Cohort Studies; Female; Harm Reduction; Hepatitis C; HIV Infections; Humans; Incidence; Male;

2007
Intimate partner violence and HIV risks: a longitudinal study of men on methadone.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2007, Volume: 84, Issue:5

    Topics: Adult; HIV Infections; Humans; Longitudinal Studies; Male; Methadone; Narcotics; Risk-Taking; Sexual

2007
Increased HIV risk associated with criminal justice involvement among men on methadone.
    AIDS and behavior, 2008, Volume: 12, Issue:1

    Topics: Adult; Female; HIV Infections; Humans; Interviews as Topic; Law Enforcement; Logistic Models; Male;

2008
Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    AIDS patient care and STDs, 2007, Volume: 21, Issue:8

    Topics: Adult; Ambulatory Care Facilities; Anti-HIV Agents; CD4 Lymphocyte Count; Directly Observed Therapy;

2007
Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.
    Journal of acquired immune deficiency syndromes (1999), 2007, Nov-01, Volume: 46, Issue:3

    Topics: Adolescent; Adult; Age of Onset; Cocaine-Related Disorders; Cross-Sectional Studies; Female; Hepatit

2007
Impact of methadone on drug use and risky sex in China.
    Journal of substance abuse treatment, 2008, Volume: 34, Issue:4

    Topics: Adult; China; Cross-Sectional Studies; Demography; Female; Heroin Dependence; HIV Infections; Humans

2008
Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance.
    Journal of substance abuse treatment, 2008, Volume: 35, Issue:1

    Topics: Adult; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Risk-Taking; Sexual Behavior; S

2008
Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment.
    Social work in health care, 2007, Volume: 45, Issue:4

    Topics: Adult; Chi-Square Distribution; Cross-Sectional Studies; Depression; Female; Health Surveys; HIV Inf

2007
Societal perception and support for methadone maintenance treatment in a Chinese province with high HIV prevalence.
    The American journal of drug and alcohol abuse, 2008, Volume: 34, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Attitude to Health; China; Focus Groups; Heroin Dependence; HIV

2008
Effectiveness of first eight methadone maintenance treatment clinics in China.
    AIDS (London, England), 2007, Volume: 21 Suppl 8

    Topics: Adult; AIDS Serodiagnosis; China; Crime; Cross-Sectional Studies; Data Collection; Disease Outbreaks

2007
Alcohol and HIV sexual risk behaviors among injection drug users.
    Drug and alcohol dependence, 2008, May-01, Volume: 95, Issue:1-2

    Topics: Adult; Alcoholic Intoxication; Alcoholism; Cocaine-Related Disorders; Cross-Sectional Studies; Femal

2008
New hot topics sections: 1. China's new march forward in addiction treatment: methadone for the masses. 2. Issues in formulating DSM V.
    The American journal of drug and alcohol abuse, 2008, Volume: 34, Issue:2

    Topics: Analgesics, Opioid; China; Diagnostic and Statistical Manual of Mental Disorders; HIV Infections; Hu

2008
Methadone maintenance treatment of heroin abuse in China.
    The American journal of drug and alcohol abuse, 2008, Volume: 34, Issue:2

    Topics: Analgesics, Opioid; China; Health Policy; Heroin Dependence; HIV Infections; Humans; Methadone; Subs

2008
Estimating the total mortality among problem drug users.
    Substance use & misuse, 2008, Volume: 43, Issue:5

    Topics: Accidents; Adolescent; Adult; Age Factors; Cause of Death; Cohort Studies; Comorbidity; Data Collect

2008
Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations.
    Journal of acquired immune deficiency syndromes (1999), 2008, Mar-01, Volume: 47, Issue:3

    Topics: Adult; Antiretroviral Therapy, Highly Active; Canada; CD4 Lymphocyte Count; Drug Resistance, Viral;

2008
Southwest China opens methadone clinics in border areas to prevent spread of HIV.
    The AIDS reader, 2008, Volume: 18, Issue:3

    Topics: Ambulatory Care Facilities; China; HIV; HIV Infections; Humans; Methadone; Rural Population; Substan

2008
Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Tropical doctor, 2008, Volume: 38, Issue:2

    Topics: Anti-HIV Agents; Female; Government Programs; Harm Reduction; Heroin Dependence; HIV Infections; Hum

2008
Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    HIV medicine, 2008, Volume: 9, Issue:7

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Canada; CD4 Lymphocyte Count; Cohort

2008
Contingency management reduces drug-related human immunodeficiency virus risk behaviors in cocaine-abusing methadone patients.
    Addiction (Abingdon, England), 2008, Volume: 103, Issue:7

    Topics: Adult; Analgesics, Opioid; Behavior Therapy; Female; HIV Infections; Humans; Male; Methadone; Needle

2008
Prenatal care of HIV-infected women: analysis of a large New York State cohort.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Aug-01, Volume: 9, Issue:4

    Topics: Adolescent; Adult; Cohort Studies; Female; HIV Infections; Humans; Infectious Disease Transmission,

1995
HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Sep-01, Volume: 10, Issue:1

    Topics: Cohort Studies; HIV Infections; HIV Seroprevalence; Humans; Methadone; National Health Programs; Nee

1995
Social support and sexual risk taking among women on methadone.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 1994, Volume: 6, Issue:6

    Topics: Adult; Attitude; Bisexuality; Education; Ethnicity; Female; HIV Infections; Homosexuality, Female; H

1994
Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment.
    Addiction (Abingdon, England), 1995, Volume: 90, Issue:5

    Topics: Adult; Cause of Death; Cross-Cultural Comparison; Drug Overdose; Female; HIV Infections; Humans; Mal

1995
Patterns of cocaine use and HIV infection among injection drug users in a methadone clinic.
    Journal of substance abuse, 1994, Volume: 6, Issue:2

    Topics: Adult; Cocaine; Cohort Studies; Crack Cocaine; Ethnicity; Female; Health Knowledge, Attitudes, Pract

1994
HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992. Field Services Branch.
    AIDS (London, England), 1994, Volume: 8, Issue:10

    Topics: Adolescent; Adult; Age Factors; Demography; Ethnicity; Female; Geography; Heroin Dependence; HIV Inf

1994
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users.
    Drug and alcohol dependence, 1994, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Black or African American; Cocaine; Cohort Studies; Female; Health Behavior; Hero

1994
Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
    Drug and alcohol dependence, 1994, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Amphetamine; Baltimore; Cocaine; Cross-Sectional Studies; Female; Follow-Up Studi

1994
Skills-training groups to reduce HIV transmission and drug use among methadone patients.
    Social work, 1995, Volume: 40, Issue:1

    Topics: Adaptation, Psychological; Female; HIV Infections; Humans; Male; Methadone; Pilot Projects; Psychoth

1995
The effects of HIV infection on the development of methadone maintenance treatment in Spain.
    Addiction (Abingdon, England), 1994, Volume: 89, Issue:12

    Topics: HIV Infections; HIV Seroprevalence; Humans; Methadone; Opioid-Related Disorders; Spain; Substance Ab

1994
[Substitution treatments in Geneva].
    Annales de medecine interne, 1994, Volume: 145 Suppl 3

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Family; Female; HIV Infections; Humans; Male;

1994
Methadone treatment programmes in the United Kingdom.
    Annales de medecine interne, 1994, Volume: 145 Suppl 3

    Topics: Adult; Drug Prescriptions; Heroin Dependence; HIV Infections; HIV Seropositivity; HIV Seroprevalence

1994
[Administrative, social and clinical facilities of the implementation of the methadone program in Bordeaux].
    Annales de medecine interne, 1994, Volume: 145 Suppl 3

    Topics: France; Health Services; Heroin Dependence; HIV Infections; Humans; Methadone; Substance Abuse, Intr

1994
[Value and limitations of substitution treatments in the care of drug addicts].
    Annales de medecine interne, 1994, Volume: 145 Suppl 3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Buprenorphine; France; HIV Infections; HIV Seropositivity

1994
[How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportu
    Annales de medecine interne, 1994, Volume: 145 Suppl 3

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Buprenorphine; Emergencie

1994
[Complementary prevention actions as a means of reducing risks].
    Annales de medecine interne, 1994, Volume: 145 Suppl 3

    Topics: Acquired Immunodeficiency Syndrome; Female; Hepatitis, Viral, Human; HIV Infections; HIV Seropositiv

1994
Results of the NIDA treatment demonstration grants' cocaine workgroup: characteristics of cocaine users and HIV risk behaviors.
    Drug and alcohol dependence, 1995, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Cocaine; Comorbidity; Ethnicity; Female; Health Behavior; HIV Infections; Humans;

1995
HIV risks, gender, and cocaine use among opiate users.
    Drug and alcohol dependence, 1995, Volume: 37, Issue:1

    Topics: Adult; Cocaine; Comorbidity; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Heroin

1995
Cocaine use and HIV risk behavior in methadone maintenance patients.
    Drug and alcohol dependence, 1995, Volume: 37, Issue:1

    Topics: Adult; Cocaine; Comorbidity; Condoms; Female; Health Knowledge, Attitudes, Practice; Heroin Dependen

1995
Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients.
    Drug and alcohol dependence, 1995, Volume: 37, Issue:1

    Topics: Black or African American; California; Cocaine; Comorbidity; Crack Cocaine; Female; Follow-Up Studie

1995
The drugs in pregnancy service.
    Addiction (Abingdon, England), 1995, Volume: 90, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Female; Health Behavior; HIV Infections; Humans; Infant, Newborn

1995
HIV infection among injecting drug users in the South Australian methadone program.
    The Medical journal of Australia, 1995, Mar-06, Volume: 162, Issue:5

    Topics: Adult; Case-Control Studies; Female; HIV Infections; Humans; Male; Methadone; Multivariate Analysis;

1995
Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients.
    Drug and alcohol dependence, 1993, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Diagnosis, Dual (Psych

1993
Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users.
    Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:10

    Topics: Adult; Analysis of Variance; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Cognition Disorders;

1994
[Efficacy of interventions in drug addiction].
    Epidemiologia e prevenzione, 1994, Volume: 18, Issue:59

    Topics: Acquired Immunodeficiency Syndrome; Efficiency; Female; HIV Infections; Humans; Italy; Male; Methado

1994
Condom use rates for specific sexual behaviors among opioid abusers entering treatment.
    Drug and alcohol dependence, 1994, Volume: 35, Issue:3

    Topics: Adult; Ambulatory Care; Baltimore; Condoms; Cross-Sectional Studies; Female; Health Knowledge, Attit

1994
The care of injection-drug users with HIV infection.
    The New England journal of medicine, 1994, Dec-29, Volume: 331, Issue:26

    Topics: HIV Infections; Humans; Methadone; Narcotics; Substance Abuse, Intravenous

1994
Reporting of HIV risk behaviors by injection drug using heterosexual couples in methadone maintenance.
    Drug and alcohol dependence, 1994, Volume: 36, Issue:1

    Topics: Adult; Condoms; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Male; Methado

1994
Edinburgh drug users: are they injecting and sharing less?
    AIDS (London, England), 1994, Volume: 8, Issue:4

    Topics: Adult; Female; HIV Antibodies; HIV Infections; Humans; Male; Methadone; Needle Sharing; Risk Factors

1994
Estimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method.
    American journal of public health, 1994, Volume: 84, Issue:7

    Topics: Data Collection; Heroin; Heroin Dependence; HIV Infections; Humans; Methadone; Population Surveillan

1994
Injecting behaviour and risky needle use amongst methadone maintenance clients.
    Drug and alcohol dependence, 1994, Volume: 34, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Illicit Drugs; Male; Methad

1994
Reducing HIV risk behavior among injection drug users: effect of methadone maintenance treatment on number of sex partners.
    The International journal of the addictions, 1994, Volume: 29, Issue:6

    Topics: Adult; Female; HIV Infections; Humans; Los Angeles; Male; Methadone; Regression Analysis; Risk Facto

1994
Predictors of outcome in methadone programs: effect of HIV counseling and testing.
    Connecticut medicine, 1994, Volume: 58, Issue:3

    Topics: Adult; AIDS Serodiagnosis; Connecticut; Female; HIV Infections; Humans; Male; Methadone; Opioid-Rela

1994
[Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Der Nervenarzt, 1994, Volume: 65, Issue:5

    Topics: Adult; Austria; Crime; Dose-Response Relationship, Drug; Female; Follow-Up Studies; HIV Infections;

1994
Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
    AIDS care, 1994, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Drug Admi

1994
Methadone therapy.
    Lancet (London, England), 1993, May-15, Volume: 341, Issue:8855

    Topics: HIV Infections; Humans; Methadone; Opioid-Related Disorders; Pain

1993
HIV infection and the meaning of condoms.
    Culture, medicine and psychiatry, 1993, Volume: 17, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Condoms; Female; Gender Identity; Health Knowledge, Attit

1993
[Substitution as a possibility for the treatment of opiate dependent patients].
    Psychiatrische Praxis, 1994, Volume: 21, Issue:1

    Topics: Adult; Ambulatory Care; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Opioid-R

1994
Predictors of injecting and injecting risk-taking behaviour among methadone-maintenance clients.
    Addiction (Abingdon, England), 1994, Volume: 89, Issue:3

    Topics: Adolescent; Adult; Female; Health Behavior; Heroin Dependence; HIV Infections; Humans; Male; Methado

1994
Out-patient medical care in Edinburgh for IDU-related HIV.
    AIDS care, 1994, Volume: 6, Issue:1

    Topics: Ambulatory Care; Appointments and Schedules; Combined Modality Therapy; Health Behavior; HIV Infecti

1994
Psychosocial risk factors for HIV transmission in male drug abusers.
    Genetic, social, and general psychology monographs, 1993, Volume: 119, Issue:3

    Topics: Adult; Ethnicity; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Male; Methadone; Ne

1993
[HIV prevention in HIV-positive drug addicts. A methadone-supported model].
    Schweizerische medizinische Wochenschrift, 1993, Dec-04, Volume: 123, Issue:48

    Topics: Adult; Female; Health Education; HIV Infections; HIV Seropositivity; Humans; Male; Methadone; Middle

1993
Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 1993,Winter, Volume: 5, Issue:4

    Topics: Adult; Communication Barriers; Condoms; Female; Gender Identity; Health Education; Health Knowledge,

1993
A survey of drug deaths in western Austria.
    Forensic science international, 1993, Volume: 62, Issue:1-2

    Topics: Adolescent; Adult; Austria; Cause of Death; Data Collection; Data Interpretation, Statistical; Femal

1993
Risk dimensions of HIV-tested substance users.
    The International journal of the addictions, 1993, Volume: 28, Issue:14

    Topics: Adult; Female; Health Knowledge, Attitudes, Practice; HIV Infections; HIV Seroprevalence; Humans; Ma

1993
[Substitution of drug-dependent HIV patients with levomethadone].
    Medizinische Klinik (Munich, Germany : 1983), 1993, May-15, Volume: 88, Issue:5

    Topics: Combined Modality Therapy; Drug Administration Schedule; Heroin Dependence; HIV Infections; Humans;

1993
Correlates of alcohol use among methadone patients.
    Alcoholism, clinical and experimental research, 1993, Volume: 17, Issue:3

    Topics: Adult; Alcoholism; Black or African American; Cocaine; Cohort Studies; Comorbidity; Cross-Sectional

1993
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.
    Journal of acquired immune deficiency syndromes, 1993, Volume: 6, Issue:9

    Topics: Adult; Cohort Studies; Female; Follow-Up Studies; Health Behavior; HIV Infections; Humans; Incidence

1993
A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.
    European journal of epidemiology, 1993, Volume: 9, Issue:3

    Topics: Adult; Comorbidity; Condoms; Female; Germany; Hepatitis B; Hepatitis C; HIV Infections; Homosexualit

1993
Methadone maintenance and needle/syringe sharing.
    The International journal of the addictions, 1993, Volume: 28, Issue:10

    Topics: Adult; Female; Health Education; Health Knowledge, Attitudes, Practice; Heroin Dependence; HIV Infec

1993
The use of primary care services by drug users attending a HIV prevention unit.
    Irish medical journal, 1993, Volume: 86, Issue:2

    Topics: Adolescent; Adult; Family Practice; Female; HIV Infections; Hospital Units; Humans; Male; Methadone;

1993
Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors.
    Drug and alcohol dependence, 1995, Volume: 39, Issue:2

    Topics: Adult; Cocaine; Female; Health Knowledge, Attitudes, Practice; Heroin Dependence; HIV Infections; HI

1995
Psychological dysfunction and HIV/AIDS risk behavior.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1996, Feb-01, Volume: 11, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Female; HIV Infections; Humans; Male; Mental

1996
Can outreach work?
    Addiction (Abingdon, England), 1995, Volume: 90, Issue:10

    Topics: Community-Institutional Relations; Health Education; HIV Infections; Humans; Methadone; Needle-Excha

1995
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY.
    American journal of public health, 1996, Volume: 86, Issue:8

    Topics: Adolescent; Adult; Female; HIV Infections; Humans; Incidence; Male; Methadone; Narcotics; New York C

1996
Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.
    Drug and alcohol dependence, 1996, Volume: 41, Issue:1

    Topics: Adolescent; Adult; Cocaine; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; HIV In

1996
Harm-reduction strategies weapon of choice in BC's battle with drug addiction.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1996, Sep-01, Volume: 155, Issue:5

    Topics: British Columbia; Female; Heroin; HIV Infections; Humans; Male; Methadone; Needle-Exchange Programs;

1996
Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire.
    Addiction (Abingdon, England), 1996, Volume: 91, Issue:1

    Topics: Adolescent; Adult; Comorbidity; Female; Health Behavior; Health Status; Health Surveys; Heroin Depen

1996
Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits.
    Psychiatric services (Washington, D.C.), 1996, Volume: 47, Issue:2

    Topics: Adult; Ambulatory Care; Cocaine; Disability Evaluation; Eligibility Determination; Female; Financial

1996
HIV risk behaviors among women in methadone maintenance treatment.
    Substance use & misuse, 1996, Volume: 31, Issue:3

    Topics: Adult; Female; Health Knowledge, Attitudes, Practice; Heroin Dependence; HIV Infections; Humans; Los

1996
Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission.
    AIDS (London, England), 1996, Volume: 10, Issue:3

    Topics: Alcohol Drinking; Cocaine; Cohort Studies; Female; Heroin; HIV Infections; HIV-1; Humans; Infant; In

1996
Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease.
    The American journal of drug and alcohol abuse, 1996, Volume: 22, Issue:4

    Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Diagnosis, D

1996
Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men.
    The American journal of drug and alcohol abuse, 1996, Volume: 22, Issue:4

    Topics: Analgesics, Opioid; Analysis of Variance; Condoms; Factor Analysis, Statistical; Female; HIV Infecti

1996
Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
    Journal of epidemiology and community health, 1996, Volume: 50, Issue:5

    Topics: Adult; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Methadone; Narcotics; Needle S

1996
Psychopathology and HIV risk behaviors among injection drug users in and out of treatment.
    Drug and alcohol dependence, 1996, Dec-02, Volume: 43, Issue:1-2

    Topics: Adolescent; Adult; Antisocial Personality Disorder; Comorbidity; Female; Health Knowledge, Attitudes

1996
Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users.
    Drug and alcohol dependence, 1996, Dec-02, Volume: 43, Issue:1-2

    Topics: Adult; AIDS-Related Opportunistic Infections; Dose-Response Relationship, Drug; Drug Interactions; D

1996
[Does methadone lessen HIV risk behavior?].
    Deutsche medizinische Wochenschrift (1946), 1997, Feb-21, Volume: 122, Issue:8

    Topics: Condoms; HIV Infections; Humans; Methadone; Narcotics; Opioid-Related Disorders; Risk-Taking; Sexual

1997
Association of maternal drug use during pregnancy with mother-to-child HIV transmission. New York City Perinatal HIV Transmission Collaborative Study.
    AIDS (London, England), 1997, Volume: 11, Issue:7

    Topics: Cocaine; Female; Heroin; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, V

1997
Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Jun-01, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Female; HIV Infections; HIV Seropositivity; Humans; Ill-Housed Persons; Inactivat

1997
Factors associated with client-reported HIV infection among clients entering methadone treatment.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 1997, Volume: 9, Issue:3

    Topics: Adult; Cocaine; Condoms; Connecticut; Cross-Sectional Studies; Female; Health Knowledge, Attitudes,

1997
HIV infection risks, behaviors and methadone treatment: client-reported HIV infection in a follow-up study of injecting drug users in New England.
    The American journal of drug and alcohol abuse, 1997, Volume: 23, Issue:3

    Topics: Adult; Cocaine; Confidence Intervals; Connecticut; Cross-Sectional Studies; Female; Follow-Up Studie

1997
Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up.
    Drug and alcohol dependence, 1997, Jul-25, Volume: 47, Issue:1

    Topics: Adolescent; Adult; Cocaine; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; HIV In

1997
Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981-1992.
    Acta psychiatrica Scandinavica, 1997, Volume: 96, Issue:3

    Topics: Adult; Amphetamines; Cause of Death; Cohort Studies; Cross-Sectional Studies; Female; Heroin Depende

1997
Validity of three measures of antisociality in predicting HIV risk behaviors in methadone-maintenance patients.
    Drug and alcohol dependence, 1997, Aug-25, Volume: 47, Issue:2

    Topics: Adult; Antisocial Personality Disorder; Comorbidity; Female; Health Behavior; Health Knowledge, Atti

1997
Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease.
    AIDS (London, England), 1997, Volume: 11, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Disease Progression; Female; HIV

1997
Harm reduction and decriminalization in the United States: a personal perspective.
    Substance use & misuse, 1997, Volume: 32, Issue:11

    Topics: Ethics, Medical; HIV Infections; Humans; Methadone; Opioid-Related Disorders; Patient Compliance; Re

1997
Change in drug-using networks of injecting drug users during methadone treatment: a pilot study using snowball recruitment and intensive interviews.
    Substance use & misuse, 1997, Volume: 32, Issue:11

    Topics: Adult; Female; HIV Infections; Humans; Interview, Psychological; Male; Methadone; Middle Aged; Motiv

1997
Observational analysis of German injecting drug users (IDU): survival with and without methadone maintenance treatment. German AIDS Study Group GASG/IdkF.
    European journal of medical research, 1996, Jan-19, Volume: 1, Issue:4

    Topics: Adult; Analgesics, Opioid; Female; Germany; HIV Infections; Humans; Male; Methadone; Substance Abuse

1996
Effects of chronic opioid dependence and HIV-1 infection on pattern shift visual evoked potentials.
    Drug and alcohol dependence, 1998, Apr-01, Volume: 50, Issue:2

    Topics: Adult; Analysis of Variance; Case-Control Studies; Chronic Disease; Evoked Potentials, Visual; Femal

1998
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Public health reports (Washington, D.C. : 1974), 1998, Volume: 113 Suppl 1

    Topics: Adult; Female; HIV Infections; Humans; Logistic Models; Male; Methadone; Narcotics; New York City; P

1998
Addiction treatment: promoting a medical approach to substance use.
    Journal of urban health : bulletin of the New York Academy of Medicine, 1998, Volume: 75, Issue:3

    Topics: Blood-Borne Pathogens; Delivery of Health Care, Integrated; Financial Support; Health Promotion; Hea

1998
Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 1998, Volume: 10, Issue:5

    Topics: Adult; Data Interpretation, Statistical; Depression; Female; Heroin Dependence; HIV Infections; HIV

1998
Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.
    AIDS (London, England), 1998, Oct-22, Volume: 12, Issue:15

    Topics: Cohort Studies; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Incidence; Male; Methadone

1998
Medication adherence strategies for drug abusers with HIV/AIDS.
    AIDS care, 1998, Volume: 10, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Me

1998
Drug abuse treatment as HIV prevention: changes in social drug use patterns might also reduce risk.
    Journal of addictive diseases, 1998, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-R

1998
Changes in HIV risk behaviors among cocaine-using methadone patients.
    Journal of addictive diseases, 1998, Volume: 17, Issue:4

    Topics: Adult; Cocaine-Related Disorders; Female; HIV Infections; Humans; Male; Methadone; Narcotics; Needle

1998
The impact of methadone on consumption of inpatient care and mortality, with special reference to HIV status.
    Substance use & misuse, 1998, Volume: 33, Issue:14

    Topics: Adult; Female; HIV Infections; HIV Seropositivity; Hospitalization; Humans; Length of Stay; Male; Me

1998
Changes in mortality, arrests, and hospitalizations in nonvoluntarily treated heroin addicts in relation to methadone treatment.
    Substance use & misuse, 1998, Volume: 33, Issue:14

    Topics: Adult; Cohort Studies; Crime; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Hospita

1998
Use of antiretroviral therapy by intravenous drug users with HIV.
    JAMA, 1999, Feb-24, Volume: 281, Issue:8

    Topics: Anti-HIV Agents; HIV Infections; Humans; Methadone; Substance Abuse, Intravenous

1999
On-site primary care and mental health services in outpatient drug abuse treatment units.
    The journal of behavioral health services & research, 1999, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Child; Combined Modality Therapy; Cross-Sectional Studies;

1999
Safer sex strategies for women: the hierarchical model in methadone treatment clinics.
    Journal of urban health : bulletin of the New York Academy of Medicine, 1999, Volume: 76, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Attitude to Health; Condoms; Condoms, Female; Decision Ma

1999
Harm reduction: Australia as a case study.
    Bulletin of the New York Academy of Medicine, 1995,Winter, Volume: 72, Issue:2

    Topics: Alcoholism; Australia; Health Policy; HIV Infections; Humans; Illicit Drugs; Methadone; Needle-Excha

1995
Methadone withdrawal when starting an antiretroviral regimen including nevirapine.
    Pharmacotherapy, 1999, Volume: 19, Issue:4

    Topics: Adult; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; E

1999
Gender differences at admission and follow-up in a sample of methadone maintenance clients.
    Substance use & misuse, 1999, Volume: 34, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Comorbidity; Crime; Educational Status; Family Relations;

1999
Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
    AIDS (London, England), 1999, May-28, Volume: 13, Issue:8

    Topics: Adult; Anti-HIV Agents; Drug Interactions; Female; HIV Infections; Humans; Male; Methadone; Middle A

1999
Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
    AIDS (London, England), 1999, May-28, Volume: 13, Issue:8

    Topics: Adult; Anti-HIV Agents; Drug Interactions; HIV Infections; Humans; Methadone; Narcotics; Nevirapine;

1999
Translating clinical trial results into practice: the effect of an AIDS clinical trial on prescribed antiretroviral therapy for HIV-infected pregnant women.
    Annals of internal medicine, 1999, Jun-15, Volume: 130, Issue:12

    Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Clinical Protocols; Clinical Trials as Topic; Community

1999
Methadone treatment in Spain, 1994.
    Drug and alcohol dependence, 1999, Aug-02, Volume: 56, Issue:1

    Topics: Adolescent; Adult; Female; Health Care Surveys; HIV Infections; Humans; Male; Methadone; Middle Aged

1999
HIV risk reduction in outpatient drug abuse treatment: individual and geographic differences.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 1999, Volume: 11, Issue:4

    Topics: Adult; Alcoholism; Antisocial Personality Disorder; Cities; Cocaine-Related Disorders; Female; HIV I

1999
Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study.
    AIDS (London, England), 1999, Sep-10, Volume: 13, Issue:13

    Topics: Adolescent; Adult; Cohort Studies; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Ma

1999
Decreased methadone effect after ritonavir initiation.
    Pharmacotherapy, 2000, Volume: 20, Issue:1

    Topics: Analgesics, Opioid; Anti-HIV Agents; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combi

2000
Decrease in methodone levels with nelfinavir mesylate.
    The American journal of psychiatry, 2000, Volume: 157, Issue:3

    Topics: Adult; Comorbidity; HIV Infections; HIV Protease Inhibitors; Humans; Male; Methadone; Nelfinavir; Op

2000
[Nevirapine induces abstinence symptoms in patients on a methadone maintenance program with HIV infection].
    Revista clinica espanola, 2000, Volume: 200, Issue:1

    Topics: Adult; Analysis of Variance; Anti-HIV Agents; Chronic Disease; Drug Interactions; Drug Therapy, Comb

2000
Understanding condom use among heroin addicts in methadone maintenance using the information-motivation-behavioral skills model.
    Substance use & misuse, 2000, Volume: 35, Issue:4

    Topics: Adult; Comorbidity; Condoms; Factor Analysis, Statistical; Female; Health Behavior; Health Promotion

2000
Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.
    Journal of addictive diseases, 2000, Volume: 19, Issue:1

    Topics: Adult; Anti-HIV Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; HIV Infections

2000
Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic.
    Addiction (Abingdon, England), 1999, Volume: 94, Issue:10

    Topics: Adult; Benzodiazepines; Female; Hepatitis C; HIV Infections; Humans; Israel; Male; Methadone; Narcot

1999
Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study.
    Addiction (Abingdon, England), 2000, Volume: 95, Issue:4

    Topics: Adolescent; Adult; Cohort Studies; Dose-Response Relationship, Drug; Female; HIV Infections; Humans;

2000
Fear and violence: raising the HIV stakes.
    AIDS education and prevention : official publication of the International Society for AIDS Education, 2000, Volume: 12, Issue:2

    Topics: Adult; Condoms; Fear; Female; Focus Groups; Health Knowledge, Attitudes, Practice; HIV Infections; H

2000
Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use.
    The American journal of drug and alcohol abuse, 2000, Volume: 26, Issue:2

    Topics: Antiretroviral Therapy, Highly Active; Comorbidity; HIV Infections; HIV Protease Inhibitors; Methado

2000
Factors predicting entry of injecting drug users into substance abuse treatment.
    The American journal of drug and alcohol abuse, 2000, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Comorbidity; Factor Analysis, Statistical; Female; Heroin Dependence; HIV Infecti

2000
Services provided during methadone treatment. A gender comparison.
    Journal of substance abuse treatment, 2000, Volume: 19, Issue:1

    Topics: Adult; Aged; Alcohol Drinking; Communication; Counseling; Crime; Female; Health Services Needs and D

2000
Efavirenz decreases methadone blood concentrations.
    AIDS (London, England), 2000, Jun-16, Volume: 14, Issue:9

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Infecti

2000
HIV transmission and the cost-effectiveness of methadone maintenance.
    American journal of public health, 2000, Volume: 90, Issue:7

    Topics: Adult; Analgesics, Opioid; Cost-Benefit Analysis; Health Care Costs; Heroin Dependence; HIV Infectio

2000
Methadone withdrawal symptoms with nevirapine and efavirenz.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:3

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Infections; Hum

2000
Interaction of methadone with didanosine and stavudine.
    Journal of acquired immune deficiency syndromes (1999), 2000, Jul-01, Volume: 24, Issue:3

    Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Didanosine; Drug Interactions; Fe

2000
Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2000, Volume: 77, Issue:3

    Topics: Adult; Cohort Studies; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Incidence; Male; Me

2000
Drug injection rates and needle-exchange use in New York City, 1991-1996.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2000, Volume: 77, Issue:3

    Topics: Adult; Aged; Cohort Studies; Female; HIV Infections; Humans; Longitudinal Studies; Male; Methadone;

2000
Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus.
    AIDS (London, England), 2000, Sep-08, Volume: 14, Issue:13

    Topics: Adult; Baltimore; Cohort Studies; Female; Health Services Accessibility; HIV Antibodies; HIV Infecti

2000
Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs. The MANIF 2000 Study Group.
    AIDS care, 2000, Volume: 12, Issue:4

    Topics: Adult; Buprenorphine; Female; France; HIV Infections; Humans; Male; Methadone; Narcotics; Needle Sha

2000
Treatment of opioid dependence in pregnant women.
    Addiction (Abingdon, England), 2000, Volume: 95, Issue:8

    Topics: Adult; Female; HIV Infections; Humans; Infant, Newborn; Life Style; Methadone; Narcotics; Neonatal A

2000
Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.
    Journal of addictive diseases, 2000, Volume: 19, Issue:4

    Topics: Adult; Comorbidity; Female; HIV Infections; Humans; Male; Maryland; Mental Disorders; Methadone; Nar

2000
Outbreak of multidrug-resistant tuberculosis at a methadone treatment program.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2001, Volume: 5, Issue:1

    Topics: Adult; Ambulatory Care Facilities; Chi-Square Distribution; Contact Tracing; Cross Infection; Diseas

2001
Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand.
    AIDS (London, England), 2001, Feb-16, Volume: 15, Issue:3

    Topics: Adolescent; Adult; AIDS Vaccines; Cohort Studies; Educational Status; Female; Follow-Up Studies; HIV

2001
Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment.
    Journal of substance abuse treatment, 2001, Volume: 20, Issue:2

    Topics: Adult; Cocaine-Related Disorders; Crack Cocaine; Cross-Sectional Studies; Female; Follow-Up Studies;

2001
[Risk behaviours among intravenous drug users under methadone treatment].
    Medicina clinica, 2001, Mar-03, Volume: 116, Issue:8

    Topics: Adult; Algorithms; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Methadone; Narcoti

2001
[Prevalence of chronic hidden infections in a cohort of patients in substitutive treatment with methadone].
    Medicina clinica, 2001, Mar-10, Volume: 116, Issue:9

    Topics: Adult; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Male; Methadone;

2001
The role of the community pharmacist in drug abuse: a comparison of service provision between Northern Ireland and England/Wales.
    Pharmacy world & science : PWS, 2001, Volume: 23, Issue:1

    Topics: England; HIV Infections; Humans; Illicit Drugs; Methadone; Narcotics; Northern Ireland; Pharmacies;

2001
Methadone and protease inhibitors.
    AIDS patient care and STDs, 1998, Volume: 12, Issue:10

    Topics: Analgesics, Opioid; Clinical Trials as Topic; Drug Interactions; HIV Infections; Humans; Methadone;

1998
Ritonavir and ecstasy.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1997

    Topics: Cocaine; Cytochrome P-450 Enzyme System; Designer Drugs; Drug Interactions; Heroin; HIV Infections;

1997
Methadone, adherence and protease inhibitors.
    Treatment review, 1997, Issue:No 25

    Topics: Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protea

1997
Drug czar seeks new emphasis on methadone treatment.
    AIDS policy & law, 1997, Oct-31, Volume: 12, Issue:20

    Topics: Health Policy; HIV Infections; Humans; Methadone; Opioid-Related Disorders; Politics; Substance Abus

1997
Experts clarify issues raised by combination therapy.
    AIDS alert, 1998, Volume: 13, Issue:5

    Topics: Adipose Tissue; Alcoholism; Drug Interactions; Drug Therapy, Combination; Guidelines as Topic; HIV I

1998
Ritonavir (Norvir) and methadone.
    Treatment review, 1998,Spring, Issue:No 28

    Topics: Biological Availability; HIV Infections; HIV Protease Inhibitors; Humans; Methadone; Ritonavir

1998
Methadone and antiretroviral medications, part I.
    AIDS clinical care, 1999, Volume: 11, Issue:4

    Topics: Anti-HIV Agents; Area Under Curve; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy,

1999
Methadone and anti-HIV drugs.
    The Body positive, 1999, Volume: 12, Issue:5

    Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; HIV In

1999
Methadone and antiretroviral medications, part II.
    AIDS clinical care, 1999, Volume: 11, Issue:5

    Topics: Anti-HIV Agents; Area Under Curve; Cytochrome P-450 Enzyme System; Drug Interactions; HIV Infections

1999
New anti-HIV drug interactions, toxicities, and dosing options.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1999, Volume: 12, Issue:4

    Topics: Anti-HIV Agents; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as T

1999
Drug interactions studied at ICAAC.
    Positive living (Los Angeles, Calif.), 1999, Volume: 8, Issue:10

    Topics: Anti-HIV Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; HIV Inf

1999
[Substance dependent patients are rarely in treatment. Step-children in HIV medicine].
    MMW Fortschritte der Medizin, 2001, Apr-02, Volume: 143 Suppl 1

    Topics: Anti-HIV Agents; Health Services Accessibility; HIV Infections; Humans; Methadone; Patient Care Team

2001
Methadone maintenance as HIV risk reduction with street-recruited injecting drug users.
    Journal of acquired immune deficiency syndromes (1999), 2001, Apr-15, Volume: 26, Issue:5

    Topics: Adult; Female; Health Behavior; Heroin; HIV Infections; Humans; Interviews as Topic; Male; Methadone

2001
Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).
    Journal of acquired immune deficiency syndromes (1999), 2001, May-01, Volume: 27, Issue:1

    Topics: Heroin; Heroin Dependence; HIV Infections; HIV-1; Humans; Methadone; Mouth Diseases; Mouth Mucosa; N

2001
Methadone stimulates in vitro infection.
    The AIDS reader, 2001, Volume: 11, Issue:6

    Topics: HIV Infections; Methadone; Narcotics

2001
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.
    AIDS (London, England), 2001, Sep-07, Volume: 15, Issue:13

    Topics: Adult; Antiretroviral Therapy, Highly Active; Female; Health Services Accessibility; HIV Infections;

2001
Access to antiretroviral therapy in HIV-infected injection drug users.
    AIDS (London, England), 2001, Sep-07, Volume: 15, Issue:13

    Topics: Antiretroviral Therapy, Highly Active; Health Services Accessibility; HIV Infections; Humans; Methad

2001
HIV risks of men in methadone maintenance treatment programs who abuse their intimate partners: a forgotten issue.
    Journal of substance abuse, 2001, Volume: 13, Issue:1-2

    Topics: Adult; Female; HIV Infections; Humans; Logistic Models; Male; Methadone; Middle Aged; Needle Sharing

2001
Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Nov-01, Volume: 33, Issue:9

    Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Drug Antagonism; Female; HIV Infections; HIV-1; Humans;

2001
A reduction in HIV positive and an increase in hepatitis C positive subjects in methadone maintenance treatments.
    Swiss medical weekly, 2001, Jul-14, Volume: 131, Issue:27-28

    Topics: Cross-Sectional Studies; Hepatitis C; HIV Infections; Humans; Methadone; Narcotics; Opioid-Related D

2001
Impact of HIV infection on mortality in a cohort of injection drug users.
    Journal of acquired immune deficiency syndromes (1999), 2001, Dec-01, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; British Columbia; Cause of Death; Cocaine; Cohort Studies; Dru

2001
Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection.
    European journal of pain (London, England), 2001, Volume: 5, Issue:4

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Infections; HIV-1; Huma

2001
Methadone enhances human immunodeficiency virus infection of human immune cells.
    The Journal of infectious diseases, 2002, Jan-01, Volume: 185, Issue:1

    Topics: Adult; Drug Interactions; Fetus; HIV Infections; Humans; Immunosuppressive Agents; Macrophages; Meth

2002
HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme.
    European journal of public health, 2001, Volume: 11, Issue:4

    Topics: Adult; Drug Prescriptions; Female; Health Policy; Hepatitis B; Hepatitis C; Heroin; HIV Infections;

2001
Irish prison guards call for expansion of methadone access.
    Canadian HIV/AIDS policy & law review, 2001, Volume: 6, Issue:1-2

    Topics: Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Ireland; Methadone; Prisons

2001
Pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase efavirenz.
    British journal of clinical pharmacology, 2002, Volume: 53, Issue:2

    Topics: Alkynes; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Infections; Humans; Methadone; Narcotic

2002
Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment.
    AIDS research and human retroviruses, 2002, Mar-20, Volume: 18, Issue:5

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Infections; Humans; Ki

2002
Methadone treatment and needle use prevention.
    Focus (San Francisco, Calif.), 2002, Volume: 17, Issue:3

    Topics: HIV Infections; Humans; Methadone; Needles; Opioid-Related Disorders; Social Conditions; Substance A

2002
Opioid receptors on white blood cells: effect of HIV infection and methadone treatment.
    Pain, 2002, Volume: 98, Issue:1-2

    Topics: Adult; HIV Infections; Humans; Leukocytes; Methadone; Receptors, Opioid; Receptors, Opioid, delta; R

2002
A pilot survey of client opinion of the Lothian Community Drug Problem Service: likes, dislikes, efficacy and improvements.
    Health bulletin, 1992, Volume: 50, Issue:1

    Topics: Community Health Services; Counseling; HIV Infections; Humans; Methadone; Patient Satisfaction; Pilo

1992
Increased use of public and private drug services after AIDS in Italy. Implications for the control of HIV spread.
    European journal of epidemiology, 1992, Volume: 8, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; HIV Infections; Humans; Italy; Methadone; Substance Abuse Treatm

1992
Establishment of a liaison service for pregnant opiate-dependent women.
    British journal of addiction, 1992, Volume: 87, Issue:6

    Topics: Adolescent; Adult; Behavior, Addictive; England; Female; Health Promotion; HIV Infections; Humans; I

1992
Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985-1991.
    AIDS (London, England), 1992, Volume: 6, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Female; HIV Infections; Humans; Incidence; Male; Me

1992
Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy.
    Drug and alcohol dependence, 1992, Volume: 30, Issue:3

    Topics: Adult; Antisocial Personality Disorder; Female; Follow-Up Studies; HIV Infections; Humans; Male; Met

1992
[4 years' methadone substitution therapy in Austria].
    Wiener klinische Wochenschrift, 1992, Volume: 104, Issue:19

    Topics: Administration, Oral; Adult; Austria; Cross-Sectional Studies; Female; Follow-Up Studies; HIV Infect

1992
[Health status of methadone recipients before entering a methadone program].
    Schweizerische medizinische Wochenschrift, 1992, Nov-14, Volume: 122, Issue:46

    Topics: Adult; Anthropometry; Demography; Employment; Female; Health Status; Hepatitis, Viral, Human; Heroin

1992
Crack cocaine use in a cohort of methadone maintenance patients.
    Journal of substance abuse treatment, 1992,Fall, Volume: 9, Issue:4

    Topics: Adult; Cohort Studies; Comorbidity; Crack Cocaine; Female; Follow-Up Studies; HIV Infections; Humans

1992
Predictors of outcome in methadone programs: effect of HIV counseling and testing.
    AIDS (London, England), 1992, Volume: 6, Issue:1

    Topics: Adult; Counseling; Female; HIV Infections; Humans; Male; Methadone; Retrospective Studies; Risk Fact

1992
Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment.
    Drug and alcohol dependence, 1992, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Australia; Cocaine; Female; Health Behavior; Health Knowledge, Attitudes, Practic

1992
Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.
    Journal of acquired immune deficiency syndromes, 1992, Volume: 5, Issue:6

    Topics: Adult; Drug Interactions; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Substance Ab

1992
Persuading general practitioners to prescribe--good husbandry or a recipe for chaos?
    British journal of addiction, 1992, Volume: 87, Issue:4

    Topics: Drug Prescriptions; Family Practice; HIV Infections; Humans; Methadone; Patient Care Team; Persuasiv

1992
[Heroin abuse and methadone substitution in pregnancy].
    Geburtshilfe und Frauenheilkunde, 1992, Volume: 52, Issue:3

    Topics: Asphyxia Neonatorum; Cardiotocography; Dose-Response Relationship, Drug; Female; Fetal Growth Retard

1992
Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme.
    AIDS (London, England), 1992, Volume: 6, Issue:4

    Topics: Hepatitis B; Hepatitis C; HIV Infections; Humans; Incidence; Methadone; Substance Abuse, Intravenous

1992
Methadone and immune function.
    The American journal of medicine, 1992, Volume: 92, Issue:1

    Topics: HIV Infections; Humans; Methadone; Narcotics; Substance Abuse, Intravenous; T-Lymphocyte Subsets

1992
HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities.
    Journal of acquired immune deficiency syndromes, 1991, Volume: 4, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; Female; HIV Infections; Humans; Male; Met

1991
Changes in cocaine use after entry to methadone treatment.
    Journal of addictive diseases, 1991, Volume: 10, Issue:4

    Topics: Adult; Cocaine; Follow-Up Studies; Heroin; HIV Infections; Humans; Methadone; New York; Prospective

1991
Sexual behaviors and HIV infection in intravenous drug users in New York City.
    Journal of addictive diseases, 1991, Volume: 10, Issue:3

    Topics: Adult; Female; Health Behavior; Heroin Dependence; HIV Infections; HIV Seroprevalence; Humans; Male;

1991
[Stabilizing the social and health status of drug dependent patients with methadone. Long-term maintainance therapy--Vienna results].
    Wiener medizinische Wochenschrift (1946), 1991, Volume: 141, Issue:14

    Topics: Austria; Heroin Dependence; HIV Infections; HIV-1; Humans; Long-Term Care; Methadone; Rehabilitation

1991
Sexual behavior, attitudes toward safer sex, and gender among a cohort of 244 recovering i.v. drug users.
    The International journal of the addictions, 1991, Volume: 26, Issue:8

    Topics: Adult; Attitude; Cohort Studies; Contraceptive Devices, Male; Female; Gender Identity; Health Knowle

1991
Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.
    BMJ (Clinical research ed.), 1990, Dec-15, Volume: 301, Issue:6765

    Topics: Adult; Cause of Death; CD4-Positive T-Lymphocytes; Cohort Studies; Confidence Intervals; Female; HIV

1990
[HIV-infected drug addicts in a clinic for infectious diseases are dissatisfied and desire more treatment].
    Lakartidningen, 1991, Mar-20, Volume: 88, Issue:12

    Topics: Adult; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Opioid-Related Disorders;

1991
The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges.
    British journal of addiction, 1991, Volume: 86, Issue:2

    Topics: Adolescent; Adult; Female; Health Behavior; HIV Infections; Humans; Male; Methadone; Needles; Opioid

1991
A prospective assessment of opiate addiction treatment protocols for inpatients with HIV-related syndromes.
    Drug and alcohol dependence, 1991, Volume: 27, Issue:1

    Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Hosp

1991
[Drug-assisted rehabilitation of HIV-infected drug-dependent prostitutes].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1990, Volume: 96

    Topics: Adult; Female; Follow-Up Studies; HIV Infections; Humans; Male; Methadone; Opioid-Related Disorders;

1990
The effect of a needle and syringe exchange on a methadone maintenance unit.
    British journal of addiction, 1990, Volume: 85, Issue:11

    Topics: Australia; HIV Infections; Humans; Methadone; Pilot Projects; Substance Abuse Detection; Substance A

1990
Edinburgh's community drug problem service--a pilot evaluation of methadone substitution.
    Health bulletin, 1990, Volume: 48, Issue:2

    Topics: Adult; Community Health Services; Female; HIV Infections; Humans; Male; Methadone; Pilot Projects; P

1990
[Methadone substitution in HIV-infected drug addicts].
    Deutsche medizinische Wochenschrift (1946), 1990, Jun-08, Volume: 115, Issue:23

    Topics: Adult; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone

1990
[Experiences from two HIV prevention projects among drug abusers in Oslo. Is methadone maintenance treatment useful?].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1990, Jun-10, Volume: 110, Issue:15

    Topics: Adolescent; Adult; Female; HIV Infections; Humans; Male; Methadone; Norway; Substance-Related Disord

1990
Risk behaviour for HIV transmission in attenders on methadone maintenance.
    Irish journal of medical science, 1990, Volume: 159, Issue:5

    Topics: Adolescent; Adult; Female; HIV Infections; Humans; Ireland; Male; Methadone; Needles; Risk Factors;

1990
The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour.
    AIDS (London, England), 1989, Volume: 3, Issue:9

    Topics: Adult; Age Factors; Communicable Disease Control; Disinfection; Evaluation Studies as Topic; Female;

1989
[Medical and psychosocial effects of methadone substitution in HIV infected substance-dependent patients].
    Psychotherapie, Psychosomatik, medizinische Psychologie, 1989, Volume: 39, Issue:11

    Topics: Adult; Female; Follow-Up Studies; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Prospe

1989
Drug problems in Amsterdam.
    The Practitioner, 1989, Nov-08, Volume: 233, Issue:1478

    Topics: Drug and Narcotic Control; Heroin Dependence; HIV Infections; Humans; Methadone; Netherlands; Risk F

1989
HIV risk behavior: antisocial personality disorder, drug use patterns, and sexual behavior among methadone maintenance admissions.
    NIDA research monograph, 1989, Volume: 95

    Topics: Antisocial Personality Disorder; Health Behavior; HIV Infections; Humans; Methadone; Opioid-Related

1989
HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report.
    NIDA research monograph, 1989, Volume: 95

    Topics: Adult; Cocaine; Depression; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Risk

1989
Psychiatric symptoms in HIV test consenters and refusers.
    NIDA research monograph, 1989, Volume: 95

    Topics: AIDS Serodiagnosis; HIV Infections; Humans; Methadone; Opioid-Related Disorders; Patient Compliance;

1989
Intravenous heroin use: its association with HIV infection in patients in methadone treatment.
    NIDA research monograph, 1989, Volume: 95

    Topics: Adult; Heroin Dependence; HIV Infections; HIV Seroprevalence; Humans; Methadone; New York City; Risk

1989
Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program.
    Annals of internal medicine, 1989, Nov-01, Volume: 111, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; Female; HIV Infections; Humans; Male; Methadone

1989